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ABSTRACT
Burkholderia cepacia isolates were obtained from the sputum of cystic fibrosis patients 
or isolated from the environment. The isolates were characterised phenotypically by 
determining antibiotic resistance profiles and their ability to macerate onion tissue, and 
genetically by PCR ribotyping and macro-restriction analysis (genome fingerprinting). 
The replicon (chromosomal) organisation was determined by pulsed field gel 
electrophoresis (PFGE) and the presence of plasmids was also investigated. Plasmid 
transfer by conjugation was also investigated.
A high degree of genetic and phenotypic variation was found both within and between 
clinical and environmental populations of B. cepacia. Environmental isolates were 
generally less resistant to antibiotics but showed greater ability to macerate onion 
tissue. Genetic characterisation showed little evidence of acquisition ofB. cepacia 
from the environment by CF patients, but revealed strong evidence supporting person- 
to-person transmission of B. cepacia in the Cardiff CF centre and other European 
centres.
Two or more chromosomes were found in 93 % of B. cepacia isolates tested, and were 
also found in other closely related species suggesting such organisation may be 
common in P-2 proteobacteria. Plasmids, often in excess of 100 kb, were found to be 
harboured in 52 % of isolates, though were more commonly found in CF isolates (65 % 
of isolates) than environmental isolates (23 % of isolates). Plasmid transfer by 
conjugation was demonstrated into, between and from B. cepacia strains. Evidence of 
plasmids encoding antibiotic resistance was also found
l
CONTENTS
PAGE
ABSTRACT 1
CONTENTS 2
PUBLICATIONS 9
TABLE OF FIGURES 10
ACKNOWLEDGMENTS 11
LIST OF ABBREVIATIONS 13
CHAPTER 1 General Introduction 14
1.1 Burkholderia cepacia 14
1.1.1 History and taxonomy 14
1.1.2 Characteristics of B. cepacia 19
1.1.3 Genetic organisation ofB. cepacia 20
1.1.4 Clinical importance of B. cepacia 23
1.2 Cystic fibrosis and microbiology of CF . 26
1.2.1 Cystic fibrosis 26
1.2.2 Microbiology of CF: General considerations 29
1.2.3 Staphylococcus aureus 30
1.2.4 Pseudomonas aeruginosa 31
1.2.5 Haemophilus influenzae 33
\2 .6  Stenotrophomonasmaltophilia 33
1.2.7 Other bacterial, fungal and viral agents 34
1.3 B. cepacia in cystic fibrosis 35
1.3.1 B. cepacia respiratory disease 36
1.3.2 Virulence fhctors & immune evasion 38
1.4 Isolation and identification of B  cepacia 43
1.4.1 Isolation of£. cepacia 43
1.4.2 Identification 45
1.4.3 Typing 48
1.5 Epidemiology of R  cepacia in CF 53
1.5.1 Person to person transmission 53
2
1.5.2 Non-CF infections 56
1.6 JBL cepacia in the environment 58
1.6.1 B. cepacia as a phytopathogen 58
1.6.2 Production of antibiotics and biocontrol by B. cepacia 59
1.6.3 B. cepacia biodégradation and bioremediation 62
1.7 Antibiotics and antimicrobial chemotherapy and their 65 
use in B. cepacia infections
1.7.1 Action of antimicrobial drugs 65
1.7.2 Drugs that inhibit cell wall synthesis 65
1.7.3 Drugs that inhibit protein synthesis 67
1.7.4 Drugs that inhibit nucleic acid synthesis 69
1.7.5 Drugs that inhibit membrane integrity 71
1.7.6 Antibiotic uptake 72
1.7.7 Antibiotic therapy in B. cepacia infection 72
1.8 Antibiotic resistance in B. cepacia 76
1.8.1 Mechanisms of resistance 76
1.8.2 Intrinsic and acquired resistance in B. cepacia 77
1.9. Plasmids in B. cepacia 82
1.9.1 Antibiotic resistance plasmids in B. cepacia 84
1.9.2 Degradative plasmids in B. cepacia 86
1.10 Comparative properties and relationships of clinical 88
and environmental 5L cepacia isolates <>'
1.10.1 Epidemiology of environmental and clinical isolates 90
1.11 Aims of study 92
CHAPTER 2 Isolation and typing of Burkholderia cepacia 93
2.1 Introduction 93
2.2 Materials and methods 94
2.3 Results 105
2.3.1 Environmental survey #1 105
3
2.3.2 Growth ofB. cepacia and other species 106 
on selective media
2.3.3 Environmental survey #2 111
2.3.4Recovery rates of B. cepacia in Environmental 113
Surveys #1&#2
2.4 Discussion 114
2.4.1 Assessment of selective media 114
2.4.2 Recovery rate of B. cepacia from the environment 117
2.4.3 Efficacy of selective media in environmental and 119 
clinical isolation of B. cepacia
2.4.4 Isolation and identification of B. cepacia : 121 
General considerations
CHAPTER 3 Phytopathogenicity of Burkholderia cepacia 122
3.1 Introduction 122
3.2 Materials and methods 123
3.3 Results 127
3.3.1 In vitro maceration of onion tissue 127
3.3.2 Quantitative test of onion maceration 132
3.4 Discussion 135
3.4.1 In vitro maceration of onion tissue- 135
3.4.2 Development of a quantitative assay of onion 136 
maceration
CHAPTER 4 Antibiotic resistance and susceptibility of 138
Burkholderia cepacia
4.1 Introduction 138
4:1.1 Kirby Bauer disc diffusion test 138
4.1.2 Determination of minimum inhibitory concentration 140 
(MIC) by agar dilution
4.2 Materials and methods 142
4
4.3 Results 145
4.3.1 Kirby Bauer disc diffusion test for determination of 145 
antibiotic reisitance/susceptibility
4.3.2 MIC determination by agar dilution 153
4.4 Discussion 157
4.4.1 Antibiotic resistance/susceptibility 157
4.4.2 MIC determination 160
4.4.3 Resistance in environmental and clinical isolates 162
4.4.4 Antimicrobial resistance/susceptibility: 163 
General considerations
CHAPTER 5 Isolation and purification of plasmid DNA from 165
Burkholderia cepacia
5.1 Introduction 165
5.1.1 Principles of plasmid DNA isolation and purification 165
5.1.2 Plasmid isolation and detection in B. cepacia 169
5 .1.3 Methods for detection and purification of plasmid DNA 169
used in this study
5.2 Materials and methods 170
5.3 Results 178
5.3.1 Isolation of plasmid DNA t' 178
5.3.2 Estimation of plasmid size and distribution of plasmids 181
5.3.3 Isolation of plasmid DNA for transformation and 188 
plasmid mapping studies
5.3.4 Amplification of plasmid DNA by growth in Terrific Broth 188 
and by chloramphenicol amplification
5.4 Discussion 189
5.4.1 Detection of plasmid DNA 189
5.4.2 Sizing ofB. cepacia plasmids 191
5.4.3 Distribution and sizes of plasmids 1 193
5
5.4.4 Isolation of B. cepacia plasmid DNA for restriction 194 
mapping and transformation studies
5.4.5 Improvements, alternatives and future work 195
CHAPTER 6 Plasmid curing and its effect on phenotype 197
6.1 Introduction 197
6.2 Materials and methods 198
6.3 Results 201
6.3 .1 Loss of antibiotic resistance by curing 201
6.3.2 Investigation of plasmid loss 202
6.4 Discussion 210
CHAPTER 7 Conjugal transfer of plasmid DNA in Burkholderia cepacia 213
7.1 Introduction 213
7.1.1 Investigation of conjugal transfer of plasmid DNA 213
7.1.2 Conjugative DNA transfer in the epilithon 214
7.2 Materials and methods 216
7.3 Results 226
7.3.1 Transfer of broad host range plasmids 226
7.3.2 Transfer of antibiotic resistance between B. cepacia strains 232
7.3.3 Exogenous isolation of mercury resistance plasmids 233 
from river epilithon with a B. cepacia recipient
7.4 Discussion 234
7.4.1 Conjugal transfer of broad host range plasmids 234
7.4.2 Transfer of piperacillin resistance between B. cepacia 238 
strains
7.4.3 Exogenous isolation of mercury resistance plasmids 239 
from the environment
7.4.4 General considerations and future work 239
6
CHAPTER 8 Typing of Burkholderia cepacia isolates 240
8.1 Introduction 240
8.1.1 PCR Ribotyping 240
8.1.2 Typing of B. cepacia by macrorestriction analysis 241
8.2 Materials and methods 244
8.3 Results 253
8.3.1 PCR ribotyping 253
8.3.2 Macrorestriction analysis 256
8.4 Discussion 260
8.4.1 Typing of B. cepacia by PCR ribotyping and 260 
macrorestriction analysis
8.4.2 Significance of typing results 261
8.4.3 Failure of specific PCR primers 263
8.4.4 Problems with, and improvements to methods 263
CHAPTER 9 Investigation of multiple replicons in Burkholderia cepacia 266
9.1 Introduction 266
9 11 Multiple bacterial replicons 266
9.1.2 Detection of rRNA genes on multiple replicons 267
9.2 Materials and methods 269
9.3 Results 272
9.3.1 Detection of multiple replicons ‘ 272
9.3.2 Size estimation of large replicons in B. cepacia 282
9.3.3 Detection of rRNA genes on multiple replicons by 289 
PCR ribotyping
9.4 Discussion 290
9.4.1 Multiple replicons in B. cepacia 290
9.4.2 Multiple replicons in other species 294
9.4.3 Identification of rRNA genes on replicons by 295 
PCR ribotyping
7
9.4.4 Identification and sizing of multiple replicons: 
improvements and alternatives
297
CHAPTER 10 General discussion and conclusions 299
10.1 K  cepacia in the environment 299
10.2 Relationship between clinical and environmental isolates of 304
B. cepacia
10.3 Genetic organisation of R  cepacia 307
10.4 Conclusions 312
REFERENCES 316
APPENDICES 346
Appendix I Reagents and Media 346
Appendix II Composition of media in commercial plasmid 351
isolation kits
8
PUBLICATIONS
Material contained within Chapters 3,4,5 & 8 of this thesis has been published as: 
Wigley, P. & Burton, N.F. (1999) Genotypic and phenotypic relationships in 
Burkholderia cepacia isolated from cystic fibrosis patients and the environment. 
Journal o f Applied Microbiology in press.
Material contained in Chapter 9 forms part of a paper submitted for publication: 
Burton, N.F. & Wigley, P. (1999) Multiple chromosomes in Burkholderia cepacia and 
Burkholderia gladioli, and their distribution in clinical and environmental strains of 
Burkholderia cepacia. Submitted to Journal o f Applied Microbiology.
9
TABLE OF FIGURES
Figure No. Title Page
1.1 History and taxonomy of Burkholderia cepacia 5
5.1 Standard plot of logu molecular size against logio distance 182
travelled for K  coli V517 plasmids
5.2 Frequency distribution of plasmids in B. cepacia 187
9.1 Plot of molecular size against distance travelled for H. wingei 283
marker
9.2 Frequency distribution of large replicons numbers in B. cepacia 287
isolates investigated in this study
10
ACKNOWLEDGMENTS
There seem almost too many people to thank who have helped or provided support to 
me during the last few years Firstly I would like to thank Professor Tony Hazell for 
providing the initial opportunity for this work and his continued support and 
encouragement throughout the project, and Dr Maureen Bowen for both the financial 
support and for considerable encouragement throughout the project and also for the 
determination that the project would be successful
Within the School of Biomedical Sciences I have received tremendous support from 
everyone, but I would particularly like to thank Alex, Amanda, Bob Munro, Malcom 
Edwards, Rose Cooper and Keith Morris for his help with the statistical and 
mathematical analysis. I would like to especially thank all the secretarial and technical 
staff and in particular Lynda Chadwick for her help with the identification of bacterial 
isolates, Gareth Walters and Paul Joseph for transport and general help, Sean Duggan 
for help with several of the figures and conducting the environmental sampling and 
Carol James for her computing and technical skills. Outside UWICI would like to 
thank Dr Henry Ryley, Department of Medical Microbiology UWCM, for his expert 
help and advice with the PCR ribotyping and Mr. Alan Pauli, Chief MLSO, PHLS, 
Cardiff, for kindly providing the B. cepacia isolates from CF patients. I would like to 
give my deepest thanks to my supervisory team for all their advice and help; Dr Ken 
Jones at UWIC, Dr Martin Day at UWCC and especially Dr Neil Burton at UWIC. I 
thank Neil and his family (Penny, Bronwen and Jack) for all their support and 
encouragement.
11
On a personal note I would like to thank Treorchy Rugby, Swansea City Football and 
Glamorgan County Cricket Clubs for being a release of frustration (or cause 
sometimes!). I would like to thank all my friends and family for the support and love 
over the last few years and in particular David, Margaret and Andrew Jenkins, my 
brother Marcus and Sharon, Brian and my Mother. Many thanks to you all. Finally I 
wish to thank three people; Alison for all your love and support and my grandparents 
Alice and the late Robert Tabor. I sincerely wish that Bob could have seen this work 
completed and I would like to dedicate this to your memory.
12
LIST OF ABBREVIATIONS
NA nutrient agar
NB nutrient broth
DST diagnostic sensitivity test
LB Luria-Bertani broth
EDTA ethylenediaminetetra acetic acid
Tris tris(hydroxylmethyl) methylamine
SDS sodium dodecyl sulphate
DNA deoxyribonucleic acid
RNA ribonucleic acid
rRNA ribosomal ribonucleic acid
PCR polymerase chain reaction
PFGE pulsed field gel electrophoresis
MLEE multilocus enzyme electrophoresis
RFLP restriction fragment length polymorphism
CF cystic fibrosis
CFTR cystic fibrosis transmembrane regulator
NCIMB National Collection of Industrial and Marine Bacteria
NCPPB National Collection of Plant Pathogenic Bacteria
NCTC National Collection of Type Cultures
ATCC American Type Culture Collection
v/v Volume/volume
w/v weight/volume
MIC minimum inhibitory concentration
V cm'1 Volts per centimetre
bp base pairs
kb kilobase pairs
Mb megabase pairs
Da Daltons
kDa kilodaltons
MDa megadaltons
Chanter 1 General introduction
1.1 Burkholderia cepacia
Burkholderia cepacia is a Gram negative rod-shaped bacterium. It is important 
clinically, particularly causing respiratory infections in cystic fibrosis patients, and in the 
environment as a phytopathogen and as a potential agent of bioremediation and 
biocontrol (Govan et al 1996).
1.1.1 History and taxonomy
In 1950 Walter H Burkholder first described the causative organism of "Sour skin" 
onion rot, commonly found in New York state, U.S.A. This is a bacterial rot that 
affects onion bulb scales resulting in a characteristic sour, vinegar-like smell, hence its 
name. He described the pathogen as a yellow pigmented, non-fiuorescent, Gram 
negative, non-spore-forming rod of around lto2.8 pm in length, with 1 to 3 polar 
flagellae. His description placed the bacterium within the genus Pseudomonas and so 
he named it Pseudomonas cepacia from the Latin noun caepa or cepa meaning onion. 
Burkholder had previously described 2 other phytopathogenic pseudomonads. Ps. 
allicola and Ps. carophylli, now known to be close relatives of B. cepacia.
In 1959 Morris and Roberts published studies on unnamed organisms isolated from 
water and soils in Trinidad. Stanier and co-workers (Stanier et al 1966) further studied 
the strains of Morris and Roberts along with clinical and further soil isolates. They 
named the organism Ps. multivorans (Latin-eater of everything), based upon the ability 
of the strains to utilise a large range of organic compounds as sole carbon, and energy
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sources. In 1970 synonymy between Ps. multivorans and Ps. cepacia was established 
(Ballard et al 1970), and its description enlarged upon. In the same year Jonsson 
proposed a new species 'Ps, kinga' based on the work of King who had previously 
described an organism found in clinical isolates as Eugonic oxidiser (EO -1) as it could 
grow on most media and use most carbohydrate sources (King 1964, Jonsson 1970).
In 1972 "Ps. kingii" was established (Snell et al 1972) as a synonym o f Ps. cepacia, 
giving Ps. cepacia priority in the nomenclature.
In 1973 Palleroni and co-workers divided the genus Pseudomonas into five groups, as 
there were great differences of phenotypic properties within the genus. The 
categorisation was based upon rRNA-DNA hybridisation, with the genus type species 
Ps. aeruginosa placed into RNA homology group I. Ps. cepacia was placed into 
group II along with four other phytopathogens. Ps. gladioli (previously known as Ps. 
marginata or Ps. allicola), Ps. carophylli, Ps. solanacearum and Ps. pickettii, and the 
animal pathogens Ps. mallei and Ps. pseudomallei.
The name Ps. cepacia was omitted from the Approved List of Bacterial names in 1980 
and so lost its validity, however a year later Palleroni and Holmes (1981) revived the 
name on the basis of Ballard's work a decade earlier. Grouping by the methods of 
Woese (1987) placed this group in the P-proteobacteria with species such as 
Alcaligenes eutrophus, and Ps. aeruginosa in the y-proteobacteria group.
In 1992 it was proposed that the RNA homology group II should be transferred to the
h
new genus Burkholderia, after W. H. Burkholder (Yabuuchi et al 1992). The transfer
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was based upon similarities in the seven constituent members' 16S rRNA sequences, 
fatty acid and cellular lipid composition and phenotypic characteristics, as compared 
with other members of the Pseudomonas genus, in particular the type species Ps. 
aeruginosa. Therefore seven new combinations: B. cepacia, B. gladioli, B. carophylli, 
B. solanacearum, Burkholderia pickettii, B. mallei and B. pseudomallei were 
proposed. In 1993 these were validated (List No 45 Int. J. Syst. Bacteriol) with B. 
cepacia as the type species. Subsequently several other Pseudomonas and newly 
described species have been placed in the genus Burkholderia including B. plantarii, B. 
glumae, B. vandii and B. vietnamensis (Urakami et a/ 1994).
Recent work has highlighted great phenotypic and genetic variation within the B. 
cepacia nomenspecies. A study of metabolic properties in a range of clinical and 
environmental isolates of B. cepacia, including catabolic properties and 
phytopathogenicity to onion, gave four phenetic clusters or phenoms upon statistical 
analysis of the results (Yohalem and Lorbeer 1994). DNA-DNA and DNA-ribosomal 
RNA (r-RNA) hybridisation analysis, along with analysis of fatty acid and cellular 
protein composition revealed that B. cepacia isolates from cystic fibrosis patients in 
Belgium and the UK fell in three distinct groups, different firom the type strain of the 
species (Vandamme 1995, Revets et al 1996, Govan et al 1996). Differing genomic 
groups within a nomenspecies that cannot be readily differentiated phenotypically at 
present have been proposed to be called genomovars (Ursing et al 1995). It was 
proposed that genomovars should be numbered with the species type strain being 
placed in genomovar I. It is also suggested that each genomovar should have an 
individual type strain. In B. cepacia the species type strain ATCC 25416 (NCPPB
2993) has been placed into genomovar I together with the majority of environmental 
isolates so far analysed by DNA-DNA hybridisation (Govan et al 1996). The majority 
of CF isolates group into genomovar HI. Subsequently it has been proposed that B. 
cepacia be divided into five distinct genomic groups, with genomovar n  being re­
classified as a separate species, Burkholderia multivorans, within the B. cepacia 
complex (Vandamme et al 1997). It has also been proposed that several of the genus 
Burkholderia be re-assigned to the newly proposed genus Ralstoriia (Yabuuchi et al 
1995), and that Ps. phenazium, Ps. pyrrocinia and Ps. glathei be transferred to the 
genus Burkholderia along with the newly discovered rhizospheric bacterium 
Burkholderia graminis (Vandamme et al 1997, Viallard et al 1998).
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Figure 1.1 History and Taxonomy of Burkholderia cepacia.
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Palleroni et al 1973 
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1.1.2 Characteristics of R  cepacia
The characteristics of B. cepacia are much as originally described by Burkholder 
(Palleroni, 1984). It is an aerobic, glucose non-fermenting rod, 1.6 to 3.2 pm long, 0.8 
to 1.0 pm in diameter. It is non-fluorescent and may produce a green-yellow pigment, 
though more frequently colonies are white or cream in colour.
B. cepacia is an ubiquitous organism. It has been found in water and soils (Morris and 
Roberts 1959), plants (Burkholder 1950), a wide range of fomites in hospitals and a 
number of clinical specimens (Gilardi 1983, Holmes 1986).
B. cepacia is biochemically diverse and can oxidise a large number of compounds as a 
carbon source. A large number of carbohydrates and polyalcohols may be utilised as 
well as a diverse range of compounds including Penicillin G, aromatic compounds, and 
chlorinated aromatic compounds recalcitrant to biodégradation (Holmes 1986).
Plasmids appear to play a role in some of these catabolic processes. A role has been 
demonstrated in the degradation of the herbicide 2,4 dichlorophenoxyacetate (2,4 -D) 
(Bhat et al 1994) and degradation of toluene (Shields et al 1995) in strains of B. 
cepacia.
B. cepacia is resistant to several disinfectants including solutions of benzalkonium 
chloride and chlorhexidine gluconate (sold under the tradename of Savlon) (Holmes
1985). Resistance to a wide range of antimicrobial agents is also found (discussed in 
detail later).
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1.1.3 Genetic organisation of & cepacia
Relatively little is known about genetic organisation in B. cepacia. It is apparent that 
the genome contains large numbers of insertion sequences and that these play a role in 
the genomic plasticity of B. cepacia and its' degradative ability (Byrne and Lessie 
1994, Cheng and Lessie 1994). However there is little known regarding the 
distribution of these insertion sequences or gene organisation.
Genome organisation
B. cepacia has a large genome of around 6.5 Mb to 8.1 Mb. This is larger than the 5.8 
Mb genome oîP s aeruginosa and is around twice the size of the average prokaryotic 
genome (Grouthes and Tummler 1991, Cheng and Lessie 1994, Rodley et al 1995).
The use of pulsed field gel electrophoresis has revealed that the genome of B. cepacia 
is arranged into multiple circular replicons rather than a single circular chromosome 
(Cheng and Lessie 1994, Rodley et al 1995). Cheng and Lessie (1994) described the 
organisation of the genome ofB. cepacia strain ATCC 17616 into three circular 
replicons of 3.4, 2.5 and 0.9 Mb, along with a cryptic plasmid of 170 kb, giving an 
overall genome size of 7.0 Mb. Southern hybridisation studies showed that each of the 
large replicons contained rRNA genes and previously identified insertion sequences. 
Rare cutting restriction enzymes were used to map the replicons. The transposon Tn5- 
751s containing a Swa I recognition site was used to inactivate and hence map the 
position of genes by insertional mutagenesis. This indicated that the 3.4 Mb replicon 
contains genes encoding for the amino acids isoleucine, arginine, histidine and 
threonine, whilst the 2.4 Mb replicon contains genes encoding for the synthesis of 
lysine, p-lactamase activity and the use of ribital and trehalose as carbon sources.
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Rodley and co-workers (1995) produced a restriction map of the B. cepacia type strain 
ATCC 25416 (or NCPPB 2993). They also described three large circular replicons of 
3.65 Mb, 3.17 Mb and 1.07 Mb along with a 200 kb plasmid, a total genome size of 8.1 
Mb. Three other B. cepacia strains were also analysed. These gave multiple replicons 
of 3.5 Mb and 1.0 Mb, though analysis of restriction fragments showed the genome to 
be somewhat larger suggesting that the 3.5 Mb replicon band may be two replicons of 
similar size. Other closely related bacteria of the P-2 subdivision of proteobacteria 
(Woese 1987) were also demonstrated to have multiple replicons. B. glumae contained 
replicons of 3 and 3.8 Mb, whilst B. picketti, B. solanacereum, Alcaligenes eutrophus 
and Ps. glathei all contained more than one replicon, though nothing was detected in B. 
gladioli. Strains from the neighbouring and more distantly related p-1-subdivision did 
not appear to contain multiple replicons. Lessie et al (1996) have subsequently 
determined the replicon organisation of 12 B. cepacia strains. Between two and four 
replicons were found with a total genome size of 4.6 to 8.1 Mb.
The presence of multiple replicons differs from the traditional view of a single circular 
chromosome in bacteria though there is evidence for multiple replicons in the afore 
mentioned species and in unrelated species including a  proteobacteria such Rhizobium 
meliloti where three circular replicons of 3.4, 1.7 and 1.4 Mb have been observed 
(Sorbal et al 1991,Honeycutt et al 1993), Agrobacterium tumefaciens which appears 
to have both a circular 3 Mb and linear 2.1 Mb chromosome (Allardet-Servet et al
1993) whilst linear chromosomes have been described in Borrelid and Streptomyces 
(Hinnebusch and Tilly 1993).
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Insertion sequences
B. cepacia has a genome rich in insertion sequences or IS elements (Cheng and Lessie
1994). IS elements are small (less than 2 kb) transposable elements that carry no genes 
unrelated to their insertion function (Reviewed by lidia et al 1983). IS elements have 
been identified in many prokaryotic and eukaryotic organisms. Their ability to undergo 
transposition (homologous recombination-independent transfer) to new sites and 
replicons and duplication are characteristic features that have genetic consequences in 
deletion, insertional inactivation, fusion of independent replicons and transcriptional 
activation of genes (Haugland et al 1990).
The IS elements in B. cepacia has implications in the promotion of genetic 
rearrangement of plasmid and chromosomal replicons (Byrne and Lessie 1994). IS 
elements have been found to play a role in gene activation by increasing expression of 
the p-lactamase gene on the plasmid pRPl up to thirty fold (Scordilis et al 1987), in 
activation of the transposon Tn7 bla gene on plasmid pTGL52 (Ferrante and Lessie 
1991) and in the activation of lac genes in B. cepacia and other Gram-negative bacteria 
(Wood et al 1990, Wood et al 1991). IS elements are thought to play a role in 
obtaining foreign genes for catabolic functions such as degradation of 2,4,5 trichloro- 
phenoxyacetic acid (2,4,5,-T) (Haugland eta l 1990) or P-lactam antibiotics (Scordilis 
et al 1987).
The above evidence has given rise to the thought that IS elements play a role in the 
broad catabolic and biodegradative properties of B. cepacia as well as its genomic 
plasticity both by genetic rearrangement and recruitment of foreign DNA from
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conjugative plasmids and transposons to develop degradative pathways, and by the 
ability to express ‘foreign’ genes at high levels (Cheng and Lessie 1994).
1.1.4 Clinical Importance of B. cepacia
In the 1980's B. cepacia emerged as an important pathogen in CF respiratory disease. 
Reports from Canada (Isles et al 1984) described an adverse outcome for a number of 
patients. Such reports were confirmed in centres in N. America (Tablan et al 1985, 
Thomassen et al 1985) and in the UK (Simmonds et al 1990).
An increase in affected patient numbers throughout the late 1980's into the early 1990's 
have given rise to great concern, particularly in the light of growing evidence of person 
to person transmission. (Millar-Jones et al 1992, Govan et al 1993, Walters and Smith 
1993). Of particular concern is evidence .of strains causing a necrotising pneumonia 
(Tomashefski et al 1988) and the high levels of antimicrobial resistance displayed by 
the organism (Santos Ferreira e ta l 1985, Kumar e ta l 1989).
Although B. cepacia infection is an increasingly serious problem in CF, it is generally 
regarded as a low grade pathogen. B. cepacia is not a frequent human pathogen, most 
isolates being present as saprophytes or commensals. However B .cepacia may act as 
an opportunistic agent in compromised patients such as diabetics, intravenous drug 
users, alcoholics and immunocompromised patients as well as cystic fibrosis sufferers. 
(Gilardi 1983). The ability ofB. cepacia to grow in antiseptic, anaesthetic and 
disinfectant solutions, as well as distilled or deionized water, mark it down as a 
potentially dangerous source of nosocomial infection.
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In 1986 Holmes reviewed the sources of 195 strains of B. cepacia sent to the national 
collection of type cultures (NCTC) for identification. These represented around 4% of 
the total Gram negative, non fermenting bacteria sent for identification. Most clinical 
isolates were isolated in the US or UK from sources including blood, sputum, vaginal 
fluid, urine, bronchial washings and synovial fluid. The majority of clinical isolates 
were obtained from compromised patients, though not CF patients, whilst a number 
were isolated from contaminated medical materials such as disinfectants. Amongst the 
cases reviewed urinary tract infections had occurred from the use of contaminated 
catheters or catheter irrigation fluid, though these were largely asymptomatic and most 
ceased upon removal of the catheter, septicaemia with endocarditis caused by B. 
cepacia had arisen following heart surgery. B. cepacia endocarditis, sometimes fatal, 
has also been reported in intravenous drug users. B. cepacia septicaemia has also been 
fatal in bums patients and wound infections have occurred due to the application of 
contaminated antiseptic and disinfectant solutions, whilst a case of septic arthritis was 
reported following the intra-articular injection of contaminated methyl-prednisilone. 
More recently an outbreak of B. cepacia bacteremia occurred in an oncology clinic in 
Alabama (Pegues et al 1993). This case was traced back to a contaminated heparin 
flush solution, used to flush venous catheters
Several cases of respiratory disease in non-CF patients have been reported (Holmes
1986) though in each case the patient was found to be compromised in some way. An 
individual developed a case of necrotising pneumonia after cleaning air conditioning 
systems. After treatment he recovered but the pneumonia recurred. Upon further 
investigation a phagocyte dysfunction was found. In children with a similar condition,
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chronic granulomatous disease (CGD), there is an association with B. cepacia 
colonisation and pneumonia in several reported cases( Speert et a/1994). À fatal 
pneumonia has also been described in a diabetic, after therapy with an ultrasonic 
nebuliser. The source of 5. cepacia in this case was found to be contamination of the 
nebuliser reservoir.
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1.2 Cvstic fibrosis and microbiology of CF
1.2.1 Cystic fibrosis
Cystic fibrosis is the most common lethal hereditary disease in Caucasian populations.
It is typified by thick secretions and recurrent bacterial respiratory infections. The 
disease is the result of an abnormal chloride channel protein. Anderson (1938) first 
described Cystic Fibrosis (CF) in a group of 49 children who failed to thrive despite 
feeding. The children had "distended abdomens and attacks of diarrhea with large, 
pale, foul smelling stools". The stools were found to have a high ratio of "split fats". 
Children who died in the neonatal period were found to have lesions of the pancreas, 
hence the term "Cystic Fibrosis of the Pancreas" was coined.
CF most commonly affects people of European origins, affecting around 1 in 2000 live 
births in Caucasians. (Tsui 1992) The gene carrier frequency is estimated to be between 
2 to 5 % of the general Caucasian population (Tsui 1992). It is fer less common in 
Blacks and Orientals where the incidence is about 1 in 100,000 live births. The 
suggestion has been put forward that the prevalence in the Caucasian population may be 
due to a selective advantage for CF gene carriers (Tsui 1992).
CF occurs as a result of abnormal secretion. This is due to a chloride channel defect in 
epithelial cells The secretions contain too little water relative to the proteins and 
electrolytes within them. This results in the characteristic thick mucus 
(mucoviscoidoses), and also the high concentrations of sodium and chloride in sweat. 
The measurement of sodium in sweat is the main diagnostic test for CF.
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The clinical manifestations of CF can range from a mild, almost asymptomatic 
condition, to a very severe disease causing death within a year of birth. The most 
serious problem is respiratory tract infection. Because of the inability of the patient to 
clear the thick, viscous mucus in the bronchial airway, the patient is susceptible to 
recurrent infections by a range of micro-organisms, including Staphylococcus aureus, 
Ps. aeruginosa, Haemophilus influenzae and B. cepacia. The establishment of 
encapsulated, antibiotic resistant strains of bacteria cause a progressive deterioration of 
lung tissue and eventually to loss of lung function; the most common cause of death.
In children the disease commonly presents with recurrent upper and lower respiratory 
tract infection resulting in bronchiectasis, the persistent dilation of bronchi and 
bronchioles (Wormsleyl986). This is usually saccular in nature, and is typified by 
coughing with purulent sputum, wheezing, progressive dyspnoea and finger clubbing.
In adults bronchiectatic infection is also common. This may be accompanied by 
pneumothorax, respiratory failure and corpulmonale.
Pancreatic insufficiency is the second most important clinical manifestation of CF. In 
many cases from early in life, or even at birth, the pancreatic ducts may become 
blocked by impissated secretions. This leads to dilation of the ducts, followed by 
inflammation, and then to deterioration of the pancreas leading to the loss of the 
digestive enzyme producing acinar tissue, which is replaced by fat and fibrous tissue. 
The result is pancreatic exocrine insufficiency, which may lead to steatorrhoea, 
creatorrhoea and diarrhoea. The reduction in production of pancreatic juice containing 
amylase, protease and lipase digestive enzymes, along with possible blockage of the bile
duct leads to digestive disorders, such as those above, and may lead to undemutrition 
in infants. It also explains the "high level of split fats" in stools, described by Anderson 
(1938)
The genetic defect leading to CF was mapped to a single gene on chromosome 7 band 
q31. The function and predicted structure of the CF gene product has been reviewed 
extensively by Riordan (1993). The resulting product is a cAMP induced chloride 
channel expressed in epithelial cells known as the Cystic Fibrosis Transmembrane 
Regulator (CFTR). By late 1992 more than 230 different CFTR mutations had been 
found (reviewed by Tsui 1992). Initially it had been thought that only a few mutations 
might occur, as suggested by the AF508 mutation, a mutation in a phenylalanine 
residue at position 508, occurring in around 70% of CF patients and the strong 
association found between haplotype and allele. The majority of CF patients have a 
form of the disease as caused by the AF508 mutation. At the end of 1992 some 30,000 
mutant chromosomes had been analysed world-wide (Tsui 1992). 67% were found to 
carry the AF508 mutation, with only another 7 mutations occurring in more than 100 
cases. The frequency and distribution of CFTR mutations also seems to follow a s 
pattern. In parts of Scandinavia and the UK the ÀF508 mutation runs in over 90% of 
CF patients. This falls in a south easterly direction to 55% in Milan and as low as 22% 
in the Ashkenazic Jewish population of Jerusalem. In the latter group, 60% of CFTR 
mutations are the W1282X mutation, found in 2% of the world-wide CF population 
(Tsui 1992).
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The use of gene therapy in CF has been proposed, with both adenovirus and liposome 
delivery systems having been used in limited trials (Johnson 1995). However this has 
been of limited success, with no immediate prospect of clinical use.
1.2.2 Microbiology of C F.: general considerations
Chronic progressive lung disease due to bronchopulmonary infection is the most 
important pathological consequence of CF; 90 % of deaths result from 
bronchopulmonary disease. As a result of the defective CFTR gene, there is viscous 
mucus found in the airways and along with defects in respiratory epithelia this leads to 
defective mucocilliary clearance of infective agents, and hence the pathological 
consequences discussed earlier. The microbiology of these infective agents has been 
reviewed by Gilligan (1991) and Govan and Nelson (1992). It has been recently 
proposed that the defective CFTR -associated chloride transport may lead to 
colonisation of bacteria in the lung. (Smith et cd 1996). Normal lung epithelium 
appears to have a bactericidal effect against both S. aureus and Ps. aeruginosa but the 
high sodium chloride concentrations found in CF inhibit this, leading to decreased 
ability to kill the bacteria and increased susceptibility to infection.
Upon birth, the lungs of CF patients are histologically normal, but infections are soon 
detected. These occur mainly in the major and minor airways rather than the alveoli. 
The infections are insidious and recurrent, eventually leading to chronic colonization 
with bacteria. A relatively narrow spectrum of infectious agents infect CF patients, 
however as antimicrobial therapy has led to an increased life expectancy, the spectrum
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of opportunistic and infective agents has increased, most notably to now include B. 
cepacia and Mycobacterium.
The bacteria most commonly found to cause chronic infection in CF are S. aureus and 
Ps. aeruginosa. In a 1986 survey of US CF Centres, 60 % of patient’s sputum cultures 
showed Ps. aeruginosa and 27% contained S. aureus. Haemophilus influenzae is 
found in around 10-15% of cases, whilst B. cepacia is an increasing problem. In 
addition non-glucose fermenters (Legionella pneumophilia and Mycobacterium spp) 
viruses and fungi, especially Aspergillus spp. have been implicated in cases of CF lung 
disease.
Generally patterns of infection follow a sequence throughout the patients life. This 
begins with S. aureus colonization in infancy, frequently followed by 77. influenzae. In 
early adolescence Ps. aeruginosa infection becomes most common, whilst B. cepacia 
and mycobacteria have their highest incidence in young adults.
1.2.3 Staphylococcus aureus *
S. aureus'was the first- organism described as causing chronic lung disease in CF, 
(Anderson 1938) and was the biggest cause of death in CF patients prior to the 
development of antimicrobial chemotherapy. Few CF patients survived beyond infancy 
due to S. aureus infection, and it is still of great importance in CF patients under the 
age of 10. The virulence of S. aureus in CF depends on 2 main factors; the ability to 
adhere to respiratory epithelium and the ability to evade immune clearance though the 
exact mechanisms of adherence are not known (Govan and Nelson 1992). Anti-
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staphylococcal therapy has proved effective in CF. p-lactam drugs such as oxacillin and 
dicloxacillin, fusidic acid, co-trimoxazole, tetracyclines and first generation 
cephalosporins have all proved effective, (Gilligan 1991, Govan and Nelson 1992), The 
widespread and intense use of antimicrobial therapy in CF S. aureus infection is 
somewhat controversial, particularly where it is used prophylactically. In Edinburgh 
treatment for S. aureus is only used when a high sputum carriage (>107 cfu ml'1) is 
found (Govan & Nelson 1992): The use of prophylaxis may lead to the development of 
resistant strains. This seems particularly to be the case with the use of co-trimoxazole 
(trimethoprim-sulphamethoxazole) which can lead to thymidine dependent resistant 
strains. It has also been suggested that antimicrobial therapy acts 'to prime' the lungs 
for subsequent Ps. aeruginosa and Haemophilus influenzae colonization.
1.2.4 Pseudomonas aeruginosa
With the development of effective anti-staphylococcal therapy, Ps. aeruginosa has 
become the most important infection in CF. Infection by Ps. aeruginosa in CF has two 
key features. The first is that colonization remains restricted to the lungs and the 
second is phenotypic adaptation occurs within the lung. The most evident phenotypic 
characteristic is the appearance of mucoid variants formed by the production of large 
amount of exopolysaccharide alginate. This alginate appears to play a role in cellular 
adhesion, protection against immune clearance and indirect tissue damage (Gilligan 
1991, Govan and Nelson 1992).
Colonisation of CF airways by Ps. aeruginosa seems usually to be by non-mucoid 
forms. After a period of time, sometimes 3 months or less, mucoid variants are found
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to occur. Chronic colonization generally involves a single strain of Ps. aeruginosa that 
phenotypically varies over a period of time, though in some cases more than one strain 
may be carried. It is thought that the upper respiratory tract is initially colonised, 
leading to the eventual colonization of the lower airways. This is supported by 
evidence of in vitro binding and in patients who, following heart-lung transplantation, 
have a recurrent infection with the same strain of Ps. aeruginosa that colonised pre­
transplant. This suggests an upper tract reservoir of the bacterium (Gilligan 1991, 
Govan and Nelson 1992).
The persistence of Ps. aeruginosa in CF lung infection appears to be due to the high 
amounts of alginate produced by mucoid variants. The production of the 'mucoid 
exopolysaccharide, or MEP, seems to be governed by a chromosomal region 
designated muc or alg ST. The conversion of non-mucoid to mucoid phenotype 
seemingly occurs as a result of a mutation in the muc region, in response to 
environmental stimuli in the lung. The alginate produced is an anionic polysaccharide 
formed of 1-4 linked p-D-mannuronic acid and a-L-guluronic acid. It is highly viscous, 
binding to water and divalent cations to form a gel. This appears to happen in CF, 
where post-mortem lung material has revealed Ps. aeruginosa microcolonies enclosed 
in a larger alginate matrix. This can be explained by gel formation due to interaction 
with the high levels of calcium ions found in CF lungs. The resulting 'gel enclosed' 
microcolonies are even more difficult to remove by mucocilliary clearance, and so give 
rise to persistent Ps. aeruginosa colonization. In addition, increased damage to the 
lungs occurs due to 'frustrated phagocytosis'. Immune complex formation and presence 
of immunoglobulins stimulates phagocytes, in particular neutrophils, which when
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to occur. Chronic colonization generally involves a single strain of Ps. aeruginosa that 
phenotypically varies over a period of time, though in some cases more than one strain 
may be carried. It is thought that the upper respiratory tract is initially colonised, 
leading to the eventual colonization of the lower airways. This is supported by 
evidence of in vitro binding and in patients who, following heart-lung transplantation, 
have a recurrent infection with the same strain ofPs. aeruginosa that colonised pre­
transplant. This suggests an upper tract reservoir of the bacterium (Gilligan 1991, 
Govan and Nelson 1992);
The persistence o f Ps. aeruginosa in CF lung infection appears to be due to the high 
amounts of alginate produced by mucoid variants. The production of the 'mucoid 
exopolysaccharide, or MEP, seems to be governed by a chromosomal region 
designated muc or alg ST. The conversion of non-mucoid to mucoid phenotype 
seemingly occurs as a result of a mutation in the muc region, in response to 
environmental stimuli in the lung. The alginate produced is an anionic polysaccharide 
formed of 1-4 linked P-D-mannuronic acid and a-L-guluronic acid. It is highly viscous, 
binding to water and divalent cations to form a gel. This appears to happen in CF, 
where post-mortem lung material has revealed Ps. aeruginosa microcolonies enclosed 
in a larger alginate matrix. This can be explained by gel formation due to interaction 
with the high levels of calcium ions found in CF lungs. The resulting 'gel enclosed' 
microcolonies are even more difficult to remove by mucocilliary clearance, and so give 
rise to persistent Ps. aeruginosa colonization. In addition, increased damage to the 
lungs occurs due to 'frustrated phagocytosis'. Immune complex formation and presence 
of immunoglobulins stimulates phagocytes, in particular neutrophils, which when
confronted by the relatively huge microcolonies release reactive oxygen radicals or 
elastases and so cause immune mediated damage to the lungs. The wide range of 
virulence factors produced by Pseudomonas aeruginosa also contribute to the 
pathology seen in CF lungs (Gilligan 1991, Govan and Nelson 1992).
1.2.5. Haemophilus Influenzae
Respiratory disease due to non-capsulated, non-typable H. influenzae is often 
undiagnosed. Surveys have found a frequency of 10-14% in CF sputum, and it is found 
particularly in young children. It is often undiagnosed due to the difficulty of culture 
and difficulty in distinguishing from commensal H. influenzae. Although a contributory 
factor to CF lung disease H. influenza does not persist within the lung, and does not 
seem to play a primary role in CF respiratory disease (Gilligan 1991, Govan and Nelson 
1992).
1.2.6. Stenotrophomonas maltophilia
Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) appears to be an 
emerging problem amongst CF patients with prevalence rate of up to 30% in some CF 
centres (Denton 1997). Little is known about epidemiology or virulence factors in 
Sten. maltophilia infections, though like B. cepacia high levels of antibiotic resistance. 
The mechanisms of disease appear to be similar to those in Ps. aeruginosa. Sten. 
maltophilia has been mis-identified as B. cepacia (Burdge et al 1995).
33
1.2.7 Other bacterial, fungal and viral agents
Although the role of mycobacteria in CF has not been studied to any great extent, fatal 
disease in CF patients has been reported as a result of opportunistic infection by the 
atypical mycobacteria M  fortuitum andM chelonei. Infection withM tuberculosis is 
very rare in CF Patients should be monitored for possible mycobacterial infections. 
Streptococcus pneumoniae and enteric bacteria have all been cultured from CF 
respiratory secretions. Their clinical significance, if any, is not known.
Aspergillus Jumigatus is the most important fungal agent associated with CF. It is 
estimated that up to 80% of CF patients may be colonised with A. Jumigatus. Between 
0.5 to 11% of patients develop non-invasive allergic bronchopulmonary aspergillosis 
(ABPA). Around a third of CF patients have precipitating antibodies to A. Jumigatus. 
Invasive infections are rare. Treatment for ABPA is usually by corticosteroids (Dunnill 
1982). Candida albicans is often found in CF respiratory tracts, particularly in patients 
undergoing antimicrobial or steroid therapy, though its* role in disease is not defined.
The role of viruses in CF is not yet known. Respiratory syncytial virus (RSV) and 
influenzae infections are common, an<T it has been suggested they play a 'priming' role 
for subsequent bacterial infection (Gilligan 1991, Govan and Nelson 1992).
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1.3 B. cepacia in cvstic fibrosis
B. cepacia had been cultured from the sputum of CF patients throughout the 1970's but 
was regarded as little more than a harmless commensal of little clinical significance. 
However in 1984 a report from Toronto, Canada (Isles et al 1984) outlined the 
emergence of B. cepacia as an increasing problem in CF patients. At this CF centre the 
carriage rate of£. cepacia increased from 10% in 1971 to 18% in 1981. B. cepacia 
was also found to cause a more severe pulmonary disease than Ps. aeruginosa, further 
compounded by difficulty in treatment due to the high levels of antimicrobial resistance.
A similar pattern ofB. cepacia infection was also found in Cleveland U.S.A.
(Thomassen et cd 1985), where an increase in prevalence in CF patients from 7% in 
1978 to 15% in 1983 occurred. Of considerable cause for concern was the increasing 
number of patient deaths associated with B. cepacia. In 1978 9% of deaths were 
associated with B. cepacia, five years later this had risen to 55%. Over the 5 years of 
the study 85 chronic and 31 non-chronic cases oîB. cepacia infection were observed at 
this CF centre. The patients were classified by chronic/non-chronic status, and by the 
clinical course of the infection. The patients were classified into 3 groups:- 
Group I - Patients chronically colonised with B. cepacia who did not undergo change 
in clinical condition. These patients were in good, moderate or poor condition at the 
time of colonisation.
Group II - Patients chronically colonised with B. cepacia who continued to decline 
clinically. These patients were in moderate or poor condition at the time of 
colonisation.
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Group m  - Patients chronically colonised with B. cepacia who underwent a rapid and 
Unexpected clinical decline ending in death. These patients were in good or moderate 
condition at time of colonisation.
The increase in B. cepacia infection and mortality was also observed at the Philadelphia 
CF centre (Tablan et al 1985).
In the United Kingdom an increase of B. cepacia infection to a maximum prevalence of 
B. cepacia infecting 7%of patients was observed at the Leeds CF centre (Simmonds et 
al 1990). 27% ofB. cepacia infected patients died, compared with 7% chronically 
infected by Ps. aeruginosa. Isolation from CF patients of B. cepacia in both the UK 
and N. America CF centres have risen in the early part of the nineties, some CF centres 
reporting a prevalence of up to 40% in CF patients (Anonymous 1992, Tablan 1993) 
though overall prevalence rates in the U.S.A. seem to have levelled out at 3.5%, with 
an annual incidence of new cases rate of 1% amongst CF patients.
1.3.1 B. cepacia respiratory disease
The role oîB. cepacia in CF lung disease has proved somqwhat controversial. In some 
quarters it has been suggested that B. cepacia is merely a commensal, and acts as a 
marker for underlying disease (Gilligan 1991). However the current weight of opinion 
is that B. cepacia can cause either a non-chronic transient infection, or a chronic 
infection following one of three clinical pathways initially described by Thomassen and 
co-workers (1985, Govan & Nelson 1992)
The three clinical courses of chronic B. cepacia infection are 
1, Chronic asymptomatic carriage
2. Progressive deterioration
3. Rapidly fatal deterioration
The first two of these categories resemble other CF respiratory tract infections, most 
notably Ps. aeruginosa. The result of the second category is the chronic progressive 
disease normally associated with CF; obstructive airway disease leading to 
bronchiectasis and deterioration of the airways as described previously.
The third group however, differs greatly from other CF cases. These patients undergo 
a rapid decline with a necrotising pneumonia, and in some cases septicaemia, a rare 
occurrence in CF. The progress of this group begins with recurrent fevers, 
leucocytosis and progressive alveolar infiltration seen by x-rays. This is then followed 
by acute necrotising disease. Microabscesses are formed in the lung giving a 
'honeycomb-like' appearance and may be accompanied by septicaemia. Formation of 
the abscesses leads to a rapid decline and death (Tomashefski et al 1988).
This progression has been reported by many groups (including Thomassen et al 1985, 
Isles et a l 1985, Simmonds é ta l 1990). The first recorded death due to A  cepacia 
infection in a British CF patient, a nine-year-old girl, followed this pattern.
In some ways the pattern of acute pneumonia and septicaemia resembles meliodosis, 
caused by the closely related B. pseudomallei. This was observed by Dailey and Berner 
in 1968. They made the comparison from a case of acute B. cepacia pneumonia in a 
non-CF patient. The main difference between meliodosis and the B. ce/xrc/a-associated
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illness is that in meliodosis necrotising granulomata are seen. This is not the case in the 
pneumonia found in CF patients.
1.3.2 Virulence factors and immune evasion
The knowledge of the role of virulence factors is rather limited in comparison to Ps. 
aeruginosa (Nelson et al 1994) Indications based on studies using animal models 
indicate that B. cepacia is less virulent than Ps. aeruginosa.
Factors involved in binding to respiratory epithelia
The ability to adhere to host mucosal and epithelial surfaces is important in the 
establishment of lung disease. In B. cepacia only a few potential adhesins have been 
described, with work centred upon the role of fimbrae in adhesion. Around 60 % of B. 
cepacia strains have been found to have peritrichous fimbrae, whilst other strains have 
polar fimbriae. A 16 kDa protein similar to that of other bacterial species has been 
identified as the fimbral sub-unit with a role in adhesion. However this protein displays 
neither little cross-reactivity with monoclonal antibodies against Ps. aeruginosa pilin 
protein nor any homology with a Ps. aeruginosa pilin protein gene DNA probe. In 
vitro studies have shown fimbrae to increase binding to epithelia, and also a possible 
synergistic effect between Ps. aeruginosa and B. cepacia has been suggested, possibly 
due to Ps. aeruginosa modifying the epithelial cell surface to allow increased B. 
cepacia adhesion (Nelson et al 1994).
B. cepacia isolates from CF have been demonstrated to bind to mucin from both CF 
and non-CF sources, though to a lesser extent than Ps. aeruginosa. The degree of
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binding varies. Those strains showing the greatest level of binding to mucin seem to 
give rise to the most severe respiratory disease. This has led to speculation of the role 
of binding to mucin in B, cepacia mortality and morbidity, and to why some strains are 
transient within the lung and others are never lost. A 22 kDa pilin-associated protein 
distributed sparsely in pilated strains ofB. cepacia has been identified as a mucin 
binding adhesin. Subsequently the pilin has been found to have a novel morphological 
structure of giant intertwined fibres. The resulting cable-like structure lead to it being 
termed Cable Pilin (Cbl). The major 17 kDa subunit gene (cbl A), has been sequenced 
(Sajjan ef a / 1995)
Extracellular virulence factors and siderophores
B. cepacia strains may express at least three siderophore mediated iron transport 
systems including pyochelin, cepabactin and azurechelin. Siderophores compete for 
iron with host iron-binding proteins and may be linked to the ability of bacteria to 
establish and maintain infection. In B. cepacia it has been postulated that siderophores 
aid dissemination and inflammation in the lungs. The production of pyochelin can be 
correlated with morbidity and mortality in CF patients, hoWever it is only found in 
around half of clinical strains (Nelson et al 1994).
B. cepacia produces a number of extracellular factors . They appear to be more 
frequently found in clinical strains. Amongst these is a 34 kDa proteinase which can 
break down a number of proteins. (McKevitt et al 1989). Intratracheal instillation of a 
purified form of the protein into rat lungs gives rise to a bronchopneumonia with 
polymorphonuclear cell infiltration and exudation into the airways. The protein also
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produces an immune response, however this is not protective against subsequent 
infection with B. cepacia.
B. cepacia isolates have been found to produce lipolytic activity. This may be 
involved in reducing the activity of host phagocytic cells. Rat pulmonary macrophages 
pre-incubated with lipase, or in the presence of lipase, have a significantly lower level 
of phagocytosis. In addition several other extracellular factors including haemolysins 
and catalases are known to be produced. (Nelson et al 1994)
Cell surface factors
Proteins and lipopolysaccharide have both been described on the cell surface of B. 
cepacia. Both rough (R-LPS) and smooth (S-LPS) lipopolysaccharide phenotypes 
have been isolated from CF patients, whilst other clinical and environmental isolates are 
predominately of S-LPS phenotype. The R-LPS phenotype gives rise to dry colonies 
when plated. Serum antibodies to B. cepacia lipopolysaccharide from CF patients 
show little cross-reactivity with Ps. aeruginosa lipopolysaccharide indicating 
differences in structure and composition. Initial analysis seemed to indicate the 
absence of 3-deoxy-D-manno-2-octulsonic acid (KDO) in B. cepacia strains, however 
Straus and co-workers (Straus et al 1989) indicated its presence in two out of ten 
clinical isolates. KDO is believed to play an important role in toxicity and subsequent 
studies have since confirmed its presence in B. cepacia (Nelson et al 1994). The 
lipopolysaccharide differs in composition from that of Ps. aeruginosa in having lower 
levels of phosphorous but higher levels of heptose. The major saccharide components 
are glucose and rhamnose.
B. cepacia lipopolysaccharide extracts have been found to be toxic to mice. A complex 
of surface carbohydrate antigens, lipopolysaccharide and protein was found to be toxic 
(Straus et or/1989), with the lipopolysaccharide component seeming to confer the 
toxicity. It has been proposed that this complex is responsible for the tissue necrosis 
and lethality associated with B. cepacia pneumonia.
Exopolysaccharide production
Unlike Ps. aeruginosa there is little evidence to indicate the production of alginate by 
B. cepacia. Polymerase Chain Reaction (PCR) studies using primers from the algD 
gene of Ps. aeruginosa have indicated the absence of the gene for GDP mannose 
dehydrogenase, essential for alginate production, indicating the absence of alginate in 
B. cepacia (Nelson 1994). This is supported by earlier evidence where an 
exopolysaccharide was detected but not alginate. (Sage et al 1990). This group found 
the polysaccharide to consist of galactose, glucose, mannose, glucuronic acid and 
rhamnose with a little uronic acid but no mannuronic or guluronic acid. It was found to 
be produced by glucose dehydrogenase deficient mutants (Gcd*) and may lead to 
mucoid-type colonies. No correlation between exopolysaccharide production and 
clinical disease has been found.
In contrast to the above evidence Straus and co-workers (1989) investigating the 
toxicity of the surface antigen complex, found in one B. cepacia strain, 61g, that the 
carbohydrate component included an alginate-like compound containing 72 % 
guluronic acid, with 1.75 % acétylation of as yet unknown signifigance.
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Immune evasion
B. cepacia seems able to resist a relatively strong humoral immune response. A wide 
range of sensitivity to serum antibodies and resistance to killing by polymorphonuclear 
cells has been described. This may be due to phenotypic differences in the cell 
envelope. As described previously, patients with chronic granulomatous disease 
(CGD), a defect in phagocytic cells' oxidative killing mechanism, are particularly 
susceptible to B. cepacia infection. This appears to be a result of B. cepacia’s ability 
to resist neutrophil mediated non-oxidative killing (Nelson et al 1994).
The high levels of immunity displayed by B. cepacia have led to speculation regarding 
the relative ease of the bacteria's ability to survive within the CF lung. Recent evidence 
that B. cepacia can invade respiratory epithelial cells in vitro suggests that the bacteria 
has the ability to invade and survive within lung epithelium (Bums et al 1996a).
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1.4 Isolation and identification of B. cepacia
1.4.1 Isolation of R  cepacia
Prior to the mid 1980*8 the study of B. cepacia was hindered considerably by lack of a 
suitable isolation media. In the mid 1980s media for the isolation for B. cepacia from 
CF patients (Gilligan et al 1985, Welch et al 1987) and the environment were 
developed (Wu and Thompson 1984, Hagedom et al 1987).
Media developed for the isolation of B. cepacia from CF patients’ sputum rely to an 
extent on the intrinsic antimicrobial resistance of the species. Prior to the development 
of these media, isolation was primarily conducted on sheep blood agar or MacConkey 
agar followed by identification. Ps. cepacia (PC) medium (Gilligan et al 1985) consists 
of inorganic salts, 0.5 % pyruvate and 0.1 % protease peptone as nutritive components, 
with 0.0001 % crystal violet, 0,15 % bile salts, 100 pg ml'1 tiçariçillin and 300 U ml^of 
polymixin B as selective agents. OFPBL agar (Welch et al 1987) is a supplemented 
oxidation-fermentation (OF) agar. To produce the OFPBL agar, lactose, polymixin B 
(300 U ml"1) and bacitracin (0.2 U ml"1) are added to OF medium.
On PC medium 38 of 50 A  cepacia stock isolates grew after 48 hours of incubation
compared with none on MacConkey agar (Gilligan et al 1985). In clinical testing 35
out of 169 CF respiratory secretions were found to contain B. cepacia using PC
medium as compared with 21 using MacConkey agar. The PC medium inhibited 112
of 124 streak isolates of various other species found in CF respiratory secretions and
»
only 6 of 221 other potential pathogenic isolates grew (two Ps. aeruginosa, one
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Serratia marcescens, two molds and a yeast). B. cepacia often produces pink colonies 
on PC medium. OFPBL was also found effective in clinical trials yielding B. cepacia in 
58 of 725 samples as compared with 19 by MacConkey or sheep blood. Acidification 
of the medium by B. cepacia produces a yellow colour which differentiates it from 
yeasts, though acidification by B. gladioli and Ps aeruginosa were reported.
Both media were subsequently used in the study of B. cepacia and in diagnostic use by 
microbiology laboratories. PC medium has been produced commercially by Mast 
diagnostics, and is widely used in UK laboratories. Growth of drug resistant 
Pseudomonas species, Candida spp, Comomonas acidovorans and Stenotrophomonas 
maltophilia may be problematical and lead to misidentification (Burdge et al 1995, 
Henry et al 1997). To counter such problems BCSA (B. cepacia selective agar) has 
been recently developed (Henry et al 1997). This medium contains, sodium chloride, 
sucrose, lactose, yeast extract, trypticase peptone, crystal violet, phenol red, polymixin 
B (600 U) and gentamicin (10 pg ml'1). Vancomycin at 2.5pg ml'1 may also be added. 
BCSA appears to have similar sensitivity to OFPBL or PC detecting 190 of 191 CF B. 
cepacia isolates (99.5%), compared with 100 % for OFBDand 94 % for PC, but with 
fewer non- B. cepacia isolates-growing; 10 of 189 (5.3 %) Gram positive and Gram 
negative organisms grew on BCSA without vancomycin, compared to 13.8 % false 
positives on PC and 19.6 % on OFPBL. The addition of vancomycin reduced the rate 
of false positives to 3.7 % without affecting the growth of B. cepacia isolates. Growth 
on BCSA also appears to be more rapid and could allow quicker identification.
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Identification ofB. cepacia in water samples is important in the pharmaceutical 
industry. The versatile nature of the organism means it is able to grow in 
pharmaceutical compounds if introduced by a contaminated water source. Wu and 
Thompson (1984) developed a media consisting of plate count agar supplemented with 
9-chloro-9 (4-diethylaminophenyl) -10-phenylacridan, a quinacrine compound 
inhibiting DNA replication, at 1 pg ml"1 and polymixin B at 75 pg ml*1 The medium 
inhibited growth of all tested bacteria except B. cepacia and Serratia marcescens, 
which can be differentiated by morphology and oxidase activity.
Hagedom et al (1987) developed a medium for isolation ofB. cepacia from soils. TB- 
T combined trypan blue (TB) and tetracycline (T) with mineral salts, glucose as a 
carbon source and L-asparagine as a nitrogen source along with crystal violet and/or 
nystatin to inhibit fungal growth, at pH 5.5, platings from soil cultured 300 isolates,
216 of which were identified as B. cepacia (72 %). The remainder of organisms (28%) 
identified mainly as Serratia species could be separated from B. cepacia by anaerobic 
glucose fermentation. The media is not as selective as clinical media but allows 
recovery ofB. cepacia from soil at low dilutions. 1
1.4.2 Identification
A number of factors make the identification of B. cepacia difficult. Maintenance of 
cultures is difficult as B. cepacia is only viable for a short time on nutritive agars and 
many isolates do not survive at 4°C requiring maintenance at -70°C (Gilardi 1983, 
Govan and Harris 1985, Pitt and Govan 1993). Gilardi (1983) described the use of 
biochemical tests and sugar acidification/fermentation for identification. The use of
biochemical and nutritive tests has proved difficult due to variable properties in key 
tests. Hagedom et al (1987) describe both oxidase negative and oxidase positive 
isolates of B. cepacia, whilst two identification methods describe the organism as 
oxidase negative in one case, positive in the other. Pitt and Govan (1993) describe the 
difficulty posed by asaccharolytic strains.
In UK clinical laboratories B. cepacia is usually identified by growth on Mast PC 
selective medium followed by confirmation using BioMerieux API 20 NE identification 
strips (Pitt and Govan 1993). In the US a number of commercial identification 
methods have been applied notably API Rapid NET, however problems with 
misidentification due to either growth on selective media or confirmation with 
commercial methods have been noted (Burdge et al 1995, Kiska et al 1996). Kiska et 
al (1996) assessed the accuracy of four commercial systems: Rap ID NF plus, API 
Rapid NET, Vitek AUTO MICROBIC system and Remel Uni N/F Tek and NZF 
Screen, in typing B. cepacia and other Gram negative non-fermenting bacilli from CF 
patients. Accuracy of B. cepacia typing ranged from 46 to 86 % and 57 to 80 % for 
other non fermenting bacteria. Various Pseudomonas species and other Burkholderia 
species were misidentified as B. cepacia, suggesting a requirement for further 
confirmatory tests.
Fatty Acid Methyl Ester (FAME) profiling based upon the fatty acid composition of 
cells by gas chromatography is a highly accurate method of typing (Leff et al 1995), 
especially in environmental strains. However the technique is rather specialised for a 
standard laboratory. A number of molecular techniques based upon ribosomal RNA (r
RNA) genes have been described for identification and typing of B. cepacia. Typing is 
discussed in detail in the following section. Leff et al (1995) described the 
identification of aquatic B. cepacia using hybridisation with species specific 16S and 
23 S rRNA gene probes. This proved more accurate than API test strips or selective 
media and more efficient than FAME profiling.
Amplification of 16S rKNA DNA sequences by polymerase chain reaction (PCR) 
followed by DNA hybridisation has been used to identify B. cepacia and Ps. 
aeruginosa directly from patients’ sputum (O’Callaghan et al 1994). PCR 
identification based on primer sequences from 16S-23S rRNA gene internal transcribed 
spacers (ITS) for B. cepacia and other Burkholderia species and pseudomonads has 
also been tried, along with tRNAs and structural genes (Tyler et al 1995). The 
prokaryote rRNA operon (tttî) contains genes from 16S, 23 S and 5S rRNA. Multiple 
rrn loci frequently occur with différences in repetition, arrangement and linkage of the 
loci. Identification can be made on the basis of the differences in ITS length 
polymorphisms. PCR amplification using primers based on ITS sequences should 
therefore identify species on basis of inter-species polymorphisms. This approach was 
successful for several Burkholderia and Pseudomonas species, however 2 of the 3 B. 
cepacia reference strains and many of 103 tested clinical isolates were not detected 
using primers obtained from sequence data obtained from strain ATCC 25609. 
Alternate primers were designed using other ITS sequences, again these were specific 
for B. cepacia but the method proved incapable of detecting a range of isolates leading 
to the abandoning of ITS sequence primers. Primers targeting 23 S rRNA genes
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directly were developed. These were successful, being specific for B. cepacia and 
detecting all isolates tested.
1.4.3 Typing
Typing is needed for epidemiological studies and also to assess prognosis by detection 
of epidemic strains. Several methods have been used to type B. cepacia including 
FAME analysis, serological typing, bacteriocin typing, ribotyping, multilocus enzyme 
electrophoresis and pulsed field gel electrophoresis (PFGE) analysis (Rabldn et al 
1989, Pitt and Grovan 1993, Wilkinson and Pitt 1995a). An international collaborative 
study was conducted in the late 1980’s to assess several potential typing systems 
(Rabkin et al 1989). The survey found serotyping and ribotyping to be specific and 
sensitive. Typing by antimicrobial susceptibility and biotyping, such as use of API 
strips to be both less specific and sensitive. Bacteriocin typing was found to be the 
most sensitive method, though much variation in production and sensitivity was found 
between isolates. The use of bacteriocin typing is based upon production and 
sensitivity to bacteriocins. Bacteriocins are antimicrobials that affect related species or 
other strains of the same species. Bacteriocin typing was first applied in B. cepacia by 
Gonzalez and Vidaver (1979). Govan and Harris (1985) developed a method using a 
multipoint inoculator to inoculate B. cepacia or Pseudomonas test strains onto agar 
plates. These are grown for 5 hours, then test isolates are chloroform killed. The B. 
cepacia or Pseudomonas indicator is added in an agar overlay and incubated for 18 
hours. Bacteriocin production or sensitivity is indicated by an inhibition zone. 
Inhibition patterns allow typing of isolates into groups based on production and 
sensitivity.
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Serological typing using agglutination to detect heat stable antigens has been used by 
several groups (Wilkinson and Pitt 1995a). Initially five serogroups were defined and 
subsequent studies found seven O and five H antigens, other groups found five and ten 
different antigen groups.
Ribotyping has been employed as a consistent and accurate typing method (Rabkin et 
al 1989). The process involves digestion of chromosomal DNA with a restriction 
endonuclease; usually EcoKl followed by Southern blot hybridisation with labelled E  
coli RNA. Typing is achieved by restriction fragment length polymorphisms (RFLP) 
between isolates leading to variances in number and position of hybridisation bands. At 
least 55 different ribotype patterns have been observed in UK CF isolates (Wilkinson 
and Pitt 1995a). More detailed analysis may be conducted by external ribotyping 
(Rozee et al 1994). This utilises typing by digesting with four restriction enzymes.
This group have also employed multilocus enzyme electrophoresis (MLEE) (Rozee et 
al 1994, Johnson et al 1994) as a typing method. This involves analysing the 
electrophoretic mobilities of 14 enzymes. The use of MLEE typed 83 mainly CF 
isolates into 20 electropherotypes (ET’s). These approaches allowed genetic linkage 
and relationships to be investigated. One type ET 12 was found to be responsible for an 
epidemic of fatalities in the UK and Canada. Extended ribotyping allowed detailed 
analysis of ET 12 clones in the UK and Canada. Strains from London, and particularly 
Manchester and Ontario were closely related, suggesting a common origin. ET 12 
clones from Edinburgh and Belfast were found to be more distantly related, More 
recently use of PCR methods similar to those developed for identification have been 
applied to typing and have the advantage of not being as complex or labour intensive as
conventional ribotyping. PCR ribotyping, as the technique has been dubbed, was first 
used to type B. cepacia by Kostman et al (1992) by differences in amplification 
patterns of the intergenic spacer between 16S rRNA and 23 S rRNA genes. As 
described previously most bacteria have multiple copies of the rm operon (rRNA 
operon) and also differences in the length and sequence of 16S-23s intergenic spacer 
regions between opérons within the same genome and between the opérons in a 
bacterial species may occur. Amplification of the spacer regions will therefore give rise 
to multiple PCR products. Different lengths and numbers and PCR products could 
arise due to the polymorphisms between strains, so electrophoresis of the PCR 
products may yield different patterns between species strains (Kostman et al 1992). If 
isolates are of the same strain an identical pattern would be obtained i.e. are of the 
same ribotype; differing strains would have a different pattern or ribotype. The 
concordance of PCR ribotyping with conventional ribotyping was found to be 93% for 
90 isolates from seven well characterised outbreaks of B. cepacia infection including in 
the UK and Denmark (Ryley et al 1995, Ryley et al 1996). Amplification with primers 
to the 16S-23S rRNA genes was followed by a Taq I restriction digest to give distinct 
ribotyping patterns. The use of the Taq I digest gives rise to more easily discernible 
patterns. Seven distinct patterns of ribotypes were found in 16 isolates from CF 
patients in Wales (Ryley 1995). Seven isolates were found to be of one ribotype 
pattern, four others showed a distinct pattern and two another. None were found to 
be of the ET12 epidemic strain. In Denmark 12 isolates were investigated with 8 
different ribotypes found by this method. DNA finger printing by Pulsed Field Gel 
Electrophoresis (PFGE) has been applied to typing of B. cepacia strains (Anderson et 
al 1991). This technique involves embedding bacteria cells in agarose in which the
cells are lysed with sodium lauroyl sarcosine-proteinase K buffer. Embedded 
chromosomal DNA is then digested with a rare cutting restriction enzyme. The 
digested DNA is then separated by PFGE. A DNA fingerprint is so obtained for the 
isolate tested. A number of enzymes may be used to obtain such fingerprints. 
Comparison of fingerprints may be made between isolates to characterise them. The 
technique has also been called macro-restriction analysis. In the UK analysis after 
digestion with Xba I and Spe I has been utilised to type 366 isolates (Pitt et al 1996). 
More than 50 different patterns were found, with 68 patients found to harbour one 
strain termed ribotype 1 at 8 different UK CF centres.
Randomly amplified polymorphic DNA typing or RAPD analysis has recently been
applied to typing of B. cepacia (Mahenthiralingam et a! 1996a, 1996b). The method
:: 1:;!; ^  h.- r  - .
uses PCR primers from DNA extracted from B. cepacia KICC  25416 (Initially a range 
of 100 random primer* were used, those that were able to detect polymorphisms, 8 In
i
this case, were able to give fingerprints). The selected primers were used to randomly 
amplify DNA by PCR, each primer producing a fingerprint of 5 to 20 bands of 100 bp 
to 5 KB. The fingerprints produced can be analysed to tyjie strains on basis of 
similarity and difference. The technique was able to type 627 B. cepacia isolates 
previously typed by PFGE or conventional ribofyping with greater sensitivity than PCR 
ribotyping. A conserved DNA marker of 1.4 Kb was found by RAPD analysis of
epidemic strains (Mahenthiralingam et al 1997). The marker was found in strains from
* '* •  ■ ■ 5 . ‘ M,.- f -  y \ : . "  y > - ; ■
seven CF epidemic strain outbreaks but riot in non-epidemic strains. The marker was
designated as B. cepacia epidemic strain marker (BCESM). Only one of the seven
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strains was found to contain the cable pilin subunit gene (cblA) found in an epidemic 
strain from UK and Canada.
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1.5 Epidemiology of B. cepacia in CF
Studies in the early to mid 1980’s recognised the importance of B. cepacia in CF. 
Several factors were suggested to increase the rank of B. cepacia colonisation 
(Reviewed by Tablan et al 1987a and b):
a) Existing severe underlying CF lung disease,
b) KB. cepacia colonised CF sibling,
c) Increased age,
d) Prior treatment with aminoglycoside antibiotics was all implicated in colonisation 
and morbidity. However because of the lack of a selective medium and adequate 
typing techniques made the identification of source of infection and transmission 
difficult. Development of specific isolation media improved the isolation of B. cepacia. 
The subsequent development of typing techniques has allowed more effective study.
1.5.1 Person-to-person transmission
Due to the the development if the above methods strong evidence of person-to-person 
transmission of A  cepacia amongst CF patients has been dbtained. Evidence of 
person-to-person transmission has been described in both the UK and N. America. 
Initial evidence was reported in the US in 1990 (Li Puma et al 1990, 1994), with 
subsequent evidence in Wales (Millar Jones etal  1992), Scotland (Govan etal  1991, 
Govan et al 1993), England (Smith et al 1993) and Canada (John et al 1994). There is 
also substantial evidence that social contact between patients has led to transmission. 
Smith et al (1993) reported evidence of incidence oîB. cepacia in the East 
Birmingham Hospital adult cystic fibrosis unit despite segregation of B. cepacia
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positive and B. cepacia negative patients within the hospital. Subsequent questioning 
of patients' social activity revealed considerable social contact with infected patients, 
even a case of intimate contact. Govan and co-workers (1993) found similar evidence, 
including transmission between patients in British CF centres and patients attending 
Canadian CF summer camps. Studies in Canada (John et al 1994) have produced 
similar evidence whether transmission indirect via droplet, or via intimate contact with 
fomites such as drinking cups is unclear. Govan et al (1996) also described the 
isolation of B. cepacia from drinking cups, sputum containers and gloves of doctors 
attending B. cepacia colonised patients. There is also evidence of airborne 
dissemination of A  cepacia in adult CF patients (Humphreys etal 1994). Surface and 
air sampling onto selective medium recovered B. cepacia in 5/6 patients.
The evidence of person-to-person transmission has led to segregation polices in many 
hospitals to avoid possible transmission of B. cepacia from infected to non-infected CF 
patients, and the prevention of B. cepacia colonised patients attending CF summer 
camps in N. America and Europe. In the UK the CF trust requires B. cepacia 
colonised patients not to attend social events and meetings ' Such policies have serious 
social implications for colonised patients but seem to be necessary to prevent further 
infection. Reports have also linked home-use nebulizers with B. cepacia and other 
Gram negative bacterial infections in CF (Hutchinson et al 1996). 3 of 35 nebulizers 
tested were found to harbour B. cepacia. Most of the patients in this study were 
receiving colistin or gentamicin therapy, this being a suggested predisposition for B. 
cepacia infection. The study also suggested the requirement for good cleaning, drying
54
and maintenance of nebulizers to avoid their becoming potential reservoirs of B. 
cepacia or other Gram negative infection.
Ribotype 1 appears to be the main epidemic strain within the UK and Ireland and has 
been found in 68 patients at several different centres indicating cross-colonisation (Pitt 
et a/1996) However the levels of antimicrobial resistance within ribotype 1 appear to 
vary greatly. Comparative study of B. cepacia infection by multilocus enzyme 
electrophoresis and ribotyping of Canadian and UK epidemic strains along with other 
CF isolates, non CF nosocomial infections and environmental isolates revealed 20 
electrophoretic types (ET’s) or clones. The strains causing the B. cepacia epidemic 
amongst CF patientswere found to be one clone (ET 12). Ribotype 1 fells into this 
clone. Isolates of ET 12 clones have been found to vary in their enzyme ribotypes. The 
variability of ribotypes may be associated with the highly virulent strain leading to poor 
prognosis (Rozee et al 1994). Another Canadian CF clone, ET16, has much lower 
variability and is associated with a better progress. Similarly between some of the 
Canadian and British strains have led to the suggestion that the epidemic strain was 
brought to the UK by patients attending CF summer camps in Canada. Data on the 
virulence of ribotype 1 (Pitt et al 1996) is patchy but its- clinical presentation in the UK 
seems to vary from asymptomatic to highly virulent but appears to be highly 
transmissible. As described previously the exact factors determining B. cepacia 
virulence in CF are unknown, however Edinburgh CF strains of ribotype 1 display a 
level of mucin adherence six times greater than other strains.
More recent evidence has indicated that some B. cepacia strains display low 
transmissibility as transmission only occurred in 3 of 8 sets of CF siblings and evidence
of person to person transmission occurred in only 16.7% of unrelated cases of B. 
cepacia infection (Cazzola et al 1996), whilst a number of sporadic cases appeared to 
have an environmental source. Despite segregation policies in hospital person to 
person transmission appears to occur. This appears to be due to social contact outside 
hospital. Such transmission appears to be either by direct contact or by indirect contact 
(Cazzola et al 1996, Amalfitano et al 1996). The ability of B. cepacia to survive in 
respiratory droplets and environmental surfaces for long periods of time is significant in 
terms of indirect person-to-person transmission (Drabick et al 1996). It has also been 
suggested that B. cepacia may be disseminated into the environment during 
physiotherapy (Ensor et al 1996). This reaffirms the need for segregation policies in 
hospitals and also guidelines given to patients in Europe and N. America to avoid 
activities that increase the spread of B. cepacia. The guidelines issued in Canada for 
example suggest avoiding close social contact such as kissing, segregation in hospitals, 
not sharing respiratory therapy equipment, toothbrushes or handkerchiefs or sharing a 
room during physiotherapy or exercise. Good personal hygiene and care of equipment 
such as nebulizers is also recommended to avoid infection from the environment 
(Canadian Cystic Fibrosis Foundation 1995). v
1.5.2 Non CF infections
In the US a significant increase in non-CF nosocomial infections has been observed in 
recent years (Pegues et al 1996). In the period 1980 to 1985, 3.5 per 100,000 medical 
admissions and 3.3 per 100 000 surgical admissions to US hospitals were found to have 
acquired B. cepacia infections, 31% of the cases involving lower respiratory tract 
infections.
In a recently described nosocomial outbreak (Pegues et al 1996) the majority of 
infected patients had undergone mechanical ventilation in the intensive care unit. These 
patients were more likely to have undergone 2 or more days of ventilation and multiple 
intubations than the non-5. cepacia infected control group. In addition the infected 
patients were significantly more likely to have undergone nebulised therapy or a course 
of antimicrobial therapy with cephalosporin and aminoglycoside. Other reports have 
linked the use of nebuliser therapy with nosocomial outbreaks of B. cepacia and other 
bacteria; one of the more recent reports linking nebulised albuterol therapy with a B. 
cepacia outbreak (Hutchinson et al 1996). These reports suggest the need for good 
practice and disinfection to avoid nebulizers and other respiratory equipment being the 
source of non-CF nosocomial outbreaks
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1.6. Burkholderia cepacia in the environment
There are a number of areas in which B. cepacia is of interest in the environment; as a 
potential reservoir of infection (as described previously), as a phytopathogen, as an 
agent of bioremediation particularly due to its versatile catabolic properties and as an 
agent of biocontrol against phytopathogenic fungi damaging crops.
1.6.1 K  cepacia as a phytopathogen
B. cepacia was first described as a phytopathogen in 1950 by Burkholder. He 
described a rot affecting the outer storage scales of onion {Allium cepa) causing 
maceration of tissue accompanied by a yellow, slimy appearance and a distinct sour 
‘vinegar-like* odour. The disease had been termed ‘sour skin* or ‘slippery skin* onion 
rot by onion growers in New York State, USA, and had been attributed to be the cause 
of the loss of up to 20% of the onion crop. Burkholder isolated the causative agent, a 
Gram negative rod-shaped bacterium, and named it Ps. cepacia.
B. cepacia, along with B. gladioli and Erwinia herbicola ate known to be the
causative agents of bacterial soft rot of onions. B. cepacia is described as causing a rot
of onion bulb scales, usually occurring near maturity or sometimes in storage. It affects
most Allium  species but is not thought to be a strongly invasive pathogen, attacking
mainly weakened plants or those nearing maturity (Bradbury 1986). It has also been
found to cause rots in maize, beans, peas and tomatoes if inoculated into these plants.
B. gladioli p.v. allicola causes a rot with softening and dark discoloration of outer
>
scales, whilst E. herbicola is primarily a rot of onion storage. Both B. cepacia and B.
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gladioli produce pectic enzymes, Erwinia does not. It is thought that it is this 
pectinolytic activity which causes the maceration of onion tissue by these bacteria.
The pathogenicity of B. cepacia strains may be assessed by conducting host tests, 
either by the inoculation of onion tissue slices or whole onions. Such tests have been 
used to investigate the pathogenicity of clinical and environmental strains. One study 
showed clinical strains to have little or no ability to macerate onion tissue, or have little 
pectinolytic activity (Gonzalez and Vidaver 1979). Pathogenicity to onion and 
pectinolytic activity were used as part of the criteria in the division of B. cepacia into 
four groups or phenoms(Yohalem and Lorbeer 1994). Differences have been found 
both between and within clinical and environmental strains, but generally indicated that 
clinical strains are poor plant pathogens. However, onion maceration by clinical 
strains, including the epidemic strain associated with CF, has subsequently been 
demonstrated (Butler e ta l 1995).
Ps. aeruginosa has been reported to cause a Burkholderia-Xikc onion rot (Cother et al 
1976), though rot only seems to occur under a very spécifié set of growth and storage 
conditions. It does not cause rot in vitro, and at most could be considered a ‘quasi- 
pathogen* (Cother et al 1976).
1.6.2 Production of antibiotics and biocontrol by B. cepacia 
B. cepacia has been found to produce a number of antibiotics including pyrrolnitrin, 
altercidins, cepacin and xylocandins (Homma et al 1989). Although cepacin and 
xylocandins have been investigated for potential therapeutic use, it is in the field of
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biocontrol, the biological control of plant pathogens, that such compounds would 
appear to be most effective.
B. cepacia antibiotics and their potential therapeutic use
B. cepacia ATCC 29356 was found to produce two acetylenic antibiotics, cepacin A 
and B (Parker et al 1984). Cepacin A has strong activity against Staphylococci (a 
minimum inhibitory concentration (MIC) of 0.2 pg ml"*) and weaker activity against 
Streptococci. Cepacin B has some activity against Gram negative bacteria and . 
excellent activity against Staphylococci (MIC < 0.05 pg ml'1). Xylocandins, a complex 
of novel peptides isolated from strain ATCC 39277 show considerable activity against 
a range of Candida species and other dermatophytic fungi in vitro (Meyers et al 1987). 
However the lack of efficacy of xylocandin in in vivo studies in mice, and the relative 
toxicity of cepacin have curtailed any further development as therapeutic 
antimicrobials.
J3L cepacia as an agent of biocontrol
The failure of control measures against plant pathogenic fungi is largely due to the 
development of resistance to chemical fungicides. This resistance along with public 
concern over the safety of such chemicals, has lead to an interest in the use of . 
biological methods in controlling phytopathogens. This involves the protection of fruit 
and vegetable crops either by the use of organisms antagonistic to pathogens, or by the 
compounds produced that cause the antagonism. B. cepacia has been reported to 
suppress the growth of many phytopathogenic fimgi including soil home diseases such 
as Fusarium sp. wilt of tomato, ‘damping-off of radish and Verticullvm sp. wilt of
aubergine (Homma et al 1989). This suppression was achieved either by using B. 
cepacia as a seed-coating or a root-dip. Antagonism of Bipolaris maydis, the 
causative agent of leaf blight in maize by B. cepacia has also been recorded (Sleesman 
and Leben 1976).
Study of the compounds that suppress pathogen growth produced by B. cepacia KB 
42S showed that pyrollnitrin and two pseudane derivatives (HMQ and NMQ) were the 
main suppressive compounds ( Homma et a l 1989). These compounds were found to 
have activity against a range of phytopathogenic fungi including Verticullvm chahiae, 
Rhizoctoniia solani, Pythium ultimum and Fusarium oxysporium, but showed little 
antibacterial activity. B. cepacia has also been described as an antagonist of Blue mold 
(Pénicillium expansum) and Gray mold (Botyris anerea) of apples and pears 
(Janisiewicz and Roitman 1988). Pyrrolnitrin, isolated from a B. cepacia strain 
growing on apple leaves, was used to treat apples and pears in vitro. The treated fruit 
displayed no fungal lesions or rot when inoculated with either B. anerea or P. 
expansum, whilst untreated fruit developed considerable rot. Pseudomonas 
fluorescens has also been found to produce pyrrolnitrin and has been used to protect 
cotton seedlings from Rhizoctonia solani rot. Altercidins, a type of phenazine 
antibiotic, are also produced by B. cepacia. This type of antibiotic produced by Ps. 
fluorescens has been shown to suppress a fungal disease of wheat caused by 
Gaeumcamomyces gramnis (Thomashow and Weller 1988):
More recent research has demonstrated the potential of B. cepacia as a suppressor of 
phytopathogenic fungi in maize (Jayasawal et al 1990. Hebbar et al 1992). Maize is
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one of the most important cereal crops worldwide, but is susceptible to soil-borne 
fungi. B. cepacia is antagonistic to a number of these fungi including Trichodema, 
Fusarium and Aspergillus species. B. cepacia seems to be particularly effective as a 
biocontrol agent in maize, as seed inoculation with a small amount of bacteria leads to 
rapid colonisation of the roots and the rhizosphere. This is due to its* high growth rate, 
production of extracellular enzymes and its* ability to utilise a wide range of plant 
exudates (Hebbar et al 1992). B. cepacia also suppresses the sunflower (Helianthus 
arums) phytopathogen Sclerotina sclerotionum which causes root rot and wilt of the 
plant (McLoughlin et al 1992). Inhibition of the fungus was found to be as a result of 
pyrrolnitrin production, along with production of the related compounds 
aminopyrrolnitrin and monochloroaminopyrrolnitrin.
1.6.3 B. cepacia, biodégradation and bioremediation
The ability of B. cepacia to utilise a wide range of carbon sources has been known for 
some time. The contamination and growth in disinfectants (Holmes 1986) and the 
ability to utilise penicillin Gas a sole carbon source (Beckman and Lessie 1979) are 
examples of the extraordinary metabolic diversity of the ofganism. The previous 
synonym Pseudomonas multivorans suggests this ability more clearly than the present 
nomenclature. The ability to catabolise a range of compounds recalcitrant to 
breakdown including chlorinated aromatic compounds, notably 2, 4, 5- 
trichlorophenoxyacetic acid (2, 4, 5-T) by the B. cepacia strain AC1100(Kilbane et al 
1982), have earmarked B. cepacia as a potential agent of bioremediation (Govan et al 
1996). 2, 4, 5-T has been widely used a a herbicide, particularly as the major 
component of the defoliant Agent Orange used extensively by US forces in the Vietnam
War and has been demonstrated to have severe toxicological effects as a carcinogen 
and teratogen (Kilbane et al 1982). It has been suggested that this metabolic diversity 
may be due to the high degree of plasticity within the B. cepacia genome (Lessie et al 
1996). The extensive array of insertion elements promote genetic rearrangement and 
promote expression of recombinant genes. This has been suggested to have played a 
role in the evolution of novel catabolic processes, including that of 2, 4, 5-T (Haugland 
e ta l 1991).
Degradation of phenoxyacetate herbicides such as 2, 4, 5-T and 2, 4- 
dichlorophenoxyacetate (2, 4-D) has been well described in B. cepacia and the genetics 
of the degradation pathways elucidated, such as the tft genes in 2, 4,5-T degradation 
by AC1100 (Daubaras et a l 1996) Frequently these pathways are plasmid encoded. 
Bhat et a l (1994)found a 90 kb plasmid they named pMAB 1 in wild type B. cepacia 
CSV 90 encoding the ability to use 2,4 dichlorophenoxyacetate 2,4-D and 2 methyl-4 - 
chlorophenoxyacetate as sole carbon source. 2,4-D" mutants were found not to 
contain this plasmid or contain a smaller 70 kb plasmid termed pMAB 2. Cloning of a 
10 kb fragment absent from pMAB 2 but in pMABl into È. co// resulted in the 
production of a 3,5 dichlorocatechol dioxygenase, a likely component of a degradative 
pathway. Xia e ta l(1998) described a 105 kb plasmid,pUBl, possesing a 41 kb 
transposon, Tn5J30, encoding for 2, 4-D degradation. Haak et al (1995)described a 70 
kb plasmid, designated pBAH 1, encoding for a 2 component 2-halobenzoate 1,2 
dioxygenase from 5. cepacia 2CBS. Toluene and trichloroethylene, a common 
groundwater pollutant, can be catabolised by B. cepaciaGA (Folsom et al 1990). This 
pathway is encoded by a 108 kb plasmid named TOM (Shields et a l 1995).
B. cepacia strain RKJ 200 is capable of utilising /vnitrophenol (PNP) as the sole 
carbon and energy source (Prakash et al 1996). A 5 kb plasmid carries the genes 
encoding for degradation via hydroquinone and the beta-ketoadipate pathway, along 
with resistance to inorganic zinc ions. B. cepacia Pc 701 catabolises 4-methylphthalate 
(Saint and Romas 1996). Phthalate wastes are produced and released by the paint, 
plastics and paper industries and are of concern due to their potential toxicity. B. 
cepacia is currently being suggested as a potential bioremediator of these wastes. 
Degradation is thought to proceed via a phthalate dioxygenase pathway. Pc 701 
contains a plasmid pMOP. This contains a gene cluster thought to encode for 
degradation and a protein thought to be involved in phthalate uptake.
In addition to the degradation of chlorinated and other aromatic hydrocarbons by B. 
cepacia, a mineral solubilising gene has been cloned (Babu-Khan et a l 1995). The gene 
results in solubilisation of calcium phosphate by gluconic acid produced by the direct 
oxidation pathway of glucose.
64
1.7 Antibiotics and antimicrobial chemotherapy and their use in 
R  cepacia infections
1.7.1 Action of antimicrobial drugs
The action of antimicrobial drugs fall into four main groups 
(Russell and Chopra 1990):
1. Drugs that inhibit cell wall synthesis - penicillins, cephalosporins, vancomycin.
2. Drugs that inhibit protein synthesis - aminoglycosides, tetracyclines,
chloramphenicol and erythromycin.
3. Drugs that inhibit nucleic acid synthesis - sulphonamides, trimethoprim and
quinilones.
4. Drugs that inhibit membrane integrity - polymixins, iontophoric antibiotics,
polyene drugs.
1.7.2 Drugs that Inhibit cell wall synthesis
P-lactam antibiotics are the main group of drugs that inhibit cell wall synthesis (Franklin 
and Snow 1989, Russell and Chopra 1990). These are bactericidal drugs that act by 
preventing cross-linkage of peptidoglycan in cell wall synthesis. There are 2 main 
groups of P-lactams; penicillins and cephalosporins. Both share the common structure 
of a P-lactam ring* a 4 membered, cyclic amide ring.
The synthesis of peptidoglycan occurs in 4 stages. The first stage is the synthesis of 
pre-cursors in the cytoplasm. This is followed by formation of a pentapeptide. The 
pentapeptides are then linked to form a linear peptidoglycan polymer, which is then
cross-linked to give a strong rigid structure. The mode of action of P-lactams is based 
upon similarity between the P-lactam ring and the D-alanine D-alanine end of the 
peptidoglycan side-chain. p-lactams compete with the side chains for binding to the 
transpeptidases and carboxypeptidoses that catalyse polymerisation of the glycan chains 
- and cross linking. The p-lactams form stable complexes when bound to the enzymes 
leading to enzyme inactivation and causing termination of polymerisation and cross- 
linking. Intermediates of peptidoglycan will accumulate causing the activation of 
autolysis and destruction of the cell. The enzymes to which P-lactams bind are also 
known as penicillin binding proteins of PBP’s.
A number of other drugs inhibit peptidoglycan synthesis, ^-cycloserine and fosfomycin 
act in the early stages of synthesis to prevent pentapeptide formation. Bactitracin 
blocks the dephosphorylation of a lipid , carrier molecule preventing transfer of 
pentapeptide units in the formation of the peptidoglycan polymer. Vancomycin binds 
to the D-alanine D-alanine terminus of the peptidoglycan precursor units preventing 
transglycosylation of the units and formation of the peptidoglycan polymer chain 
(Franklin and Snow 1989).
P-lactams are widely used in the treatment of CF respiratory infections. Ps. 
aeruginosa and B. cepacia are both resistant to most first generation penicillins and 
cephalosporins (Prince 1986). However antipseudomonal and extended spectrum 
penicillins such as azlocillin and piperacillin have been widely used, with most B. 
cepacia strains moderately susceptible to these drugs in vitro (Bhakta et al 1992). 
These drugs are usually administered parenterally, often in combination with
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intravenous oral or nebulised aminoglycosides in the treatment and prophylaxis of CF 
lung infection with Ps. aeruginosa or B. cepacia (Kumar et al 1989). However B. 
cepacia almost invariably proves resistant to aminoglycosides, so such treatment is 
generally ineffective and somewhat controversial as it has been suggested that 
prophylactic treatment with aminoglycosides 'primes' the lungs for subsequent B. 
cepacia infection (Govan & Nelson 1992).
The aminothiazole cephalosporin ceftazidime is very active against both B. cepacia and 
Ps. aeruginosa in vitro, and has proved effective against Ps. aeruginosa infections in 
CF but unfortunately it has proved less successful against B. cepacia in vivo, probably 
due to difficulty in achieving a high enough concentration of the drug within the lungs 
(Gold et a l 1983). This being one of several problems associated with antimicrobial 
chemotherapy of the CF lung. (Discussed in further detail later) Despite these 
problems ceftazidime is one of the main weapons in the therapy of B. cepacia infection. 
With around 90% of clinical isolates found to have susceptibility in vitro (Bhakta et al 
1992) it is one of the most effective agents available for treatment of B. cepacia 
respiratory tract infection. It is given intravenously, often in combination with other 
antibiotics such as lincomycih (Simmbnds et al 1990)
1.7.3 Drugs that inhibit protein synthesis
A number of drugs act to inhibit protein synthesis, employing several different modes of 
action. Aminoglycosides are a group of compounds that consist of 2 or more amino 
sugars linked by glycosidic bond to a central hexose core. Aminoglycosides are 
bactericidal and work in a number ways. Streptomycin binds to the 30s ribosomal
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subunit blocking protein synthesis by preventing binding of amino acyl t-RNA. 
Neomycins, gentamicins, kanamycins and tobramycin bind to multiple sites on the 
ribosome directing 16S RNA to bind to the 30 S subunit and so inhibiting translocation 
of amino acids from the A to P sites on the ribosome. This then prevents elongation of 
the polypeptide chain (Russell and Chopra 1990).
As described previously various regimens of aminoglycoside antibiotics in combination 
with p-lactam antibiotics have been used in treating CF lung infections, though these 
are generally ineffective due to the high levels of aminoglycoside resistance displayed 
by B. cepacia. Nebulised antibiotics, i.e. delivered as an aerosol, have proved more 
effective than other dosage forms as they are delivered directly to the lung epithelia, 
with tobramycin, a drug well tolerated by both adults and children, proving effective in 
controlling lung infection by Ps. aeruginosa (Friel 1995).
Tetracyclines are broad-spectrum antibiotics that inhibit protein synthesis in 70 S 
bacterial ribosomes and 80 S eukaryotic ribosomes. They are bacteriostatic, acting by 
preventing binding of amino acyl t-RNA to the acceptor A site (Franklin and Snow
1989). Chloramphenicol is a bacteriostatic drug that binds to the 50 S subunit of 70 S 
ribosomes, and acts by inhibiting peptidyl transferase activity. Although 
chloramphenicol inhibits many strains of B. cepacia in vitro (Santos -Ferreira et al 
1986, Prince 1986), resistance soon develops and the levels of the drug required to be 
effective in CF respiratory infections would have too many side-effects to be of clinical 
value. Macrolide antibiotics such as erythromycin, along with lincomycin and its semi­
synthetic derivative clindamycin, inhibit protein synthesis by inhibiting dissociation of
peptidyl tRNA from ribosomesLincomycin may be used in conjunction with ceftazidime 
for A cepacia therapy (Simmonds et al 1990)
1.7.4 Drugs inhibiting nucleic acid synthesis
A number of antimicrobial drugs act to inhibit nucleic acid synthesis Their actions can 
be divided into 3 main groups:
1. Compounds inhibiting precursor biosynthesis
These include sulphonamides and trimethoprim. Both drugs rely on the need for 
bacteria to synthesise folate, whilst mammalian cells take up folate supplied by diet. 
Sulphonamides are synthetic bacteriostatic agents based upon the structure of azo dyes. 
Sulphonamides inhibit folic acid biosynthesis as they are structural analogues of p- 
aminobenzoic acid (PABA). PABA is a substrate for dihydropreroate synthetase 
(DHPS). Sulphonamides compete with PABA for DHPS and are incorporated by the 
enzyme into inactive folate analogues with no biological usefulness. As mammalian 
cells have no DHPS the sulphonamides have selective toxicity for bacteria.
Trimethoprim belongs to a group of synthetic compounds, 2,4 -diaminopyrimidines that 
inhibit dihydrofolate reductase (DHFR) an enzyme of folate metabolism. Although 
most cells, including mammalian cells, have DHFR, trimethoprim is around 50,000 
times more active against bacterial DHFR. Trimethoprim is often used in combination 
with a sulphonamide, sulphamethoxazole, in a combination known as co-trimoxazole. 
Cotrimoxazole has been used with success in treatment of nosocomial infections of B. 
cepacia and is also initially effective in CF, but quickly develops high levels of 
resistance (Gilligan 1991). This limits its' use in CF therapy.
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2. Compounds that interfere with the DNA template
A wide range of compounds interferes with the DNA template including acridines and 
phenanthridines such as ethidium that intercalates into the DNA causing disruption. 
They have poor selective toxicity and would interfere with the patients DNA and RNA 
replication, along with that of the bacteria.
3. Compounds that inhibit enzymatic action 
Inhibitors of RNA polymerase
The rifemycins are a group of closely related antibiotics. Rifampicin is the most widely 
used. A semi-synthetic antibiotic, it acts by binding to DNA-dependent RNA 
polymerase and inhibits the initiation of RNA replication. It is selective for bacterial 
enzymes, having no effect on mammalian RNA polymerases.
Inhibitors of DNA gvrase (topoisomerase H)
The bacterial chromosome consists of DNA as a circular, highly supercoiled molecule, 
achieved by a number of enzymes. When DNA replication1 takes place daughter DNA 
strands may become entangled as a reult of torsional forces involved in supercoiling. 
Therefore enzymes are required to allow separation of daughter chromosomes and 
then to catalyse supercoiling of the DNA. The enzymes involved are known as 
topoisomerases. These enzymes include DNA gyrase, a topoisomerae II enzyme.
Several quinolone derivatives inhibit gyrase activity. The first used clinically was 
Nalidixic acid synthesised in the 1960s. Several other 4- quinolones have since been
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developed notably ciprofloxacin. Quinolones act by binding to DNA gyrase. This 
causes an impairment of function and the cells produce an 'SOS' response, filamenting 
and stopping replication of damaged DNA to daughter cells until DNA repair 
mechanisms can repair damage. The induction of the repair mechanisms whilst there is 
continued gyrase interference may be fatal to the cell. Mammalian topoisomerase II 
structure is sufficiently different for quinilones to have a selective reaction for bacterial 
cells.
Newer fluoroquinolones such as ciprofloxacin are not as well characterised as other 
classes of antibiotic drugs for use in CF, though significant levels of resistance to 
ciprofloxacin by B. cepacia have been observed (Bhakta et al 1992). The quinolones 
have the advantage of being delivered orally and have been employed with some 
success in prophylaxis o f Ps. aeruginosa in conjunction with inhaled colistin at the 
Edinburgh CF centre (Govan & Nelson 1992)
1.7.5 Drugs that inhibit membrane integrity
.Polymixin antibiotics are among the most widely used of these antibiotics. Polymixins 
are cyclicopolycationic peptides with a fatty acid chain joined by an amide bond. They 
have bactericidal activity as a result of their interactions with the cytoplasmic 
membrane causing disorganisation of membrane structure. They are of limited clinical 
use as they also have an affinity, if somewhat lower, for mammalian membranes. The 
polymixin colistin has been used in conjunction with ciprofloxacin in the prophylaxis of 
Ps. aeruginosa (Govan and Nelson 1992).
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1.7.6 Antibiotic uptake
To be effective antibiotics must be uptaken by the bacterial cell, crossing the cell 
membrane or membranes to reach their target within the cell or cell wall.
Several classes of antibiotics cross the outer membrane by passive diffusion through 
porin channels including chloramphenicol, tetracyclines and P-lactams. After entry p- 
lactams then act upon peptidoglycan synthesis in the cell wall. Chloramphenicol and 
tetracyclines cross the inner membrane via an active transport system.
Other classes of antibiotics use self-promoted mechanisms to enter the cell. 
Aminoglycosides cross the cell membranes by the displacement of cations from 
lipopolysaccharides by the polycationic drug. This then interferes with cross bridging 
of lipopolysaccharide molecules leading to destabilisation of the membrane and 
allowing the uptake of the antibiotic. Polymixms are believed to be taken up in a 
similar way. Quinolones cross membranes both through porin channels and by cationic 
displacement like aminoglycosides.
1.7.7 Antibiotic therapy in A  cepacia infections
The treatment of B. cepacia infections has proved very difficult particularly in CF. B 
cepacia is inherently resistant to or quickly develops resistance to many antibiotics 
(Lewin et al 1993). Trimethoprim/sulphamethoxazole (co-trimoxazole) and 
chloramphenicol have been historically used against B. cepacia infections as they 
demonstrate good activity in vitro. P-lactam drugs, particularly antipseudomonal 
penicillins such as carbenicillin and ticaricillin and cephalosporins have been the main
source of anti-pseudomonal chemotherapy over the last thirty years but have been 
shown to be largely ineffective against B. cepacia (Prince 1986). Aminoglycoside 
antibiotics, often inhaled by use of a nebulizer have proved effective in CF, particularly 
against Ps. aeruginosa (Friel 1995), sometimes in conjunction with P-lactams.
However virtually all B. cepacia isolates have inherent resistance to aminoglycosides. 
Combination therapy with intravenous temocillin and intravenous aminoglycosides has 
shown some clinical effect (Taylor et al 1992) (with 9 out of 12 courses showing 
positive effect despite resistance to aminoglycosides in most cases), but others have 
suggested aminoglycoside therapy may predispose for a B. cepacia infection (Govan 
and Nelson 1992). Resistance profiles and minimum inhibitory concentrations (MIC) 
to a range of the newer and more commonly used antibiotics have been determined for 
nosocomial isolates (Santos-Ferreira et al 1985) and CF isolates (Bhakta et al 1992). 
Both groups demonstrated resistance to aminoglycosides in 90-100% of isolates, whilst 
resistance to a similar degree to a range of cephalosporins and first generation anti­
pseudomonal penicillins such as conbericillin was described in the nosocomial isolates. 
Activity of newer anti-pseudomonal penicillins was much greater, 67% of nosocomial 
strains were susceptible to azlocillin and 85% to piperacillin, whilst only 15% of CF 
isolates were resistant to mezlocillin and only 11% resistant to piperacillin. The third 
generation aminothiazole cephalosporin, ceftazidime was found to be effective in vitro. 
93% of nosocomial and around 90% of CF isolates were found to be susceptible to co- 
trimoxazole (93%) and chloramphenicol (78%). High levels of resistance to quinolones 
were also found, with 60% of CF isolates being resistant to ciprofloxacin. More 
recently in the UK, (Lewin et al 1993, Butler et al 1995) higher levels of resistance
73
have been described with up to 92% of CF isolates resistant to chloramphenicol, 81% 
resistant to ceftazidime and 42% resistant to piperacillin.
Studies on experimental antibiotics have demonstrated mixed efficacy. Only 2 of 9 
experimental drugs demonstrated activity against B. cepacia when tested alongside the 
currently available antibiotics (Bhakta et al 1992). The other 7 antibiotics were a range 
of cephalosporins and fluorinated quinolones. The cephalosporin cefpirome showed 
only low level activity with only another deacetylcefotaxime showing a reasonably 
good level of activity. Studies on fluorinated quinolones have shown increased activity 
over current drugs such as ciprofloxacin (Espinoza et al 1988, Tamura et al 1988, 
Lewin et al 1993). Results with cephalosporins have been more mixed (Bosso et al 
1991, Bhakta et al 1992) although cefiprime was shown to have activity by one group 
(Bosso et al 1991), another demonstrated almost complete resistance to it (Bhakta ct al 
1992). The experimental polyene antibiotic faerieflingin demonstrated activity against 
B. cepacia but all Pseudomonas species tested were found to be resistant (Mulks et al
1990).
Despite their activity in vitro, antibiotics used in treatment of B. cepacia especially in 
CF often produce mixed results. Ceftazidime used frequently in treatment is often poor 
in curing B. cepacia CF lung infections (Gold et al 1983), as are co-trimoxazole and 
chloramphenicol (Prince 1986). The antipseudomonal penicllinases are also often 
ineffective. The use of a P-lactamase inhibitor, clavulanic acid has improved the 
activity of azlocillin against some strains oîPs. aeruginosa (Calderwood et a l 1982) 
but does not produce the same effect in B. cepacia (Prince 1986). However sulbactam,
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another P-lactamase inhibitor, has been found to have its own antibacterial activity 
against B. cepacia (Jacoby and Sutton 1989). The reasons for the poor in vivo activity 
are not clear. It may be due in part by failure to obtain a sufficiently high concentration 
of antibiotic within the lung to be effective (Gold et al 1983) whilst in vitro studies 
have suggested the CO2 levels and pH in the CF lung may decrease the susceptibility of 
B. cepacia but not Ps aeruginosa (Corkhill et al 1994).
The use of carbapenems, potent broad-spectrum P-lactam antibiotics, shows some 
promise. Meropenem appears to show better activity in vitro than several commonly 
used antibiotics to a range of CF and environmental strains (Lewin et al 1993, Butler et 
al 1995) whilst imipenem appears to have a synergistic effect in combination with a 
range of antibiotics (Kumar et al 1989). Although B. cepacia produces a carbapenem 
hydrolysing p-lactamase (Baxter and Lambert 1994) it is thought to be inactivated by 
p-lactamase inhibitors such as tazobactam and clavulanic acid and it appears the 
carbapenem or imipenem in conjunction with inhibitors may be successful (Simpson et 
al 1993). Environmental strains of A  cepacia often display high levels of resistance to 
many antibiotics. However recent research suggests they are somewhat more 
susceptible to drugs such as ceftazidime, piperacillin and meropenem (Butler et al 
1995, Pitt et a l 1996). It is of particular concern that 2 isolates from CF patients in 
Scotland and Wales were found to be resistant to all antibiotics tested against them 
including ceftazidime, piperacillin, ciprofloxacin and meropenem (Lewin et al 1993). 
Such multi resistant isolates present a particular problem in management of CF, and 
their potential for predominance is of great worry.
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1.8 Antibiotic resistance in B. cepacia
1.8.1 Mechanisms of resistance
Since the initial years of antibiotic therapy it has been known that certain species of 
bacteria were not killed by the actions of antibiotics. It was therefore recognised that 
antibiotic-resistant bacteria existed (Russell and Chopra 1990).
Two broad-based categories of antibiotic resistance are recognised; intrinsic and 
acquired or extrinsic resistance. Intrinsic resistance involves the inherent features of 
the cell being responsible for the failure of antibiotic action. Intrinsic resistance is 
normally expressed from chromosomal genes. It is the basis of much of the resistance 
of B. cepacia, Ps. aeruginosa and many opportunistic bacteria.
Acquired resistance is usually the result of selective pressure placed upon bacteria by 
antibiotic therapy. It is usually acquired either by mutation of chromosomal genes or 
by the acquisition of plasmid or transposon genes. The emergence and spread of 
acquired resistance is of great concern to medical science as resistance genes are 
relatively easilyacquired or passed on and can result in multiple resistance. This causes 
difficulty in treatment of resistant bacterial infections.
Bacteria have developed a number of strategies of antibiotic resistance (Russell and 
Chopra 1990). The main mechanisms include:
1. Alteration or inactivation of antibiotic.
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2. Antibiotic target site in bacterial cell is insensitive to the antibiotic and can still 
perform its normal function
3. Decreased accumulation of the antibiotic either by impaired uptake of the antibiotic 
or by increased efflux.
4. By -passing the antibiotic sensitive step by expression of an alternative target site 
that is insensitive to antibiotic action.
5. Overproduction of the target site so much higher concentrations of antibiotic are 
required to be effective.
6. Absence of an enzyme or metabolic pathway that is the target site for the antibiotic.
1.8.2 Intrinsic and acquired resistance in B. cepacia
Resistance in B. cepacia is primarily intrinsic,based largely around impermeability of 
the cell to antibiotics (Wilkinson and Pitt 1995b), though there is some evidence of 
acquired mechanisms of resistance, there is little knowledge of antibiotic resistance 
encoded by plasmids.
\
Trimethoprim resistant dihydrofolate reductase (DHFR) has been found to be produced 
in resistant B. cepacia CF isolates (Bums et al 1989b). The resistant DHFR producing 
isolates had MIC's of > 1000 pg mil*1 compared with,maximum levels of 10 pg ml*1 in 
non-producers, though only 39% were susceptible .This suggested though DHFR is the 
main mechanism of resistance in some strains, others have different resistance 
mechanisms.
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Resistance to p-lactams
Chromosomally encoded P-lactamases in B. cepacia have best known since the 1970s. 
B, cepacia 249 is able to utilise penicillin G as a carbon source (Beckman and Lessie 
1979), whilst P-lactamase deficient forms were not. In 1980 an inducible P-lactamase 
was obtained from B. cepacia (Hirai et al 1980). The majority of p-lactamases 
described in B. cepacia are inducible penicillinases (Baxter and Lambert 1994). One of 
the best described of these is the product of the penK  gene in B. cepacia 249 (Prince et 
al 1988, Proneca et al 1993). This was found to have homology with amp-C encoded 
p-lactamase from Enterobacteriacae and Ps. aeruginosa. The sequence of the penA 
gene is more closely related to the Enterobacteriacae suggesting it may have been 
acquired by B. cepacia from the Enterobacteriacae. There is evidence that all B. 
cepacia strains also express carbapenem hydrolysing p-lactamases or carbapenemases 
(Simpson et al 1993). Bacteria very rarely produce carbapenemases although B. 
cepacia along with Stenotrophomonas maltophilia and some strains of Serratiay 
Aeromonas and Bacteroides appear to be the exception. A carbapenem hydrolysing 
inducible P lactamase has been isolated from a clinical isolate of B-. cepacia (Baxter and
V
Lambert 1994). This was found to hydrolyse carbapenems, penicillins and 
cephalosporins including ceftazidime. The action of the enzyme was inhibited by metal 
ion chelators such as EDTA but this action was reversed by zinc indicating the 
requirement for metal ions- a métallo beta lactamase. The enzyme was named PCM-1 
{Pseudomonas cepacia métallo enzyme 1) and was subsequently found to be present in 
8 other B. cepacia clinical isolates (Baxter and Lambert 1994).
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Intrinsic antibiotic resistance is very important in B. cepacia. The resistance is 
primarily based upon the impermeability of the membrane to antibiotics Three main 
mechanisms of intrinsic resistance have been found
1. Decreased or altered membrane porin proteins
2. The nature of lipopolysaccharide in the outer membrane prevents binding of cationic 
antibiotics
3. An active antibiotic efflux pump decreases accumulation of drugs
1. Resistance by diminished porin content
The outer membrane of Gram negative bacteria has a low permeability to hydrophillic 
molecules. Forms are outer membrane proteins that form transmembrane pores that 
allow diffusion of hydrophillic molecules into the bacterial cell. B. cepacia, like Ps 
aeruginosa, is highly impermeable to hydrophillic molecules such as hydrophillic 
antibiotics including P-lactams. The permeability is around ten times less than for K  
coli (Parr et al 1987). Studies indicated that the porins of B. cepacia and Ps. 
aeruginosa have a small pore size thereby allowing only little diffusion of hydrophillic 
antibiotics, leading to general low susceptibility to such antibiotics. Porins in B. 
cepacia have been found to consist of an 81 kDa protein complex formed from two 
units of 36 kDa thought to be the main porin protein and 27 kDa protein. Reduced 
amounts of the 36 kDa protein and reduced expression of the 27 kDa protein have been 
found in CF antibiotic resistant isolates and p-lactam resistant mutants (Aronoff 1988). 
These alterations caused reduced permeability leading to resistance to ciprofloxacin and 
ceftazidime. Thediminished expression of the 27 kDa protein lead to speculation of its
role as the porin protein or as a major component of the porin complex. Salicylate 
induced resistance in a susceptible B. cepacia isolate has also been demonstrated to be 
the result of diminished expression of porin proteins (Bums and Clark 1992). The 
presence of a 40 kDa outer membrane protein was suppressed by growth with 
salicylate. The absence of the protein leads to decreased permeability to 
chloramphenicol, trimethoprim and ciprofloxacin but not to ceftazidime. The 40 kDa 
protein was termed OpcS (salicylate-suppressible outer membrane protein), whilst the 
36 kDa protein was found not to decrease with the presence of salicylate was termed 
OpcP.
2. Outer membrane LPS Structure
The outer membrane of B. cepacia and its' lipopolysaccharide structure prevent 
polycationic antibiotics such as polymixins and aminoglycosides binding to the outer 
membrane (Wilkinson and Pitt 1995b). These antibiotics have a self promoted uptake 
mechanism that requires cross bridging with LPS to cause cationic displacement to 
allow them to permeate through the bacterial membrane. Unlike Ps. aeruginosa, B. 
cepacia cells will not bind the fluorescent probe dansyl-polymixin (Moore and Hancock 
1986). It was thought that cation-binding sites on LPS were in some way concealed or 
protected. More recent studies (Cox and Wilkinson 1991, Wilkinson and Pitt 1995b) 
also suggested poor binding to the outer membrane. This finding was based upon the 
LPS structure of B. cepacia having few phosphate or carboxylate groups and the 
presence of the protonated amido sugar 4-amino-4 deoxyarabinose (Ara 4N) This 
results in a weakly anionic structure that therefore has poor binding to the cationic 
antibiotics.
3. Antibiotic Efflux Pump
Decreased permeability to chloramphenicol, trimethoprim and ciprofloxacin in B. 
cepacia had been reported on the basis of a 21.9 kb DNA fragment in B. cepacia 
(Bums et al 1989a). Analysis of a subcloned 3.4 kb fragment identified one complete, 
and one partial open reading frame (ORF) (Bums et a l 1996b). Based upon sequence 
data, outer membrane protein analysis, protein expression systems and lipoprotein 
assay, homology was found with 2 of 3 components of the Ps aeruginosa mexA-mexB- 
oprM  antibiotic efflux operon (Nikaido 1994). A lipoprotein with homology to oprM  
was found with the complete reading frame, homology at protein level to the C 
terminus of the mexB protein product was found with the partial reading frame. This 
analysis suggests the presence of an efflux pump, that would actively ‘pump out' 
antibiotics thereby preventing accumulation within the cell. Such an efflux pump would 
be similar to the proposed mexA-, mexB-oprM  pump proposed in Ps. aeruginosa.
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1.9 Plasmids in B. cepacia
Plasmids are DNA molecules that can replicate independentlyof, and co-exist with the 
host chromosomes) (Day 1982). They are in essence mini chromosomes usually 
formed of negatively supercoiled circles of double stranded DNA. Plasmids carry 
genes that encode for a wide variety of functions including antibiotic resistance, heavy 
metal resistance, bacterial conjugation, bacteriocin production, antibiotic production 
and metabolism of simple and complex compounds (Summers 1996). Plasmid genes do 
not normally encode for essential functions in the bacterial host or plasmid under 
normal conditions, but rather encode for properties that allow growth under abnormal 
growth conditions; extending host range into atypical environments or encoding for 
increased metabolic diversity (Day 1982, Summers 1996). Plasmid genes are 
transferable between individual bacteria and between species and therefore are 
important agents in horizontal gene transfer and bacterial evolution. Plasmids are most 
frequently transferred by bacterial conjugation, but may also be transferred via 
bacteriophage (transduction) or by uptake of naked DNA (transformation) (Amabile- 
Cuevas and Chicarel 1992).
Relatively few B. cepacia plasmids have been studied in detail, with few phenotypic 
characteristics assigned to plasmid genes.. Gonzalez and Vidaver (1979) found 
plasmids in 15 of 16 environmental and clinical isolates. The plasmids found varied in 
size from 9 to 120 MDa (14-185 kb). The type strain, ATCC 25416 contained a 185 
kb plasmid. The presence of such large plasmids suggested a role in antibiotic 
resistance to the researchers. Subsequently smaller plasmids encoding antibiotic 
resistance were found (Williams et al 1979, Hirai et al 1982). Lennon and DeCicco
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(1991) found 84 % of clinical, pharmaceutical and environmental isolates (31/37) 
harboured one to four plasmids between 2.7 to 222 kb in size. Large plasmids of 146 
to 222 kb were commonly found in clinical isolates with a higher antibiotic resistance 
phenotype so, like Gonzalez and Vidaver, Lennon and DeCicco suggested these large 
plasmids played a role in antibiotic resistance without assigning any phenotypic traits to 
specific plasmids. Large plasmids o f208 and 212 kb were also found in strains 
obtained from onions. Restriction digest analysis showed significant differences 
between 212 kb plasmids in pharmaceutical and environmental strains but demonstrated 
identity between two 222 kb plasmids in pharmaceutical isolates. Analysis of the 222 
kb plasmids showed high levels of homology, suggesting a close relationship or 
common source of these plasmids. This group sized the type strain cryptic plasmid at 
212 kb whilst Rodley et a l (1995) sized it at 200 kb as compared to the 185 kb 
described by Gonzalez and Vidaver (1979). In addition transfer of plasmid DNA into 
B. cepacia by conjugation was demonstrated. R751, a plasmid of incompatibility Inc 
P-l, encoding for trimethoprim resistance was transferred from Ps. aeruginosa into 
four B. cepacia isolates at a transfer frequency of between 4 x io*7 to 7 x 10*4 donor 
cells ml-^of mating mix. Transfer of plasmid from a B. cepacia R751 transconjugant to 
three other B. cepacia recipients at frequencies of 2 x io-6 to 3  x io*5 donor cells ml-1 
of mating mix was achieved. This showed the ability of plasmid DNA, and significantly 
antibiotic resistance, to be conjugatively transferred into and between B. cepacia 
strains. Despite the high levels of B. cepacia plasmids in these studies McKevitt and 
Woods (1984) found plasmids in only 11 o f48 (23%) B. cepacia isolates from CF 
patients as compared to 84% of plasmid containing isolates found by Lennon and 
DeCicco (1991) in non CF isolates. Seven isolates contained a 60 MDa (92 kb)
plasmid, another isolate contained 2 plasmids of 100 mDa (154 kb) and 50 mDa (77 
kb) and the final isolate a 50 MDa (77 kb) plasmid. No phenotypic characteristics were 
assigned to the plasmids.
#
More recently a number of conjugative plasmids encoding catabolic phenotypes have 
been described (Bhat et al 1994, Haak et al 1995, Shields et al 1995, Prakash et al 
1996). These are discussed in detail later.
Insertion elements have been found within B. cepacia plasmids. Byrne and Lessie 
(1994) described two IS 3 family insertion elements, IS 401 and IS 408, within the 170 
kb cryptic plasmid pTGL 1 in 5. cepacia ATCC 17616. These elements have been 
demonstrated to play a role in the genetic rearrangement of the plasmid. The novel 
insertion elements IS 1071 and IS 1471 have also been found in B. cepacia plasmids 
(Xia et al 1996). IS 1471 inserts into IS 1071 found on the 102 kb plasmid pUB 1. 
These sequences do not belong to any known IS group.
1.9.1 Antibiotic resistance plasmids in R  cepacia
The rôle of plasmids encoding for antibiotic resistance in B. cepacia has not been 
extensively explored (Wilkinson and Pitt 1995). Prior to the study of Lennon and 
DeCicco (1991), which did not assign any resistance phenotypes, there had been only 
two descriptions of antibiotic resistance plasmids in B. cepacia. Transformation of 
plasmid DNA from B. cepacia 4G9 into E. coli HB101 resulted in the discovery of a
2.9 MDa (4.4 kb) plasmid, pJW 2, encoding tetracycline resistance and a 5.2 MDa (8 
kb) plasmid , pJW 3 , encoding for constitutive ampicillin resistance (Williams et al
1979). Electron microscopy also permitted visualisation and identification of a 1.78 
MDa plasmid, pJW 1. These plasmids were of insufficient size to be conjugative.
A larger 32 MDa (49 kb) plasmid, Rms 425, was found to mediate streptomycin and . 
mercury resistance in B. cepacia GN11131 (Hirai et a l 1982). Transformation of 
plasmid DNA was achieved between GN11131 a non-resistant mutant, ML5062, and 
Ps. aeruginosa PAO 21242 (Hirai et a l 1982). Plasmid DNA was obtained by 
equilibrium gradient ultracentrifugation. It was also possible to transform the plasmid 
from Ps. aeruginosa PAO 21242 transformants to E. coli, B. cepacia and other Ps. 
aeruginosa strains. Mating experiments were also conducted from Ps. aeruginosa and 
E  coli plasmid-transformarits into E. coli and Ps. aeruginosa nalidixic acid resistant 
recipients to determine conjugative properties of the plasmid. Transfer was achieved at 
a low frequency (2 % 10 '7 to < 10"* ) by membrane filter mating, but no transfer was 
found by broth mating. No transfer was achieved using B. cepacia as the donor, 
possibly due to a defect in the transfer mechanisms. Incompatibility testing placed the 
plasmid in the Inc P-l group. The resistance to streptomycin was believed to be due to
V
a streptomycin phosphotransferase (Hirai et al 1982).
Subsequently there has been little published evidence of antibiotic resistance plasmids in 
B. cepacia, though a number of broad host range mercury resistant plasmids have been 
described(Rochelle et al 1988, Sabate et al 1994). The 78 kb plasmid pQM3 was 
found in a river epilithon B. cepacia strain (Rochelle et al 1988) and the 54 kb plasmid 
pAMJ6 (Sabate et al 1994) from natural water. pAMJ6 was placed in incompatibility 
group Inc P-l.
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1.9.2 Degradative plasmids in B. cepacia
The majority of the plasmids described as encoding catabolic pathways in B. cepacia 
are large conjugative plasmids (Bhat et al 1994, Haak et al 1995, Shields et al 1995). 
Shields and co-workers found a 108 kb TOM plasmid encoding for the unique toluene- 
oztAo-monooxygenase (TOM) toluene degradative pathway. This pathway is 
significantly different from the pathways of the common TOL plasmids in having an 
initial monooxygenase step, then proceeding by toluene hydroxylation. TOL plasmids 
encode the ability to oxidise toluene via a benzoate intermediate. On the basis of the 
Tom enzyme the plasmid was named TOM. Curing of the plasmid removed the ability 
to grow on toluene or phenol. Conjugative transfer of TOM to other B. cepacia 
isolates, E. coli and into a TOM cured isolate was achieved . However transfer to E. 
coli was not accompanied by toluene degradation, possibly due to lack of recognition 
of the TOM promoter, though cloning of tom A and tomB genes from the tom operon 
and transfer into a recombinant £. coli lead to expression of the genes. The 
recombinant E. coli did not encode for the full pathway, but showed trichloroethylene 
degradation activity, supporting the suggestion that the promoter was not recognised in 
the E. coli transconjugants.
Haak et al (1995) described a 70 kb plasmid, pBAH 1, encoding for a 2-halobenzoate
1.2 dioxygenase in B. cepacia 2 CBS. Conjugative transfer of the plasmid was 
investigated by first transforming into E. coli and then using the transformant as a 
donor for conjugal transfer into a Ps. putida recipient. The gene cluster encoding for 
the enzyme, cbdABC, was sequenced and cloned. Cloned genes were subsequently
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expressed in Ps. putida, which could then metabolise chlorobenzoates. Sequence 
homology to an Acinetobacter sp. 1,2 dioxygenase was found.
Bhat et al (1994) described a 90 kb plasmid, pMAB 1, encoding genes involved in 2,4- 
D degradation in B. cepacia CSV 90. The role of the plasmid was deduced by curing 
and transformation studies. Replica plating on media with and without 2,4-D was used 
to find spontaneously cured CSV 90 clones unable to grow on 2,4-D. These 2,4-D" 
isolates were subsequently checked for presence of the plasmid. The cured strains 
were found to have lost pMAB 1. Transformation of cured isolates with pMAB 1 was 
conducted using electroporation. The electroporated cells were able to grow on 2,4-D 
and contained a 90 kb plasmid. Cloning of a 10 kb plasmid fragment and expression in 
K  coli found a gene, IftC, encoding for a dichlorocatechol dioxygenase. Sequence 
homology analysis found the gene to be identical to a gene from a 2,4,-D degrading 
Alcaligenes eutrophus plasmid, pJP4. However restriction mapping of the pJP4 and 
pMABl plasmids found them to be different overall, implying that the gene had been 
acquired from the other plasmid or a common source.
In contrast small plasmids, e.g. a 5 kb /7-nitrophenol degradative plasmid, are also 
found in B. cepacia (Prakash et al 1996). This degradative property could be 
transferred conjugally, either through plasmid mobilisation or through incorporation 
into a transposon. The plasmid also encoded for zinc resistance.
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1.10. Comparative properties and relationships of clinical and 
environmental B. cepacia isolate»
The potential to acquire B. cepacia infection from environmental sources is of serious 
concern, especially in view of its use as an agent of biocontrol in agriculture and 
bioremodiation. There are considerable gaps in the knowledge about transmissibility of 
B. cepacia, although there is strong evidence for person to person transmission, there 
are large contrasts in the transmission rates in CF centres world-wide (Govan et al 
1996) and between CF siblings (Cazzola et al 1996). It is therefore important to 
understand relationships between clinical and environmental isolates of B. cepacia.
Early studies compared clinical and environmental isolates on the basis of bacteriocin 
production, plasmid content, pectinolytic activity and the ability to macerate onion 
tissue (Gonzalez and Vidaver 1979). The results divided isolates into two broad 
groups. Generally environmental isolates had strong pectinolytic and onion macerating
v
activity, whilst clinical isolates had much weaker activity. Both groups contained 
plasmids and were found to be equally lethal to mice in in vivo studies. More recent 
phenotypic studies between rhizosphere and clinical strains again showed differences in 
properties (Bevivino et a l 1991). The rhizosphere strains were able to grow at a wider 
range of temperatures and were antagonistic to a wider range of phytopathogenic fiingi 
than clinical strains. Clinical strains could bind to human uroepithelial cells, whereas 
environmental strains could not. In contrast to this Butler et al (1995), found CF
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strains, notably the epidemic ET12 strain, were as capable of causing in vitro onion 
maceration as environmental strains.
The study of Yohalem and Lorbeer (1994) used virulence to onion, catabolic ability, 
pigment production, gelatin hydrolysing and pectinolytic activity to group 218 clinical, 
soil and phytopathogenic isolates into four phenoms or clusters. Phenom I was a 
heterogeneous group of onion macerating and non-macerating strains. Phenom n  
were highly pectinolytic, onion macerating bacteria many of which produced diffusible 
pigments. This group included the species type strain. Phenom HI were non­
macerating and contained the majority of clinical isolates. Phenom IV contained only 
strains isolated from celery fields. The use of DNA-DNA and DNA-rRNA 
hybridisation studies have shown B. cepacia to consist of at least four genomovars 
(Vandamme 1995, Govan et al 1996). Most environmental isolates fall into genomovar 
I with the species type strain. The strains associated with a rapid decline in CF all fall 
into genomovar HI.
\
Differences in antibiotic resistance between clinical and environmental isolates have 
also been noted. Although the majority of isolates are resistant to many antibiotics 
intrinsically, differences in resistance to quinolones and newer B-lactam drugs have 
been found; clinical isolates having higher resistance levels to piperacillin, ceftazidime, 
meropenem and ciprofloxacin (Butler et al 1995).
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1.10.1 Epidemiology of environmental and clinical strains.
Comparative analysis of clinical and environmental strains has suggested that 
environmental strains are incapable of causing human infection (Bevivino et al 1994). 
This is almost certainly not the case as * swamp foot* lesions in US marines have been 
demonstrated to be caused by B. cepacia (Taplin et a l 1971). Evidence of any 
epidemiological relationships between clinical and environmental strains is poor, 
hampered by a lack of information. Investigations by clinicians of the prevalence of B. 
cepacia in the environment have suggested that it is difficult to isolate B. cepacia from 
the environment using media routinely used in clinical laboratories. B. cepacia was 
recovered from 18 % of samples taken in the homes of CF patients infected with B. 
cepacia, and from 4 % of samples from the general urban environment (Mortensen et 
al 1995). A previous study had found B. cepacia at lower rates(Fisher et al 1993). B. 
cepacia was only recovered from 1 % of samples taken in patient homes and 4.5 % of 
samples in food bars and supermarket salad and vegetable counters (Fisher et al 1993). 
The main source of B. cepacia appears to be organic soils, where an isolation rate of 
over 20 % has been found (Butler et al 1995).
t
The development of effective typing techniques has enabled better epidemiological 
studies of environmental strains. Fisher et al (1993) used ribotyping to demonstrate 
that the predominant CF ribotype could also be found in the environment, where it 
could be a potential reservoir of infection. In the UK no evidence of potential 
environmental transmission has been found suggesting the environment is of little 
hazard to CF patients. Butler et al (1995) used PFGE macrorestriction analysis with 
the endonucleases Xba I anàSpe I and produced unique profiles for each of 12 tested
environmental strains. These differed from 11 clinical isolates including the epidemic 
ET 12 strain. No environmental strain tested has yet been placed in genomovar HI with 
the ET 12 CF epidemic strain.
Typing of N. American isolates by multilocus enzyme electrophoresis and ribotyping 
has placed all tested environmental strains into separate electropherotype clusters to CF 
or nosocomial B. cepacia isolates (Johnson et al 1994). However a close genetic 
relationship between the ET 12 epidemic strain and the species type strain has been 
found. More recent evidence from Italy (Amalfitano et al 1996, Cazzola et al 1996), 
has suggested that person-to-person transmission and environment-to-person 
transmission may occur in CF patients.
The knowledge regarding the infectious potential of environmental B. cepacia strains is 
very limited, particularly as so few isolates have been studied. This has lead to caution 
being advised over the use of B. cepacia as an agent of biocontrol and bioremediation 
by some groups ( Butler et al 1995, Govan et al 1996).
91
1.11. Aims of study
The primary aim of the study is to characterise and compare B. cepacia isolates 
obtained from the sputum of CF patients and a range of environmental sources. The 
majority of the CF isolates were from the South Wales area, so to assess the 
relationships between environmental and clinical isolates in this area a number of B. 
cepacia strains were isolated from a range of environmental sources. These isolates, 
along with a number of others from clinical and environmental sources from the UK 
and world-wide, were then be characterised phcnotypieally by their phytopathogcnicity 
and antibiotic resistance profiles. Genetic characterisation would be made on the basis 
of PCR ribotyping and macrorestriction analysis. The replicon arrangement of the 
genome was investigated by PFGE.
The second major aim of the study was to investigate plasmids in B. cepacia. Plasmid 
content and size was characterised by a range of plasmid DNA isolation methods. 
Identification and characterisation of antibiotic resistance plasmids was undertaken by 
curing studies and mating experiments. Conjugal transfer of antibiotic resistance and
V
other plasmids was investigated by laboratory mating experiments. Transfer of 
plasmids from environmental sources was also investigated.
In addition to these main aims a number of other factors were investigated: assessment 
and development of selective media for isolation of B. cepacia from the environment, 
development of quantitative tests for phytopathology of onion, assessment of methods 
for plasmid DNA isolation in B. cepacia and the application of molecular typing 
methods to environmental B. cepacia isolates.
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Chanter 2 Isolation and identification of Burkholderia cepacia
2.1 Introduction
As described in the general introduction, a number of media have been developed for 
the isolation of B. cepacia from clinical specimens, most notably CF sputum, and the 
environment (Wu and Thompson 1984,Gilligan et a l 1985, Hagedom et a l 1987). B. 
cepacia from CF patients in the UK is primarily isolated from liquefied sputum on 
Mast cepacia (PC) agar based on that described by Gilligan et al (1985) (Govan and 
Nelson 1992). Confirmatory identification is usually based on the API 20NE system 
and/or biochemical reactions.
Environmental surveys in the UK have used Malka minimal media supplemented with 
300U ml'1 of polymixin for initial enrichment prior to growth on the Mast medium (Pitt 
and Govan 1993, Butler et al 1995). For surveillance of surfaces, swabs moistened in 
the supplemented Malka medium have been used to swab the surface, these were either 
plated directly onto the Mast cepacia agar or placed in the Malka media and grown for 
5 days at 30°c prior to plating. Soils and vegetation (around a teaspoonful) were
V
placed directly into the Malka medium and grown for 5 days prior to plating on the 
Mast medium. Waters were filtered through a membrane filter; the filter then being 
treated as soil. Similar methods have been employed in the USA (Fisher et a l 1993) 
The low levels of B. cepacia isolated from the environment in other studies (Fisher et 
al 1993, Butler et al 1995, Mortensen et al 1995), suggest that more efficient media 
that allow the growth of B. cepacia but inhibit the growth of other species may be 
developed.
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2.2 Materials and methods 
Material»
L Chemical»
Sterile liquid paraffin (BDH Ltd., Poole, Dorset)
Salicin, Analar grade (BDH Ltd.,)
Maltose, Analar grade (BDH Ltd.,)
Lactose, Analar grade (BDH Ltd.,)
Industrial methylated spirits (BDH Ltd.)
Trypan blue (Gurr, BDH Ltd.)
Crystal violet (Gurr, BDH Ltd.)
Tetracycline (Sigma Chemical Co., Poole, Dorset)
Gentamicin (Sigma Chemical Co,)
Tetramethyl-/?-phenylenediamine dihydrochloride crystals (Sigma Chemical Co.)
ii. Strains
Strains obtained from PELS, Dublin and Type Strain Collections
Strainsobtained from the PHLS are shown in Table 2.1, those obtained from Dublin in
t
Table 2.2 and those obtained from the National Industrial and Marine and National 
Plant Pathogenic Collections in Table 2.3. Isolates, with sources of other species used 
in the study are shown in Table 2.4
Maintenance and storage of strains
As problems have been reported with maintenance of B. cepacia at 4° C (Gilardi 
1983), all isolates obtained were frozen in broth culture with 20 % v/v sterile glycerol
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as a cryoprotective agent at -70°C. Isolates were recovered from frozen stocks as and 
when required.
Table 2.1 B. cepacia isolates from PHLS Cardiff
ISOLATE SOURCE OTHER INFORMATION
C1(KW) Cardiff CF Clinic Paediatric Isolate
C5 (JR) Cardiff CF Clinic Paediatric Isolate
C ll (DR) Cardiff CF Clinic Paediatric Isolate, Sibling of C5 (JR)
C23 (RW) Cardiff CF Clinic Paediatric Isolate, Sibling of Cl (KW)
C49 (NL) Cardiff CF Clinic Paediatric Isolate
C51 (AM) Cardiff CF Clinic Paediatric Isolate
C59 (BH) Cardiff CF Clinic Adult Isolate
C79 (KT) Cardiff CF Clinic Adult Isolate
C81 (CP) Cardiff CF Clinic Adult Isolate
C93 (AW)
C95 (PS) Cardiff CF CUnic Adult Isolate
C96 (HW) Cardiff CF Clinic Adult Isolate
Cl 16 (JJ) Cardiff CF Clinic Paediatric Isolate (Swansea)
C187 (KP) Cardiff CF Clinic Adult Isolate
C190 Quality Control Isolate Sent as part of Quality Control study
C205 (IS) Cardiff CF Clinic Adult Isolate
A562 Scotland (Edinburgh) 
CF Isolate ;
A548 Scotland (Edinburgh) 
CF Isolate ■ -  -
C1858 Scotland (Edinburgh) 
CF Isolate
Cl 860 Scotland (Edinburgh) 
CF Isolate
1478 Strasbourg (France) 
CF Isolate
J543 Strasbourg (France) 
CF Isolate
J2552 Rhizosphere of 
Cariudoucas palmata
Isolated in tropical aquatic house
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Table 2.2 R  cepacia isolates from Dublin
ISOLATE SOURCE OTHER INFORMATION
D1 (LB) Dublin CF clinic Paediatric Isolate (Failed to Grow)
D2 (DC) Dublin CF clinic Paediatric Isolate
D3(MF) Dublin CF clinic Paediatric Isolate
D4(SH) Dublin CF clinic Paediatric Isolate
D5 (SB) Dublin CF clinic Paediatric Isolate
D6  (MR) Dublin CF clinic Paediatric Isolate
Table 2.3 NCEMB and NCPPB R  cepacia strains
STRAIN SOURCE OTHER INFORMATION
NCIMB 9085 Forest soil, Trinidad Synonymous with ATCC 17759 
NCTC 10661
NCIMB 9087 Rotting tree trunk, 
Trinidad
Synonymous with ATCC 17761
NCIMB 9088 Jamaica Synonymous with ATCC 17769 
Produces purple phenazine pigment
NCIMB 9092 Jamaica Synonymous with ATCC 17772 
Produces purple phenazine pigment
NCPPB 2993 Onion, U S A Synonymous with ATCC 25416 
Species Type Strain
"NCPPB 3480 Onion 
Papua New Guinea
Strains obtained from National Collection of Industrial and Marine Bacteria (NCIMB) 
(Aberdeen, Scotland), and National Collection of Plant Pathogenic Bacteria (NCPPB) 
(Harpenden, Hertfordshire).
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Table 2.3 Other (Non-ZL cepacia) Strains used in this study
STRAIN SOURCE OTHER INFORMATION
Burkholderia 
gladioli 
NCPPB 2478
Onion,
India
allicola pathovar
Escherichia coli 
NCTC 10418
Pseudomonas
aeruginosa
PAOl/pQMl/
R300B
University of Wales 
College 
Cardiff (UWCC)
pQMl= 251 kb mercury resistance 
plasmid
Ps. aeruginosa 
PAO1/R300B
UWCC R300B = 8 .5kb plasmid
Ps. aeruginosa 
PAO 2002 ZRP1
UWCC RP1 = 65kb plasmid 
Encodes for 0-lactamase
E. coli V517 PHLS, Colindale Size marker: 
contains 8  plasmids
E. coli 39R PHLS, Colindale Size marker: 
contains 4 plasmids
Alcaligenes 
eutrophus 
NCIMB 11842
Soil Species Type Strain
Stenotrophomonas
maliophilia
5018
PHLS, Cardiff
S. maliophilia 
5851
PHLS, Cardiff \
S .maliophilia 
4543
PHLS, Cardiff
Other strains used from the collection of Microbiology Section, School of Biomedical 
Sciences, University of Wales Institute Cardiff
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Culture of R  cepacia strains
For overnight culture on agar plates B. cepacia strains were grown on Nutrient agar 
plates for 24 h at 35°C from single colonies sub-cutlured from other plates maintained 
at room temperature,or from broth culture from recovered isolates store frozen at -  
70°C.
Overnight broth cultures were grown in static culture from single colonies on agar 
plates in 10 ml of Nutrient broth at 35°C for 16h to give a culture of approximately 
10  7cfu ml-1 unless otherwise stated
The above conditions apply to all overnight cultures throughout the thesis, unless 
indicated otherwise.
iii. Media
Nutrient agar plates (Oxoid, Unipath, Basingstoke, Hants.)
Nutrient broth (Oxoid, Unipath)
Pseudomonas cepacia (PC) media and selectatabs (Mast Diagnostics, Bootle, 
Merseyside)
Andrade peptone water (Oxoid, Unipath)
k
MacConkey agar plates (Oxoid, Unipath)
Bacteriological agar (Agar No.2) (Oxoid, Unipath)
TB-T agar (Hagedom et al 1987) and variations as noted in the method section.
Onion {Allium cepa), sound and apparently disease-free, purchased from local 
supermarkets.
iv. Solutions and commercial kits
API 20NE kits, James, N IT , NTT 2 and Zn reagents (BioMerieux, Marcy l’Etoile, 
France).
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MacFarland Standards (BioMerieux)
v. Equipment
Glass Petri dish and plate spreader 
3 ml Bijou bottles 
Durham tubes
vL Disposable consumables
90 mm Petri dishes 
Sterile toothpicks
Sterile polypropelene 20 ml Universal bottles
Filter paper (Whatman No 1, Whatman International Ltd., Maidstone, Kent)
Sterile stockingette (or muslin)
Methods
i. Environmental sampling
Two separate rounds of environmental sampling were conducted, each at a range of
representative sites at industrialised and rural areas throughout South Wales. For the
%
first round of sampling (Survey #1) samples were plated only on to Mast PC agar. For 
the second set of samples (Survey #2) each was plated on PC, TB-T, TB-T-CN, 
Onion-T and Onion T-CN media.
Soils:
Around 2-3g of soil was collected into sterile universal containers. This was mixed 
with 10 ml of sterile water by vortexing for 5 minutes. This was allowed to settle 
before preparing dilutions of the upper aqueous layer in sterile water from neat to 10"2 . 
lOOpl of each dilution was spread onto the surface of selective agar plates.
Rhizosphere (Root Shake):
Plant roots were removed gently from the ground and placed into a sterile container. 
10ml of sterile water was added to the container. The samples were vortexed for 5 
minutes. The sample was allowed to settle and the upper layer treated as for soil 
samples.
Water / sediment
Around 10ml of water and sediment were aseptically collected into sterile universal 
containers in an upstream direction. Samples were vortexed for 5 minutes and allowed 
to settle. lOOpl of the upper layer was spread onto the surface of PC plates.
Rotten Onions:
A sterile loop was used to scrape the scales of rotten onions. This was then streaked 
onto the surface of PC plates.
With all types of sample the plates were incubated at 30°C for 48 h. Any growth was 
recorded and sub-cultured onto Nutrient agar plates for identification, 
i t  Identification/characterisation
A. Identification by API 20NE system
Prior to identification using the API 20NE system, all isolates were Gram stained and 
their morphology investigated. Gram negative rods were then identified by API 20NE. 
Other isolates were discarded.
The API 20NE system is a standardised system using 20 tubes and cupules on a strip 
that contains dehydrated reagents and media that form 8  conventional biochemical and 
12 assimilation tests. An oxidation test is employed as the 21st test. The oxidase test
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used was based on that of Koyacs (Barrow and Feltham 1993). A fresh solution of 
medium was prepared by adding 1 0  ml of sterile distilled water to a few crystals of 
tetramethyl-p-phenyldiamine dihydrochloride. A few drops of this solution were used 
to moisten filter paper in a sterile petri dish. The isolate was tested by picking a colony 
from a fresh plate culture with a toothpick and smearing onto the filter paper. A 
positive reaction leads to the development of a dark purple colour in 30 seconds. Ps. 
aeruginosa was used as a positive control, K  coli as a negative control. The results of 
the oxidase test were recorded on the API 20NE report form.
For the remainder of the tests, the manufacturer’s protocol was followed. After 24 h 
the results were recorded and added together to give a numerical profile. The 
numerical profile was entered into the API LAB v.3.1 program on a personal computer 
or compared with the Analytical Profile Index to identify the isolate. In some cases 
identification is not possible after 24hours due to slow growth. For such results the 
TRP and NO3 tests were covered with paraffin to prevent any ongoing reactions 
interfering with the other tests. The strip was re-incubated for another 24 hours and 
read again. The profiles were then calculated and the identification process repeated .
B. Confirmatory biochemical tests for B. cepacia
In a number of cases API 20NE results gave doubtful or unacceptable profiles for B. 
cepacia, with Ps. fluorescens, Ps. putida, Ps. paucimobilis, Stenotrophomonas 
maltophilia and Aeromonas species given as alternatives. To determine the identity, 
acidification of sugars in ammonium salt media was chosen from Cowan and Steel’s 
Manual for Identification of Medical Bacteria (Barrow and Feltham 1993). B. cepacia
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produces acid from maltose, lactose and salicin whilst Ps. fluorescens or Ps 
.aeruginosa will not give acidification with lactose or maltose, Ps. putida or 
Stenotrophomonas maltophilia will not produce acid with salicin. Ps. paucimobilis 
will not grow on MacConkey agar whilst B. cepacia will grow.
Acidification of sugars
Andrade peptone water was made up to the manufacturer’s instructions and 1.8 ml 
placed into Bijou bottles. Inverted Durham tubes were placed into the bottles, which 
were then sterilised by autoelaving. 1 0  % w/v stock sugar solutions were produced in 
distilled water ( 2  g in 2 0  ml of water) and filter sterilised. 2 0 0  pi of the stock sugar 
solution was added to each Bijou aseptically to give a final sugar concentration of 1 %.
The bottles were inoculated with the isolates to be tested. The inoculated bottles were 
incubated for 14 days at 37 °C. The bottles were checked daily for acidification. 
Acidification is indicated by presence of a pink- red colour. Presence of bubbles in the 
Durham tube indicates gas production.
Growth on MacConkey agar.
Isolates were streaked onto the MacConkey agar and then incubated at 37° for 48 
hours. After incubation plates were checked for growth.
Development of selective media and assessment of media for B. cepacia isolation 
On the basis of apparent selectivity of agar containing onion homogenate for B. 
cepacia during phytopathogenicity testing (see Chapter 3), it was decided to use onion 
within a selective medium for B. cepacia as this may allow select ion by supporting
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growth of B. cepacia whilst inhibiting growth of other species. Onion homogenate was 
produced by adding equal volumes of onion tissue, including skin, to equal volumes of 
sterile saline mixing in a Kenwood kitchen blender for 2 min and then filtering through 
conical flask alông with the onion homogenate and Ipl ml*1 of trace element solution to 
give a 2% agar with 20% onion homogenate. The agar was autoclaved at 121°C, 15 
p.s.i. for 15 minutes and then maintained at 50°C in a waterbath. The agar was either 
poured directly to give Onion (O) Agar, or tetracycline added at 20pg ml*1 ,the same 
level as in TB-T, to give Onion-T (O-T) agar, gentamicin at 5pg ml'1 to give Onion-CN 
(O-CN) agar or both tetracycline and gentamicin to give Onion-T-CN (O-T-CN) agar.
TB-T agar was produced as described by Hagedom et al (1987), using crystal violet as 
the antifiingal component. TB-T was also supplemented with gentamicin at 5pg ml'Ho 
give TB-T-CN agar. Mast selective agar (PC) was produced according to 
manufacturer’s instructions.
The suitability of each medium to select for B. cepacia and the optimum temperature 
for isolation was tested using 26 B. cepacia isolates and 12 isolates from other species, 
including isolates reported as growing on B. cepacia selective media (Gilligan et al 
1985 , Hagedom et al 1987). Three sets of plates were produced to test growth at 
20°C, 30°C and 37°C. Nutrient agar plates were included as a control for growth of 
isolates,
1 ml of overnight growth of isolates was pipetted into the PTFE dish of the Mast 
Multipoint Inoculator. The sterile pins of the inoculator were placed into the holder
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and the inoculator was operated to introduce spots of culture onto the surface of 3 sets 
of Nutrient agar, PC, TB-T, TB-T-CN, O, O-T, O-CN and O-T-CN plates. One set of 
plates was incubated at 20°c for 48 h, one at 30°C for 48 h and the final set was 
incubated at 37°C for 48 h. After the incubation growth on each plate was recorded 
On the basis of their selectivity, the ability to support growth of B. cepacia but to 
inhibit other species, the more successful media were chosen for use in the secon round 
of environmetal sampling.
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2.3 Results
2.3.1 Environmental survey #1
The sites from which isolates were obtained, along with Ordnance Survey references, 
and nature of samples from which they were obtained are shown in Table 2.5 below. 
Tablc2.5 Strains isolated in environmental survey #1:
Source, sample tvnc and media used for isolation
Isolate Sample Site 
(Ordnance Survey Ref.)
Sample
Type
Media Used 
For 
Isolation
PW1 R. Rhondda Tributary, Cwmparc, 
Treorchy, Rhondda Cynon Taff 
(SS 945 952 )
Water PC
PW 2 R. Rhondda Tributary, Cwmparc, 
Treorchy, Rhondda Cynon Taff 
(SS 944 952)
Water PC
PW 3 R. Ogwr, Ogmore Castle, Bridgend 
(SS 883 760 )
Water PC
PW 4 R. Ely, Coed Ely, Rhondda Cynon 
Taff 
(ST 022 857)
Water PC
PW 5 Woodland, Coed Ely, Rhondda 
Cynon Taff 
(ST 022 857)
Soil PC
PW 6 R. Rhondda Tributary, Cwmparc, 
Treorchy, Rhondda Cynon Taff 
(SS 945 953 )
Water PC
PW 7 Woodland, Coed Ely, Rhondda 
Cynon Taff 
(ST 022 858)
Soil PC
PW 8 Rotten
Onion
PC
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2.3.2 Growth of A  cepacia and other species on selective media.
Growth of the 26 clinical and environmental B. cepacia isolates and the 12 strains from 
non- B. cepacia species are shown in Table 2.6 for growth at 20°C, Table2.7 for 
growth at 30°C and Table 2.8 for growth at 37°C.
Key for tables 2.6,2.7 & 2.8
++ Strong growth of isolate
+ Weak growth of isolate
Growth not supported
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Table 2. 6 Growth of B. cepacia and other strains on selective media at 20°C
Isolate NA PC TB-T TBT-
CN
O O-T OCN OCN
T
Clinical B. cepacia isolates
Cl ++ - - - - - - -
C5 ++ - - - - - - -
C ll ++ - - - - - - -
C23 ++ - • - - - - - -
C49 ++ - - - - - - -
C51 + - - - - - -
C79 + . - - - - - - -
C95 + - -• - - - - —
Cl 16 + - - - - - - -
C187 + - - - - - - -
0 9 0 + - - - - - - -
C205 + - - - - - - -
A548 + + + + + + + +
A562 + + + + + + + ■ +
D2 + - - - - - - -
D4 + + + + + + + +
D5 + - + •+ + + + +
Environmental B. cepacia isolates
NCPPB 2993 + + - + + + + +
NCIMB 9085 + - - ■ - - - - -
NCIMB 9092 - - - - - - -
32552 '+ + - — +• - + -
PW1 - - - - - - - -
PW2 + + - - + - + -
PW3 + + - - + . - +
PW4 + + - - + - + -
PW5 + + - - - + + +
Non-B. cepacia strains
Ps. aeruginosa 
PA01/ 
PQM1/R300B
+ + + + +
Ps. aeruginosa 
PA01
+ - + - + - + -
Ps. aeruginosa 
PaWl
+ - - - + - + -
Aeromonas
hydrophilia
+ - - - - - - -
Serratia
marcescens
+ - + - + + + +
Ps. putida UWC1 + + . - - + - + -
Micrococcus
luteus
+ - - - + - + -
Bùùillus Cereus + - - - - - - -
Bacillus subtilis + - - - - - - -
Bacillus mycoides + + + + + + - -
E. coli 
NCTC 10418
+ - - - + - + -
E  coli V517 + - - - + - + -
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Table 2. 7 Growth of R  cepacia and other strains on selective media at 30°C
Isolate « NA PC TB-T TBT-
CN
O O-T OCN OCN
T
Clinical B. cepacia isolates
Cl ■ + - - - + - - -
C5 + - - - + - + -
C ll + - - - + - +
C23 + - - - + - + -
C49 + - - - + - + +
C51 + - - - + - - - ■
C79 + - — - + - + • -
C95 + - - - + - - . -
Cl 16 + - - - - - - -
C187 + - - - - - - -
Cl 90 + - - - - - - -
C205 + - - - - - - -
A548 + + + + + + + +
A562 + + + + + + . + +
D2 + - - - - - - -
D4 + + + + + + + +
D5 + + + + +. + + +
Environmental B. cepacia isolates
NCPPB 2993 + + + + + + + +
NCIMB 9085 + - • - - - - - -
NCIMB 9092 + - - - - - - -
J2552 + + - - + - + -
PW1 + - - - - - - -
PW2 + + - - + - + -
PW3 + + - - + - +
PW4 + + - - + - + -
PW5 + + - - + - + -
Non-B. cepacia strains
Ps. aeruginosa 
PA01/
PQM1/R300B
+ + + + +
Ps. aeruginosa 
PA01
+ - + - + + + -
Ps. aeruginosa 
PaWl
+ - - - + - + -
Aerumunas
hydrophilia
+ - - - - - - -
Serratia
marcescens
+ - + - + + + +
Ps. putida UWC1 + + - - + - + -
Micrococcus
luteus
+ - - - + - + -
Bacillus cereus + - - - - - -
Bacillus subtilis + - - - - - - -
Bacillus mycoides + + + + + + ' - -
E. coli 
NCTC 10418
y - - + - + -
E  coliVSYl + - - - + -
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Table 2.8 Growth of B. cepacia and other strains on selective media at 37°C
Isolate NA PC TB-T TBT-
CN
O O-T OCN OCN
T
Clinical B. cepacia isolates
Cl + - - - - - - -
C5 +• - - - - - - -
C ll + - - - - - - -
C23 + - - - + - - -
C49 + - - - - - - ■ -
C51 + - - - + - - -
C79 + - - - + - -
C95 + - - - - - - -
Cl 16 + - - - - - - -
C187 + - - - - - - -
C190 + + - - + - -
C205 + - - - - - - -
A548 + - + + + ' + + +
A562 + + + + + + + +
D2 '+ - - - - - - -
D4 + + + + + + + -
D5 + - + + + + • + -
Environmental B. cepacia isolates
NCPPB 2993 + + + + + + + +
NCIMB 9085 - - - - - - - -
NCIMB 9095 - - - - - - - -
J2552 + + - - + ' + + +
PW1 - - ■ - - - - - -
PW2 + + - - + - + -
PW3 + - - - - - - -
PW4 + + - - + - + -
PW5 + - - - + - - -
Non-B. cepacia strains
Ps. aeruginosa 
PA01/ 
PQM1/R300B
+ + + +
Ps. aeruginosa 
PA01
+ - + - + l - + -
Ps. aeruginosa 
PaWl
+ - - - + - + -
Aeromonas
hydrophilia
+ - - - - - - -
Serratia . 
marcescens
+ + + + + + + +
Ps. putida UWC1 + + - - - - - -
Micrococcus
luteus
+ - - - - ■ - - -
Bacillus cereus + - - - - - - -
Bacillus subtilis + - - - - - - -
Bacillus
mycoides
+ + + + + + - -
K coli 
NCTC10418
+ - - - + - + -
E. coliVSYJ + ' - - - + -
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The percentage of B. cepacia and non- B. cepacia isolates grown on each media at 
each incubation temperature are shown in Tables 2.9, 2.10 and 2.11 below:
Table 2.9 Percentages of R  cepacia strains able to grow on selective
media at 20°C
NA PC TB-T TBT-
CN
O OT OCN OT-
CN
% R  cepacia 
Isolates 
Grown
92 37 17 21 42 21 42 2 1
% Other 
Species 
Grown
1 0 0 17 33 8 67 17 59 17
Table 2.10 Percentages of R  cepacia strains able to grow on selective
media at 30°C
NA PC TB-T TBT-
CN
O OT OCN OT-
CN
% R  cepacia 
Isolates 
Grown
1 0 0 37 19 19 69 19 58 19
%  Other 
Species 
Grown
1 0 0 17 33 8 67 17 59 17
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Table 2.11 Percentages of R  cepacia strains able to grow on «elective
media at 37°C
NA PC TB-T TBT-
CN
O OT OCN OT
CN
% B. cepacia 
Isolates 
Grown
8 8 27 19 19 50 23 31 15
% Other 
Species 
Grown
1 0 0 25 33 17 50 17 42 17
2.3.3 Environmental survey #2
13 B. cepacia isolates were obtained from 73 samples collected from sites in the South 
Wales area. 6  were isolated on Mast PC medium, 3 each on TB-T medium and Onion- 
T medium and 1 in TB-T-CN medium. Only 2 isolates PW17 and PW21 were isolated 
by different media from the same sample, though their profiles by API 20NE differed .
Isolates were identified as B. cepacia by API 20NE with confirmation by additional 
biochemical test when neccessaiy. A number of other tiram negative species were 
found to grow on the selective media. These were identified as Ps. fluorescens, Ps 
.paucimobilis, Xanthomonas ( Stenotrophomonas)&pede$) and Flavobacterium sp. on 
Mast PC media in a few cases. Pseudomonas, Aeromonas and Flavobacterium sp. 
were identified plates of each of the other media, particularly TB-T. Gram positive 
cocci were also found on a number of plates but no further identification was 
undertaken. Heavy fungal growth was also noted on a number of plates, particularly 
Onion -T plates.
i l l
The site, including Ordnance Survey reference, and sample type, along with the media 
on which isolates were obtained is shown in Table 2.12 below.
Table 2.12 Strains isolated in environmental survey #2 :
Source, sample tvnc & media used for isolation
Isolate
Sample Site 
(Ordnance Survey Ref.)
Sample
Type
Media Used 
For 
Isolation
PW 9 Ystradfellte, Powys 
(SN 932 138)
Soil PC
PW10 Storey Arms, Powys 
(SN 981 204)
Water TB-T
PW11 Llandaff, Cardiff 
(ST 157 782)
Soil Onion-T
PW 12 Llwyn-On Reservoir, Powys 
(SO 008 125)
Water PC
PW 13 Storey Arms, Powys 
(SN 981 204)
Rhizosphere
(Root
Shake)
PC
PW 14 R. Taff, Llandaff) Cardiff 
(ST 163 783 )
Water Onion-T
PW 15 Cantref Reservoir, Powys 
(SN 995 158)
Rhizosphere 
; (Root 
Shake)
TB-T
PW 16 Ystradfellte, Powys 
(SN 932 138)
Water PC
PW 17 Cantref Reservoir, Powys 
(SN 995 158)
Water Onion-T
PW 18 Llwyn-On Reservoir, Powys 
(SO 008 125)
Rhizosphere
(Root
Shake)
PC
PW 19 Blaen Lilia, Powys 
(SN 929 159)
Rhizosphere
(Root
Shake)
TB-T
PW 20 Storey Arms, Powys 
(SN 981 205)
Water PC
PW 21 Cantref Reservoir, Powys 
(SN 995 158)
Water TB-T-CN
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2.3.4 Recovery rates of JBL cepacia in environmental Surveys #1 & #2
The recovery rates of B. cepacia from environmental samples are given as the 
percentage of samples tested on each media from which B. cepacia was isolated. 
The percentage recovery rate for each of the selective media is shown in Table 2.13 
below:
.Table2.13 % Recovery Rate of R  cepacia in Environmental Surveys 
for Selective Media
Media Numbers Isolated 
/Samples Tested
Recovery Rate %
Mast PC Agar 14/106 13
TB-T Agar 3/73 4
TB-T-CN Agar 1/73 1.5
Onion-T Agar 3/73 4
Onion-T-CN Agar 0/73 0
In total 21 isolates were recovered from 106 samples giving a total recovery rate of 
20%.
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2.4 Discussion
2.4.1 Assessment of selective media
There are two major factors associated with selective media for B. cepacia. The first 
of these is the ability or failure of B. cepacia to grow on the media, the second the 
ability of the media to inhibit the growth of other species. The most selective media in 
terms of inhibiting growth of other species were TB-T supplemented with gentamicin 
and onion agar with tetracycline and tetracycline and gentamicin, the commercial Mast 
PC media and TB-T. Whilst onion agar and onion-CN allowed the growth of most B  
.cepacia isolates but also supported growth of many other species.
With the PC agar at 20°C and 30°C only 17% and at 37°C 25% of other the species 
tested grew( Tables 2.6, 2.7). The isolates that grew were Ps. putida^ Serratia 
marcescens and Bacillus mycoides . Growth of both Ps. putida  and Serratia 
marcescens on PC medium have been previously described (Gilligan et al 1985, Mast 
Diagnostics 1994). The relatively low level of growth of B .cepacia was somewhat 
surprising. Gilligan et al (1985) reported that 76% of È. cepacia stock isolates grew at 
35°C , whilst only 35% of isolates grew at 20°C and 30°C, even less at 37°C, in this 
study.
The TB-T medium supplemented with 5pg ml'1 of gentamicin allowed growth of only 
8% of non- B. cepacia isolates( Bacillus mycoides ) at 20°C and 30°C, Serratia also 
grew at 37 °C. TB-T without the addition of gentamicin also supported the growth of 
2 Ps .aeruginosa isolates giving a total of 33% of non- B. cepacia isolates that grew on 
the medium. As with PC medium, Serratia species have been reported to grow on TB-
T medium (Hagedom et al 1987). The addition of gentamicin though apparently 
increasing selectivity, appeared not to affect the growth of B. cepacia, with both media 
allowing the growth of 19%)ofB. cepacia isolates. The levels of growth were again 
rather lower than expected.
The onion agar supplemented with tetracycline and tetracycline and gentamicin allowed 
the growth of 2 non-cepacia isolates, E. coli and Serratia marcescens, a total of 17 % 
of the non- B. cepacia isolates. Both Onion-T and Onion-T-CN grew 19% at 20°C 
and 30*C, though Onion-T-CN had a decreased yield of 15% at 37®C but Onion-T had 
an increased yield of 23%. These levels being similar to those for TB-T.
Onion agar with no antibiotic supplementation was the most successful medium for 
growing B. cepacia with a 69% culture success rate at 30°C. Onion supplemented 
with gentamicin supported growth of 58% of isolates at 30°C. However these high 
levels of B. cepacia growth were also accompanied by growth of other species. Onion 
agar supported the growth of upto three-quarters of the non-B. cepacia species, The 
agar supplemented with gentamicin supported growth of up to 59% of other species 
tested.
A selective medium for use in environmental sampling would ideally allow growth of 
the bacterium being selected, whilst inhibiting the growth of other species. Although 
onion agar, either with or without gentamicin allowed growth of more B. cepacia 
strains, their inability to inhibit other species would limit their usefulness in sampling 
studies as the growth of so many other species would greatly increase the workload of 
identification and may overgrow any B. cepacia strains. TB-T or TB-T supplemented 
with gentamicin or Onion agar with tetracycline or tetracycline and gentamicin were
reasonably good inhibitors of other species, particularly where gentamicin is included. 
However the growth of B. cepacia on these media was relatively poor, less than 20% 
of isolates growing. Mast PC agar also showed good species selectivity, but allowed 
growth of higher numbers of B. cepacia, up to 35%. On the basis of this, PC agar 
would appear to be the best medium for environmental surveys. However nearly two- 
thirds of B. cepacia isolates tested failed to grow on this medium. Therefore it was 
decided to use a range of media in the subsequent environmental survey in order to 
increase recovery rate of B. cepacia. Mast PC medium, TB-T, TB-T-CN, O-T and O- 
T-CN agars were used for the subsequent environmental survey. Survey #2, on the 
basis of their specificity.
Temperature appeared to cause some variance in the growth of B. cepacia Overall 
30°C seemed to be the optimum temperature with the highest or equal highest amounts 
of B, cepacia growth on all but O-T-CN agar, In addition growth of other species was 
inhibited better at this level, notably of Serratia marcescens which did not grow on PC 
or TB-T-CN at 30°C but grew at 37°C. On the basis of this 30°C was chosen as the 
optimum growth temperature for environmnetal sampling..
The development of the Onion agar as a selective media was moderately successful. 
The use of onion alone or with gentamicin was not suitable as a selective medium as it 
failed to inhibit the growth of other species. Onion with tetracycline or tetracycline and 
gentamicin was at least as successful in this study as TB-T agar with similar levels of 
inhibition of other species and growth ofB. cepacia However it was not as effective as 
the commercial medium
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2.4.2 Recovery rate of B. cepacia from the environment
On the basis of recovery rates from the environment it would appear that Mast PC agar 
was the most successful medium for isolation of B. cepacia from the environment. A 
recovery rate of 13% was obtained using PC, compared to 4% for TB-T and Onion-T 
and less than 2% for Onion -T-CN. In Survey #2 the total recovery rate for all media 
was 18%.
The earlier Survey #1 had a higher recovery rate of 24%, 8 B. cepacia isolates from 33 
samples and sites, using PC agar alone. Combining the results of both surveys, 21 B. 
cepacia strains were isolated from 106 samples and sites, giving a total recovery rate of 
20%. This compares well to the 21% recovery rate described by Butler et al (1995). 
The use of PC agar alone would have given à total recovery rate of 13% (14/106). The 
other media isolated a total of 7 B. cepacia strains from 73 samples, a total recovery 
rate of 10%. Although the individual recovery rates for both TB-T and O-T were low 
at 4%, in combination with PC medium they increased the total recovery rate from 
13% for PC alone, to 20% for all media. This represents a substantial increase,
V
suggesting that the use of multiple media in sampling may be effective than PC alone.
It is notable that a number of strains were isolated from relatively polluted areas.
Isolates PW1, PW2 and PW6 were obtained from a river tributary downstream of old 
mineworldngs and a slag heap. PW4, PW5 and PW7 were isolated downstream of the 
site of a former coal mine and coking works, a site where considerable remedial work 
to make safe areas of toxic contamination were being undertaken at the time of 
sampling. The versatile nutritive and degradative properties of B. cepacia could allow 
it to thrive in such contaminated ecological niches .
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Butler et al (1995) surveyed sites in botanical gardens, with the majority of B. cepacia 
strains recovered, 10 of 12, were isolated in soil or rhizosphere samples from tropical, 
tropical aquatic, orchid and cycad or rhododendron houses. Such sites would be warm 
and moist with rich soils, ideal for growth of soil bacteria. A ‘tropical’ environment, 
albeit artificial, would be of relatively limited relevance to any link between the 
environmental strains of B. cepacia and those found in CF patients. CF is most 
prevalent in Caucasian populations in Northern Europe and North America, where a 
more temperate climate occurs (Tsui 1992). The levels ofB. cepacia found in this 
study of soil and water samples from industrial, urban and rural sites in South Wales is 
arguably more representative of the environment to which CF patients are exposed than 
the samples analysed by Butler and co-workers (1995).
The overall recovery rates are considerably higher than those of around 4% found by 
Fisher et a l (1993) and Mortensen et al (1995). These studies challenged the notion of
B. cepacia as an ubiquitous organism in the environment (Holmes 1985), due to the 
low levels of recovery. However, these surveys were restricted to such areas as 
fobdstores, salad bars and the ‘built’ environment. As pointed out by Butler et al 
(1995), the sample sites did not include soils, natural waters or rhizosphere samples 
that form the main environmental reservoirs of B. cepacia. The recovery rates in this 
study would appear to support this.
A notable point is that in all the sites surveyed, only one sample gave B. cepacia on 
more than one media. The isolates obtained from this site at Cantref Reservoir were 
PW 17 on onion-T agar and PW 21 on TB-T-CN agar. The two isolates showed 
different API profiles, PW17 producing a p-glucosidase hydrolysing esculin, and a
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protease hydrolysing gelatine and P-galactosidase whilst PW21 does not. PW17 also 
shows considerable in vitro phytopathogenicity to onion, whilst PW21 does not 
(Chapter 3, p i28)). Unfortunately the failure of PW21 to grow from frozen stock did 
not allow typing by PCR ribotyping of macrorestriction analysis to confirm PW21 and 
PW17 as different strains. (Chapter 8, p.250). The use of these techniques showed 
differences amongst all environmental isolates in this study.
2.4.3 Efficacy of selective media in environmental and clinical isolation of 
B. cepacia
From the assessment of the selective media it would appear that none would be truly 
suitable for an environmental survey. The media most selective for B. cepacia, Mast PC 
agar, grew only 35 % of B. cepacia strains tested, though did inhibit most other species 
tested. In addition several of the clinical B. cepacia isolates tested failed to grow on 
the Mast PC media despite being originally isolated on this media. The isolates tested 
were obtained from frozen stocks, so it would appear that either storage at -70 °C has 
affected the ability of these isolates to grow on the PC media, or more worryingly that 
the PC medium does not recover B. cepacia as efficiency as previously thought. A 
second problem, that of other species growing on selective media has been noted by 
clinicians and laboratory workers. This may lead to mis-identification, particularly of 
Stenotrophomonas maltophilia as B. cepacia (Burdge et al 1995). This problem has 
been addressed to some extent by the development of Burkholderia cepacia selective 
agar (BCSA), a medium with greater selectivity for B. cepacia (Henry et a l 1997).
Hagedom et al (1987) commented that media developed for isolation of clinical B. 
cepacia strains from sputum, or media developed for isolation of B. cepacia from
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waters or pharmaceutical solutions (Wu and Thompson 1984), use antibiotics as their 
selective component. It was suggested this would limit their suitability for soil 
sampling, as many organisms resistant to these antibiotics are found in soils, in 
particular fungi, and could overgrow the plates. In addition the high levels of 
antibiotics in BCSA would suggest that it is not suitable for environmental isolation of 
B. cepacia, particularly as environmental isolates appear to be less resistant to 
antibiotics than clinical isolates and such isolates would fail to grow on such media due 
to the high levels of antibiotics (Butler et al 1995), In contrast to the views of 
Hagedom and co-workers, the Mast PC medium, developed primarily for isolation 
from sputum, was more effective in the environmental surveys than TB-T developed 
for isolation from soils. PC had a recovery rate of 8 to 24% compared to only 4% for 
TB-T.
The Onion agar supplemented with tetracycline showed similar levels of selectivity to 
TB-T both in the assessment of the media and in the environmental survey. In Survey 
#2 TB-T and O-T both isolated 3 B. cepacia strains from 73 samples, a 4% recovery 
rate. The rate for the onion medium may have been higher if heavy fungal growth on 
plates had not prevented further analysis of a number of bacterial colonies. This fungal 
growth could be eliminated by the addition of an anti-fimgal component such as the 
crystal violet or nyaststin used in TB-T, or by cycloheximide which inhibits synthesis 
of the 80S ribosome protein synthesis (I. J. Bruce Personal communication).
Overall, considering the results of both the surveys and testing of selective media, it 
would appear that the Mast PC agar is the most effective single medium tested for 
isolation of B. cepacia. However the results of Survey #2 would indicate that the use
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of PC in combination with other media such as TB-T and O-T could be considerably 
more effective in environmental surveys. This is particularly true if one considers that 
in 73 samples in Survey #2, only one sample yielded B. cepacia on more than one 
media, even in this case the isolates showed different phenotypic properties. In effect 
this means for all the isolates detected, the other 4 media used failed to isolate the same 
B. ce/xu?a strain. This suggests a ‘scatter gun’ approach in which a variety of media is 
more effective than a single media in isolating B. cepacia from environmental sources.
2.4.4 Isolation and identification of K  cepacia: General considerations
The overall recovery rate of 20 % was similar to that of previous studies for soil and 
rhizosphere samples. A possible caveat to these results is that only 35% of B. cepacia 
isolates grew on PC agar in the assessment tests of media suitability. If such a rate 
were transferred to environmental surveys then around two-thirds of tested samples 
may contain B. cepacia strains not detected by the media. If this were to be the case 
then B. cepacia may be far more prevalent in the environment that previously thought. 
Such levels, potentially up to 50 or 60%, may have implications in the role of the 
environment as reservoir of B. cepacia .
Despite uncertainties about the levels of B. cepacia in the environment, the 
environmental surveys succeeded in providing 215. cepacia strains for further analysis, 
along with those clinical and environmental strains obtained from sources such as the 
PHLS.
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Chapter 3 Phvtopathogenicitv of Burkholderia cepacia strains
3.1 Introduction
Burkholder first described Burkholderia cepacia as a phytopathogen, identifying it as 
the cause o f ‘sour skin' onion rot (Burkholder 1950). The ability of 5. cepacia to act 
as phytopathogen in vitro rotting onions through the maceration onion tissue by 
enzymes leading to soft and slimy tissue has been known for some time, and has been 
utilised as a test of onion pathogenicity (Lelliott and Stead 1987). The ability to cause 
rot or maceration in vitro is a useful test in characterisation of A  cepacia, and recently 
onion maceration has been used as one of the criteria for typing B. cepacia in phenoms 
or genomovars (Yohalem and Lorbeer 1994, Vandamme 1995, Govan et al 1996).
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3.2 Material! and methods 
Materials 
L Chemicals
70 %V/V alcohol (Industrial Methylated Spirits) (BDH Ltd, Poole, Dorset) 
iL Strains
Overnight 10 ml broth cultures (Chapter2 p.98)of 
B. cepacia strains (As described in Chapter 2)
B. gladioli pv allicola NCPPB 2478 (As described in Chapter 2)
Ps. aeruginosa PA01 & PA2002 (As described in Chapter 2)
ML Media
Nutrient broth (Oxoid CM1, Unipath, Basingstoke, Hants.)
Bacteriological agar (Agar Nol) (Oxoid LI 1, Unipath)
Sterile saline (0.85% w/v )
iv. Solutions and other materials
Onions (Allium cepa). Sound and apparently disease-free, purchased from local 
supermarkets.
‘Sterile’ onions (autoclaved in ‘honey jars’ at 15 p.s.i. 121°C for 15 mins)
v. Equipment
Domestic kitchen blender (Kenwood)
No. 4 (8mm) cork borer 
vL Disposable consumables 
Sterile stockingette (or muslin)
Sterile toothpicks
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Sterile polythene bags (laboratory stomacher bags)
90 mm petri Dishes
Methods
L In  vitro maceration of onion slices (host test for phytopathology
The method used was based on that of Lelliott and Stead (1987). Onions were wiped 
with alcohol and then cut aseptically into slices of approximately 5mm; skins were not 
removed. Tissue slices were places into sterile petri dishes and two shallow nicks of 
around 2mm were made into the onion surface. 200pl of overnight culture of B. 
cepacia strains were used to inoculate the surface of the onion slices. The inoculated 
onion tissue was incubated at 30° C for 72 hours. After incubation levels of maceration 
were recorded using a sterile needle as a probe.
Overnight cultures of Ps. aeruginosa PAO 1 and PAO 2002/ RP1 and sterile saline 
were used to inoculate control tissue.
Phytopathogenic B. cepacia strains should cause a slimy, yellowish rot of inner scales
V
giving rise to soft macerated tissue (Bradbury 1986, Lelliott and Stead 1987). B. 
gladioli also causes maceration but can be distinguished as it gives rise to a ‘glassy’ 
appearance and does not produce the distinct ‘sour’ smell associated with B. cepacia.
Onions were also tested in the same manner to assess their suitability in quantitative 
assays or in isolation media. Onions were placed in jars and autoclaved at 15 p.s.i.,
121° C for 15 min.
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The various degrees of macerationobserved in the onion slices, were scored into 5 
levels of phytopathology:
4+
yellow/brown discoloration. Strong 
‘sour* odour.
3+ Maceration evident in majority of onion
tissue. Yellow or yellow/brown discoloration 
through most of tissue. Strong ‘sour’ 
odour.
2+ Patches of maceration and discoloration.
'Sour' odour.
1+ Little evidence of maceration. Slight
discoloration. Slight 'sour' odour.
No maceration, discoloration or odour.
ii Whole onion pathogenicity (Lelliott and Stead 1987)
Alcohol wiped onions were inoculated into the their outer scales with sterile toothpicks 
dipped into a heavy overnight B .cepacia culture. The inoculated onions were placed in 
sterile stomacher bags. The bags were sealed and incubated in the dark at room 
temperature. The onions were checked for indications of rot at 3 , 4 , 7 , 10, 14, 21
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and 28 days. At 28 days the onions were sliced in half to check for signs of pathology, 
such as discoloration or softening of the inner scales.
ML Quantitative assay of onion maceration
200 g of onion tissue without roots wiped with alcohol prior to use was placed in the 
goblet of a Kenwood kitchen blender. The blender goblet was surface sterilised with 
alcohol prior to use. 200 ml of sterile saline was added to the tissue, which was then 
homogenised for 90 s. The onion homogenate was filtered through two layers of 
sterile stockingette into a sterile container. The onion homogenate was added to 
molten bacteriological agar at concentrations of 0, 1, 2, 5, 10, 25, and 50% v/v. The 
agar was prepared to a final concentration of 2% after addition of the homogenate, 
sterilised by autoclaving at 15 p.s.i. at 121°C for 15 mins. Molten agar was maintained 
at 45°C in a waterbath prior to pouring.
The onion agar was poured into petri dishes and allowed to set and dry. Wells were 
cut into the agar plates using a No.4 (8mm) Cork borer. 150 pi of overnight culture of
w
B. cepacia along with Ps. aeruginosa and sterile saline controls were added to the 
wells. The plates were then incubated at 30* C for 72 h. Alternatively 10 pi of 
overnight, culture were spotted onto the surface of uncut plates which were then 
incubated as above. After incubation any clear zones, where onion was macerated, in 
the plates was recorded.
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3.3 Results
3.3.1 In vitro maceration of onion tissue
The results obtained for the in vitro maceration of onion slices are shown in Table 3.1. 
Maceration of a slice of onion tissue by B. cepacia NCPPB 2993 is shown in Plate 3.1.
Plate 3.1 In vitro maceration of onion tissue by B. cepacia NCPPB 2993: 
incubation at 30 °C for 72h
m
r U
NCPPB
2993
CONTROL
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Table 3.1 Ih vitro maceration of onion tissue slices ( host test) by R, cepacia
Level of 
Maceration Strain Source of strain
4+ NCPPB 2993 Rotten onion
PW17 Water
PW2 Water
3+ PW6 Water
A562 Clinical .Edinburgh CF patient
NCPPB 3480 Rotten onion
PW11 Soil
B. gladioli NCPPB 2478* Rotten onion
PW20* Water
PW19 Rhizosphcre Soil
2+ NCIMB 9085 Soil
NCIMB 9087 Rotting Tree Trunk
A548 Clinical .Edinburgh CF patient
J543 Clinical. Strasbourg CF patient
C93 Clinical. Cardiff CF patient
PW8 Rotten Onion
PW14 Water
PW4 Water
PW1 Water .
C79 Clinical. Cardiff CF patient
1+ C23 Clinical, Cardiff CF patient
C190 Clinical, Cardiff CF patient
Cl 16 Clinical. Cardiff CF patient
C5 Clinical Cardiff CF patient
Cl Clinical Cardiff CF patient
NCIMB 9092 Not known
C1858 Clinical .Edinburgh CF patient
J478 Clirkical Strasbourg CF patient
32552 Soil
D6 Clinical Dublin CF patient
PW3 Water
PW5 Soil
PW7 Soil
PW9 Soil
PW10 Water
PW13 Rhizosphcre Soil
0 PW15 Rhizosphcre Soil
PW18 Rhizosphcre Soil
PW21 Water
PW22 Water
PW12 Water
Cl 860 Clinical .Edinburgh CF patient
D2 Clinical. Dublin CF patient
D3 Clinical. Dublin CF patient
C59 Clinical, Cardiff CF patient
Table 3.1 (continued)
Level of 
maceration
Strain Source of strain
0
C51 Clinical, Cardiff CF patient
C ll Clinical, Cardiff CF patient
D2 Clinical, Dublin CF patient
D3 Clinical, Dublin CF patient
C95 Clinical, Cardiff CF patient
C96 Clinical, Cardiff CF patient
C205 Clinical, Cardiff CF patient
C187 Clinical, Cardiff CF patient
Sterile Saline Control
Ps. aeruginosa PA02002 RP1 Control
Ps. aeruginosa PAO 1 Control
Note: Strains marked with an asterix (♦) NCPPB 2478 and PW20 produced a different form of rot without 
discoloration and the distinct smell, but with a ‘glassy’ appearance.
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Maceration of sterile onion slices
Autoclaving of onion has little effect. The ability of B. cepacia to macerate onion in 
vitro can be measured using autoclaved onion tissue, though obviously the process 
softens the onion tissue somewhat prior to addition of the test isolate. The results 
obtained are shown in Table 3.2:
Table 3.2 In vitro maceration of sterile (autoclaved) onion slices
Strain Level of Rot Comments
B. cepacia NCPPB 2993 4+ Appearance very similar to that of 
‘normal* onion inoculated with isolate
B. cepacia NCPPB 3480 3+ Appearance very similar to that of 
normal* onion inoculated with isolate
B. cepacia C79 1+ Some increased softness, but 
otherwise as ‘normal* onion inoculated 
with the isolate.
Ps. aeruginosa PA02002 
ZRP1
0 No rot observed, but slightly softer 
than normal onion
Sterile Saline 0 No rot observed, but slightly softer 
than normal onion
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In vitro maceration of whole onion
The results obtained are shown in Table 3.3 below
Table 3.3 In  vitro maceration of whole onions (host test) by 
R  cepacia strains
Incubation time Strain Observations
72 h
PW 8 No rot observed
NCPPB 2993 No rot observed
C79 No rot observed
Sterile Saline No rot observed
4 days
PW 8 No rot observed
NCPPB 2993 No rot observed
C79 No rot observed
Sterile Saline No rot observed
7 days
PW& Yellowing at inoculation sites
NCPPB 2993 Yellowing at inoculation sites
C79 Yellowing at inoculation sites
Sterile Saline No rot observed
14 days
PW 8 Yellowing at inoculation sites
NCPPB 2993 Yellowing at inoculation sites
C79 Yellowing at inoculation sites
Sterile Saline No rot observed
21 days
PW 8 Yellowing at inoculation sites
NCPPB 2993 Yellowing at inoculation sites
C79 Yellowing at inoculation sites
Sterile Saline No rot observed
28 days
PW 8 Upon dissection: discoloration and rot of 
inner scales, strongest at inoculum sites
NCPPB 2993 Upon dissection:strong discoloration and 
rot of inner scales, strongest at inoculum 
sites
C79 Upon dissection: some discoloration of 
inner scales, stronger at inoculum sites
Sterile Saline No rot observed
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3.3.2 Quantitative test of onion maceration
Non sterile onion
No results could be recorded due to high levels of fungal growth over all test plates. 
Sterile onion
These are shown in Tables 3.4 and 3.5 shown overleaf. The growth of the test isolate 
on the plates in the spot test or within the wells is indicated by 4= growth supported, 
or - = growth inhibited
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Table 3.4 Quantitative assay of onion maceration:
well test with sterile onion
%  O n io n Iso la te C learan ce  
Z o n e  (m m )
G ro w th
+  /-
C om m ents
1%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 0 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
2%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 0 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 - ■
5%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 10 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
10%
C23 n +
Clearance observed 
but with difficulty
NCPPB 2993 16 +
PW8 12 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
25%
C23 12 +k
Reasonable clearance 
clear, particularly 
NCPPB 2993
NCPPB 2993 19 +
PW8 13 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
50%
C23 - +
Onion too thick to 
observe any clearance
NCPPB 2993 - +
PW8 - +
Ps. aeruginosa 
PAO 2002/RP1
- +
Sterile Saline - -
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Table 3.5 Quantitative assay of onion maceration: 
spot test with sterile onion
% Onion Isolate Clearance 
Zone (mm)
Growth
+  /-
Comments
1%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 0 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
2%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 0 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 +
Sterile Saline 0 -
5%
C23 0 +
Concentration of onion 
too low to observe 
clearance
NCPPB 2993 0 +
PW8 0 +
Ps. aeruginosa 
PAO 2002/RP1
0 -
Sterile Saline 0 -
10%
C23 10 +
Clearance observed 
but with difficulty
NCPPB 2993 15 +
PW8 10 +
Ps. aeruginosa 
PAO 2002/RP1
0 -
Sterile Saline 0 -
25%
C23 10 +
Clearance observed 
but with difficulty
NCPPB 2993 16 +
PW8 10 +
Ps. aeruginosa 
PAO 2002/RP1
0
-
Sterile Saline 0 -
50%
C23 - +
Onion too thick to 
observe any clearance
NCPPB 2993 - +
PW8 > +
Ps. aeruginosa 
PAO 2002/RP1
-
-
Sterile Saline - -
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3.4 Discussion
3. 4.1 In vitro onion maceration
A range of differing abilities to cause rot or maceration of onion tissue in vitro was 
found amongst the B. cepacia isolates tested. Some of the isolates, including those 
obtained from the NCPPB caused a high level of maceration accompanied by a yellow- 
brown discoloration (Lelliott and Stead 1987). An intense, distinctive sour' smell was 
associated with these isolates. Other strains produced a less pronounced rot through to 
no discernible rot. These differences are not surprising, as great variations in onion 
pathologenicity between B. cepacia strains have been described (Gonzalez and Vidaver 
1979, Yohalem and Lorbeer 1994, Govan et a l 1996).The results obtained (Table 3.1) 
generally, with some exeptions, confirm that clinical strains of B .cepacia are weak 
pathogens of onion (Gonzalez and Vidaver 1979, Yohalem and Lorbeer 1994). 
However two isolates from the Edinburgh CF centre, A548 and A562, caused high 
levels of onion pathology. Clinical isolates from this centre have previously been found 
to cause strong maceration of onion tissue (Butler et al 1995). A great deal of variation
was also seen in environmental isolates. NCPPB strains caused high levels of onion
,
maceration, as did four isolates from rivers and soils in the South Wales area: PW17, 
PW6, PW20 and PW11. Two other South Wales environmental isolates caused a 
moderate degree of rot, along with two strains from the NCIMB. All other isolates 
produced either low levels or no rot. It is also worth noting that the isolate PW8, 
obtained from rotten onion caused little rot in vitro.
The Burkholderia gladioli p.v. allicola strain, NCPPB 2478, also caused a high degree 
of onion maceration, though the nature of the rot was unlike that of B. cepacia as there 
was little discoloration or ‘sour’ odour. As described by Lelliott and Stead, the rot
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resulted in a ‘glassy’ appearance. One environmental isolate, PW20, showed a similar 
appearance, suggesting it may be a B. gladioli strain rather than B . cepacia as typed.
The ‘onion slice host test* appeared to be a more effective method than ‘whole onion 
host tests’ in terms of speed of result and the ease with which results are obtained . 
Using the onion slice method, results were clearly observable in three days and could be 
easily determined. The whole onion test results were less clear as the onion had to be 
cut in half to assess the amount of rot to the inner scales. An incubation period of two 
to three weeks was required to obtain positive results.
Onions sterilised by autoclaving in a jar showed the same properties as untreated onions 
in host tests. The fact that the use of autoclaved onions made little difference to host 
tests was a considerable advantage in the development of a quantitative test of onion 
maceration, as discussed below; and in selective media (Chapter 2).
3.4.2 Development of a quantitative assay of onion maceration
The use of non-sterile onions in the proposed quantitative assay was of little value as 
there was a large amount of fungal overgrowth in all test plates. Such growth was not 
found in the plates produced with autoclaved onion homogenate. In both the well and 
spot tests the best observable clearance of onion tissue was in plates containing 10 to 
25% onion homogenate. Below this level the concentration of onion was too low to see 
any clearance, above this the concentration appeared too high to be cleared by the test 
isolates. Even at the levels of 10 to 25% it was difficult to see the clearance of onion. 
Staining plates with iodide, to stain any starch present in the onion, did not improve the 
visibility of onion clearance, the addition of a non-specific dye to the onion homogenate 
or agar may possibly improve the visualisation of clearance.
All B. cepacia strains tested cleared at least some onion homogenate in the test plates. 
The strongly phytopathogenic NCPPB 2993 cleared a fairly large zone of up to 19 mm 
around both spot and well tests. However the more weakly pathogenic isolates C23 and 
PW8 only cleared a small zone of around 10 to 12 mm. This is only slightly larger than 
the size of the well ( 8mm) or the size of bacterial growth in the spot test. The controls 
used caused no clearance of onion homogenate at any onion concentration. At the 
higher concentrations of onion, (10%) or more, growth of the Ps. aeruginosa controls 
were inhibited, particularly in the spot test. This showed that the test was specific for B. 
cepacia against Ps. aeruginosa and also demonstrated the possibility of the use of onion 
as a selective agent for Burkholderia.
The test appears to have some specificity and shows differentiation between weakly and 
strongly phytopathogenic B. cepacia strains. To quantitatively assess the potential of 
such an onion agar test a wider range oîB . cepacia isolates with differing onion 
macerating properties would need to be tested. Nevertheless, the test shows some 
promise as a quantitative assay of onion maceration, but the use of a scoring system for 
the onion slice host test makes it a semi-quantitative assay, and may make the 
development of a quantitative assay unnecessary due to the ease of conducting such 
host tests.
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. Chanter 4 Antibiotic resistance and susceptibility of Burkholderia cepacia
4.1 Introduction
B. cepacia is resistant to many antimicrobial drugs. Determination of the antibiotic 
resistance profile or ‘antibiogram’ and the Minimum Inhibitory Concentration (MIC) of 
antibiotics for each isolate would be important both in the characterisation of the 
phenotypes of clinical and environmental strains, and for their use in further experimental 
work such as defining the role of antibiotic resistance plasmids. A number of methods 
may be used to determine antibiotic resistance profiles and MIC values (Vandepitte et al 
1991). These include disc diffusion tests, liquid media susceptibility tests and solid 
media tests
4.1.1 Kirby-Bauer disc diffusion test
The principle of disc diffusion tests is relatively simple. The efficacy of an antibiotic 
against a bacterium is determined by placing a reservoir of an antibiotic on an agar plate 
evenly seeded by bacteria. The antibiotic diffuses from the reservoir becoming less 
concentrated the further it migrates from the source . The antibiotics’ efficacy is 
determined by the size of the zone of bacterial growth is inhibition. Generally the more 
effective the antibiotic the larger the zone of inhibition (Acar and Goldstein 1985, 
Vandepitte et al 1991). In disc diffusion tests the antibiotic reservoirs are paper discs 
impregnated with known concentrations of antibiotics.
The Kirby-Bauer disc diffusion test was developed in the 1960s (Vandepitte e ta l 1991). 
It was selected as the method of choice for antibiotic sensitivity testing by the World 
Health Organisation (WHO) in 1977 as it is reproducible and technically simple 
(Vandepitte et al 1991). The method involves seeding of Mueller Hinton agar plates with
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a bacterial suspension prepared to a standard turbidity or concentration. Antibiotic discs 
are then placed onto the surface of the plate with a sterile needle, forceps, or a disc- 
dispensing device. Plates are the incubated and zones of inhibition measured. The zones 
are compared to standard published values. The results are reported as resistant, 
susceptible or of intermediate susceptibility. In some laboratories, particularly in the 
UK and Europe, Diagnostic Sensitivity Test Agar (DST Agar) has been employed. This 
is since the emergence of BSE, as Mueller Hinton agar, which contains bovine 
components has generally been discontinued on safety grounds.
The amount of antibiotic in discs and interpretation of zones of inhibition is based upon 
an approximately linear relationship between MIC and zone size.To determine the sizes 
of zones obtained with resistant and susceptible bacteria, large numbers of bacterial 
strains have MIC determined by a broth dilution method, and 1 the diameters of zone of 
inhibition are found. The disc concentration used is based on the MIC values to range of 
isolates and species. These results are plotted on a regression line with MIC on the y- 
axis, and zone diameter on the x-axis. Susceptible (S), resistant (R) and intermediate (I) 
values are then determined by reading the diameters from the graph equivalent to the
V
upper and lower critical breakpoint serum concentrations of the drug in clinical use. 
Bacteria are reported as susceptible to an antibiotic when they are likely to respond to 
treatment with the drug. Intermediate susceptibility applies to bacteria that are 
‘moderately’ susceptible to an antibiotic at the concentration tested. If the antibiotic is 
of low toxicity it may be effective at a higher concentration. The results of these tests 
may be used by clinicians to decide on the appropriate antimicrobial therapy, or used in 
the epidemiological surveillance of antibiotic resistance.
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4.1.2 Determination of minimum inhibitory concentration (MIC) 
by agar dilution
Agar media are commonly used to determine the MIC of antibiotics by use of a series of 
plates containing varying concentrations of antibiotics. Such procedures are known as 
Agar Dilution Tests. (Barry 1985). Many methods may be employed to determine MIC 
including broth dilution, agar diffusion tests and gradient plates. Agar dilution 
techniques have a number of advantages, particularly over broth methods. The use of 
replicating inoculating devices such as Multipoint Inoculators allow large numbers of 
samples to be tested together quickly and accurately with consistency of inoculum size. 
Supplements such as blood required for fastidious organisms can easily be added.. This 
may not be the case using broths where supplements may cause the media to become 
cloudy, making interpretation of end points difficult. Any contamination of the test 
isolate may be more easily detected on agar plates as differing colony morphologies may 
result. In addition the majority of further experiments to be conducted involving 
antibiotics such as mating experiments will be primarily conducted on agar, so there 
would be greater consistency if MIC values were determined on agar media.
The basis of Agar Dilution techniques is production of a series of Mueller Hinton or 
DST agar plates containing a range of concentrations of the antibiotic to be tested. 
Overnight cultures of the test isolates are inoculated onto the surface of the agar plates, 
which are then incubated. The MIC is recorded as the lowest concentration of 
antibiotic that inhibits the growth of the isolate not including the growth of a single 
colony or hazy growth at the inoculum site .
In both the determination of MIC or Disc Difiusion tests it is necessary to inri..H.
suitable reference strains as quality controls. Organisations such as the WHO or the
National Committee for CUnical Laboratory Standards publish lists of suitable control 
isolates.
4.2 Materials and methods 
Material»'
L Chemicals
Antibiotic discs (Oxoid, Unipath, Basingstoke, Hants)
Ceftazidime, gentamicin sulphate, cefuroxime sodium, tobramycin, amikacin and 
sulphamethoxazole (Sigma Chemical Co., Poole, Dorset) made up to appropriate stock 
solutions in double distilled water (or methanol if not water soluble) and filter sterilised. 
«.Strains
B. cepacia strains (as described in Chapter2)
K  coli NCTC 10418 control culture 
ML Media
DST agar plates (Oxoid CM26, Unipath Ltd, Basingstoke, Hants.)
20 ml aliquots molten DST agar
iv. Solutions
MacFarland 0.5 turbidity standard (BioMerieux, Marcy l'Etoile, France) .
10 ml aliquots of sterile 0.85% w/v saline
v. Equipment
Oxoid antibiotic disc dispenser (Unipath, Basingstoke, Hants)
Multi-point inoculator (Mast Diagnostics, Bootle, Merseyside)
Rule or measuring calipers (mm scale)
vi. Disposable consumables 
Sterile cotton wool swabs 
Sterile plastic 90 mm Petri dishes
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Methods
i. Kirby-Bauer disc diffusion test
The antibiotic discs used were based on those recommended by the WHO and by Acar 
and Goldstein (1985) for Pseudomonas species, and on their availability in the 
laboratory. The WHO recommends piperacillin, tobramycin and gentamicin as first 
choice. Other antimicrobials tested include ceftazidime, tetracycline and azlocillin as 
recommended by Acar and Goldstein (1985). The full list of antibiotics used along with 
their interpretative zone diameters are shown in Table 4.1.
An inoculum of each isolate to be tested was prepared by picking between 3 to 6 
colonies from an overnight culture on nutrient agar at 35 °Cand suspending the colonies 
in 10ml of sterile saline to a MacFarland Turbidity Standard of 0.5. The DST plates 
were then inoculated to give a lawn of growth. A sterile cotton swab was dipped into 
the prepared inoculum, the excess was removed by pressing the swab against the side of 
the container; and then the swab was then streaked over the surface of the plate three 
times, rotating 60° between each application. The inoculated plates were allowed to dry 
for 10 to 20 mins before antibiotic discs were applied to the surface of the plates using
V
an Oxoid Disc Dispenser. Plates were then incubated at 35°C for 24 to 48 h. Zones of 
inhibition were recorded, the diameters measured either with a rule on the underside of 
the plate or by using a pair of callipers. The diameters recorded were compared with 
published interpretative tables to determine whether the isolate is resistant or susceptible 
to the antibiotic (Acar and Goldstein 1985, Vandepitte etcd  1991).
it  MIC determination by agar dilution method
Molten 20 ml aliquots of DST agar were maintained at 50°C in a waterbath. Antibiotic 
stock solutions were added to the molten agar to give final concentrations of 0, 1, 2, 5,
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10, 20, 25, 50, 100, 250 and 500 pg ml"1. The agar containing antibiotics was then 
poured into appropriately labelled petri dishes. The plates were then allowed to set and 
dry for 4 h, or overnight, prior to use. 1 ml of overnight broth cultures of isolates to be 
tested were pipetted into the sterile PTFE dish of the Multipoint Inoculator. This was 
placed onto the stage of the inoculator and the sterile inoculating pins placed into their 
holder. The first plate to be inoculated, with lid removed, was placed onto the stage of 
the inoculator that was then operated by means of a foot switch. This was repeated for 
each of the test plates. After inoculation the plates were incubated for 24 to 48 h at 
35°C. The plates were then read, the MIC being recorded as the plate with the lowest 
concentration of antibiotic that inhibits growth of thé isolate not including hazy growth 
or a single colony at the inoculum site.
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4.3 Results
4.3.1 Kirby-Bauer disc difiusion test for antibiotic resistance/susceptibility of 
K  cepacia strains
The antimicrobial content and zone interpretation values are shown over in Table 4.1. 
The results obtained by this method are shown in Tables 4.2,4.3 and 4.4. Tables 4.5, 
4.6 and 4.7 show the percentages of isolates tested found resistant (R ),susceptible (S) 
or of intermediate (0  susceptibility to each antibiotic. Where susceptibility of an isolate 
to an antibiotic was not tested, or no readable value was obtained are shown by a dash 
(-).
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Table 4.1 Antimicrobial agents used in modified Kirby -Bauer testing of 
R  cepacia isolates: Disc antimicrobial content and zone 
interpretative standards (WHO)
Antimicrobial
Agent
Disc . 
Content
Code
Zone Diameter (mm)
Resistant
(R)
Intermediate
(D
Susceptible
(S)
amoxocillin 25 Mg AML <13 14-20 <21
azlocillin 75 Hg AZL < 9 10-18 <19
ceftazidime 30 fig CAZ <14 15-20 <21
cefuroxime 30 pg CXM <13 14-21 <  22
erythromycin 15 pg £ <13 14-17 <18
gentamicin 10 pg CN <12 13-14 <15
novobiocin 5 pg NV <15 16-20 <21
penicillin G 10 units P <11 12-21 <22
piperacillin 75 pg PRL <14 15-17 <18
sulphamethox­
azole
25 pg RL <13 14-16 <18
tetracycline 30 pg TET <14 . 15-19 <20
tobramycin 10 pg JOB <12 13-14 <15
Acar and Goldstein (1985), and Vandepitte et al (1991)
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4.3.2 MIC determination by Agar Dilution
MIC values, expressed as pg ml'1, obtained by Agar Dilution in DST Agar are shown on 
Table 4.8, Table 4.9 and Table 4.10 . Where the antibiotic was not tested against the 
isolate a dash (-) is shown.
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4.4 Discussion
4.4.1 Antibiotic resistance/susceptibility
The Kiiby-Bauer method proved to be a reliable method of determining antibiotic 
resistance or susceptibility of B. cepacia isolates. Isolates run as repeats, NCPPB 
2993 and C23, had diameter variations of only 1mm between each set of plates 
tested. Results obtained were broadly as expected. Virtually all isolates were 
resistant to novobiocin, amoxycillin, penicillin G and erythromycin (Table 4.7). Many 
isolates, were resistant to tetracycline (89% of clinical isolates, 74% of environmental 
isolates) and the aminoglycosides tobramycin and gentamicin (89% of clinical 
isolates), (Table 4.6). The number of isolates resistant to the antipseudomonal 
ureidopenicillins piperacillin and azlocillin, ceftazidime and sulphamethoxazole was 
found to be more variable. Environmental strains were found to be particularly 
susceptible to azlocillin (85% susceptible), piperacillin (100% susceptible) and 
ceftazidime (72% susceptible), (Table 4.5).
These results obtained compare broadly to those of Santos-Ferreira et al (1985) for 
nosocomially acquired strains of B. cepacia from non-CF patients, and Bhakta et al 
(1992) for B. cepacia isolates from CF patients.(Table 4.11)
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The numbers of isolates resistant to tobramycin reported by Bhakta eta l (1992) 
compares closely with those obtained in this study, (93% and 89% resistant 
respectively). However levels of resistance found for piperacillin (48%) and 
ceftazidime (41%) in clinical isolates are considerably higher than the levels recorded 
by Bhakta et al. (1992) . This is possibly due to increased use of these antibiotics in the 
treatment of infections in CF, particularly in the UK.
The numbers of isolates resistant to aminoglycosides and tetracycline reported by 
Santos-Ferreira et al (1985) were similar to those found amongst our isolates. The 
main differences found were in the resistance levels to novobiocin and cefuroxime. All 
isolates tested were found to be resistant to novobiocin, whereas Santos-Ferreira et al 
found all isolates to be susceptible to this drug. Conversely all isolates were found to 
be resistant to cefuroxime by Santos-Ferreira et al, (1985) compared with susceptibility 
levels of 34% in our isolates. The pattern of resistance to azlocillin, piperacillin and 
ceftazidime was similar to that found in the environmental isolates, with little resistance 
to these drugs overall.
Distinct patterns of resistance were seen amongst the clinical isolates. Generally 
isolates from Cardiff CF patients were resistant to azlocillin, piperacillin and 
ceftazidime but susceptible to sulphamethoxazole. Isolates from Edinburgh and 
Strasbourg CF centres were resistant to sulphamethoxazole but more susceptible to 
azlocillin, piperacillin and ceftazidime. Such patterns may be due to the development of 
acquired resistance to such drugs, possibly due to therapy with ureidopenicillins and
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ceftazidime being predominantly used in Cardiff, and sulphamethoxazole as a 
component of co-trimpxazole with trimethoprim more commonly used at other centres.
4.4.2 MIC determination
Although the Agar Dilution method was reasonably quick and easy to perform, a 
number of problems were found. Determination of the end point was somewhat 
difficult. Judging whether there is growth, hazy growth or a single colony is rather 
subjective unlike the determination of a zone size or an absorbance value. Variability 
was also a problem, as repeated isolates could vary considerably in MIC value. For 
example repeats of C23 varied in MIC values between 25 to lOOpg ml'1 for piperacillin.
Overall the results obtained were again comparable with published values. Bhakta et 
al (1992) described a range of M IC s in B. cepacia CF isolates of 4 to 32 pg ml"1 for 
ceftazidime as compared with 1 to 10 pg ml"1 for CF isolates tested, 16 to 128 pg ml"1 
for piperacillin compared with 5 to 250 pg ml"1, 1 to >64 pg ml"1 for amikacin as 
compared with 25 to 500 pg ml"1 and 0.25 to >16 pg ml'1 for tobramycin compared 
with 25 to 500 pg ml"1. It is notable that very high MIC levels were obtained for 
aminoglycoside drugs with some isolates. Bhakta et al (1992) also found that the 
majority of isolates, some 90 %, had MIC levels for piperacillin of 64 pg ml ™1 or below 
compared with a level of 25 pg ml"1 for most of the CF isolates tested in this study.
An earlier study of clinical and environmental isolates found MIC levels of less than 5 
pg ml'1 to 640 pg ml'1 for gentamicin (Gonzalez and Vidaver 1979). This compares 
well to the MIC levels of 1 pg ml'1 to over 500 pg ml'1 found in the isolates in this 
study.
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The MIC*s described by Santos-Ferreira et al (1985) for nosocomial B. cepacia 
isolates also compare well to the results obtained. A range of 0.125 to 16 pg ml'1 was 
found for ceftazidime, with most isolates (around 80 %), having a MIC of 1 or less.
The results obtained were in the range of 1 to 25pg m l1, with most CF isolates in the 
range of 5 to 10 pg ml-1and most environmental isolates were in the range of 1 to 5 pg 
ml"1 Santos-Ferreira et al (1985) found a MIC range of 0.125 pg ml 'ho 
32 pg ml^for piperacillin, with the majority, over 90%, having a value of 8 pg ml -1or 
less. This closer to the MIC range for environmental isolates, 1 to 10 pg m l1 than that 
of CF isolates, a range of 1 to 250pg m l-1, with the majority having an MIC of 25 pg 
ml-1. This level being higher than that of the nosocomial isolates.
A notable point is that using British Society for Antimicrobial Chemotherapy Working 
Party breakpoints few of our isolates would be regarded as resistant to piperacillin at 
the upper breakpoint of 64 mg 1 ^(or 64pg ml *1)(British Society for Antimicrobial 
Chemotherapy 1991). Only 6 of 27 CF isolates (23 %) and 1 of 23 environmental 
isolates (4  %) would be resistant at the 64 pg ml ~1 breakpoint, compared with 20 of 
42 (42 %) of CF isolates and 1 of 25 environmental isolates (4 %) found resistant by 
Butler e / a / (1995).
As with the Kirby-Bauer test results patterns of MIC levels could be seen amongst the 
CF isolates. Generally, the main exception being C93, Cardiff isolates have MIC levels 
to ceftazidime of around 10 pg ml"1 piperacillin 25 pg ml"1, gentamicin 50pg ml"1, 
tobramycin 25 pg ml"1, amikacin 25 pg ml-1and sulphamethoxazole 5 to 25 pg ml"1
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Isolates from Edinburgh and Strasbourg CF centres have lower MIC levels for 
ceftazidime Ito 5 pg ml'1, and piperacillin, 5 to 10 pg ml*1, but much higher MIC levels 
for tobramycin, gentamicin, amikacin and sulphamethoxazole. In some cases these 
values exceed 500 pg ml"1
4.4.3 Resistance in environmental and clinical strains 
Generally environmental isolates appear to be less resistant to antimicrobials than 
clinical isolates from CF patients. This seems particularly true of piperacillin, azlocillin 
and ceftazidime with most environmental isolates susceptible to these drugs. A range 
of resistance levels to aminoglycosides was found amongst environmental isolates. 
Although some isolates had high MIC levels o f250 pg ml"1 for gentamicin, many had 
low levels of Ito 5 pg ml*1 with 89 % being susceptible compared with only 11 % of 
CF isolates being susceptible. Butler et al (1995) found environmental isolates were 
more susceptible to antibiotics than CF isolates. Determination of MIC by Agar 
Dilution showed the vast majority of environmental isolates having MIC levels below 
breakpoint levels for piperacillin, meropenem and ceftazidime whereas much higher 
numbers of clinical isolates were above these levels.
Levels of resistance amongst non-CF B. cepacia clinical isolates are considerably lower 
and more comparable to environmental isolates. Gonzalez and Vidaver (1979) found 
little difference in MIC levels between environmental and non-CF clinical isolates, and 
the results of Santos-Ferreira et al (1985) more closely resemble the values obtained 
for the environmental isolates than those of the CF isolates. Although it should be 
remembered that B. cepacia is innately resistant to many antibiotics, the aggressive
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antimicrobial chemotherapy employed in CF respiratory infections would obviously 
place selective pressure on B. cepacia infecting CF patients. This could have two 
effects; firstly selecting for the more resistant strains of B. cepacia and eliminating any 
with low resistance to antimicrobials and secondly, it might lead to acquired high level 
resistance to the antimicrobials used. Alternatively such differences may be the result 
of the strains infecting CF patients having fundamental differences to those in the 
environment or causing nosocomial infections.
4.4.4 Antimicrobial resistance/susceptibility in R. cepacia: General 
considerations
The results obtained were broadly those expected, with most isolates resistant to many 
antibiotics including tetracycline, erythromycin, novobiocin, penicillins and 
aminoglycosides with varying resistance levels to ureidopenicillins, ceftazidime and 
sulphamethoxazole. B. cepacia would also be expected to be resistant to other 
antibiotics not tested including polymixins such as colistin, polymixin B and ticaricillin. 
These drugs are employed in the B. cepacia selective media described by Gilligan et al 
(1985) and produced commercially by Mast Diagnostics. Iji the clinical testing of 
antibiotics it would also be important to include trimethoprim and trimethoprim- 
sulphamethoxazole (co-trimpxazole), often used in treatment off?, cepacia infections. 
It would also be more suitable to test a broader range of antibiotics for MIC 
determination, using doubling dilutions from 1056 pg ml *to 1 pg ml-1 
The use of the Kirby-Bauer disc diffusion test for determining resistance or 
susceptibility to antibiotics proved to be convenient and reliable and although there 
were some problems with MIC determination by agar dilution, these tests were of
considerable value in determining the antibiotic resistance phenotypes for a range of 
environmental and clinical B. cepacia isolates. The tests defined levels of antibiotic 
resistance for further experiments and showed the intrinsic multiresistance to antibiotics 
displayed by B. cepacia of both environmental and clinical origin and hence the 
problems faced by clinicians in treating B. cepacia infections.
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Chapter S Isolation and purification of plasmid DNA from B. cepacia
5.1 Introduction
5.1.1 Principles of plasmid DNA isolation and purification
Isolation of plasmid DNA relies upon the small size and the covalently closed circular 
(ccc) nature of plasmid DNA compared with the larger, less supercoiled chromosomal 
DNA (Sambrook et al 1989, Rohde 1995). All methods require the lysis of cells prior 
to the purification of plasmid DNA. Lysis techniques include the use of lysozyme, 
EDTA, detergent, boiling or treatment with alkali (Sambrook et al 1989).
One of the most established methods for the separation of plasmid from chromosomal 
DNA is equilibrium centrifugation in caesium chloride (CsCl) - ethidium bromide 
gradients (Sambrook et al 1989). CsCl gradients are produced by high-speed 
centrifugation of saturated solutions of CsCl, giving gradients that are dense at the 
bottom and less so at the top. Molecules float in the gradient according to their 
buoyant densities; DNA floats in the middle of a gradient, protein floats at the top and 
RNA pellets at the bottom. The addition of ethidium bromide allows visualisation of 
DNA. Ethidium bromide is a planar molecule that intercalates between bases in DNA 
molecules. Chromosomal DNA, nicked or open circular plasmid DNA allows the 
intercalation of large amounts of ethidium bromide. This decreases the buoyant density 
of the molecule. In contrast cccDNA in the supercoiled plasmids allows the 
intercalation of only small amounts of ethidium bromide. Consequently chromosomal 
DNA is more buoyant and floats above the plasmid DNA. Illumination with ultraviolet
(UV) light visualises DNA intercalated or stained with ethidium bromide. This allows 
the lower band of ccc plasmid DNA to be withdrawn from the tube with a syringe. 
However this method is expensive, requiring an ultracentrifuge, and time consuming.
Numerous other methods have been developed to isolate plasmid DNA. Many rely on 
lysis treatments that also disrupt base pairing in DNA molecules resulting in the 
dénaturation of chromosomal DNA. ccc plasmid DNA strands are not separated as 
they are intertwined by high levels of supercoiling. A return to neutral, non-lytic 
conditions allows the plasmid DNA to return to its correct pairing accurately and 
rapidly (Sambrook et al 1989).
'Cleared lysate’ methods such as those of Rodriguez and Tait (1983) and Bimboim 
(1983) use lysis by lysozyme, detergents or alkali to break up bacterial cells and 
fragment chromosomal DNA The samples are then centrifuged to remove cell debris 
and the majority of chromosomal DNA This results in a 'cleared lysate’ containing 
plasmid DNA and any remaining chromosomal DNA. The DNA may then be 
precipitated by cold alcohol. Rapid boiling methods for small plasmids employ similar 
methods (Sambrook ef a / 1989).
The isolation method ofKado and Liu (1981) uses a high alkaline pH at a raised 
temperature to denature proteins and chromosomal DNA. The resulting lysate is then 
mixed and emulsified with a phenol/chloroform mixture. The emulsion is broken by 
centrifugation . The phenol/chloroform extraction results in the ccc plasmid DNA 
being left in the upper aqueous phase. Proteins, cell wall debris and the majority of
chromosomal DNA precipitates at the aqueous/solvent interface. The upper layer can 
be removed and the DNA precipitated if required.
A number of other methods including ion exchange, gel filtration and differential 
centrifugation with polyethylene glycol or sucrose gradients have also been utilised for 
plasmid isolation(Sambrook et al 1989). Commercial kits for plasmid purification 
often use a combination of production of a cleared lysate before separation of the DNA 
by ion exchange. Qiagen and Qiafilter systems (Qiagen 1996) use a 
diethylaminoethanol (DEAE) anion exchange resin. Anion exchange works by binding 
the negatively charged DNA to the resin. The DNA can then be eluted by use of buffer 
at lower pH or altered ionic strength. The elution with Qiagen kits is with a high salt 
buffer. Promega’s 'Wizard* system employs resin slurry and a mini spin column in a 
similar method (Promega 1996).
Large plasmids are usually of lower copy number than small plasmids. (Sambrook et al 
1989). A number of techniques have been used in E. coli to increase plasmid yield, 
notably growth in Terrific broth or using chloramphenicol Amplification (Sambrook et 
a/1989). The basis of chloramphenicol amplification is that chloramphenicol will inhibit 
protein synthesis and hence cell replication without inhibiting DNA synthesis. This 
would allow plasmid replication to continue, thereby increasing copy number 
(Sambrook et al 1989).
Agarose gel electrophoresis is the most commonly employed method for plasmid 
identification and characterisation . Gels are usually produced and electrophoresed
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either in tris-borate (TBE) buffer or inh tris-acetate (TAB) buffer. Negatively charged 
DNA migrates towards the anode in an electric field. Rate of movement is based upon 
size (small molecules move through the gel more rapidly), and conformation (any 
nicked or open circular DNA would move more slowly than cccDNA) (Gartland and 
Gartland 1993). DNA can be visualised by staining with ethidium bromide and 
illuminating with UV light and photographs can be taken to give a permanent record.
Plasmid size may be estimated by running and plotting logw of DNA size (in kb or 
MDa) of plasmids of known sizes such as those of is. coli V517 (Macrina e ta l 1978). 
against distance travelled to give a standard curve from which size can be calculated. 
This method has been applied successfully with several species, notably Salmonella 
where it has formed the basis of typing by plasmid profiling (Threlfall and Frost 1990). 
A major problem with this method is the curved line obtained resulting in inaccurate 
results. Greater accuracy can be obtained by plotting log io molecular size against log# 
relative mobility (Meyers et al 1976). This may be further improved by multiple 
regression analysis of the logw molecular size against logw relative mobility and the 
reciprocal square root of the relative mobility (Rochelle et a l 1985). This was found to 
give accurate estimations of plasmid size over a large range and with a variety of 
agarose strengths. Alternatively plasmid DNA may be digested into linear fragments 
with restrcition endonucleases and size compared with molecular markers (Gartland 
and Gartland 1993). Summation of the sizes of the fragments allows the size of the 
plasmid molecule to be calculated. Many workers regard this method as more 
accurate, particularly with large plasmids.
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5.1.2 Plasmid isolation and detection in R  cepacia
Plasmids in B. cepacia have been reported as being large in size, often in excess of 200 
kb (Lennon and DeCicco 1991, Bhat et al 1994). A number of methods of plasmid 
isolation have been employed. Equilibrium centrifugation with CsCl and ethidium 
bromide was used to isolate antibiotic resistance plasmids in B. cepacia (Williams et al 
1979, Hirai et al 1982), and more recently degradative plasmids (Haak et al 1995). 
Lennon and DeCicco (1991) used a modified method based on that of Birnboim 
(1983), including an additional phenol/chloroform extraction. Methods based on those 
ofKado and Liu (1981) have been used to isolate mercury resistance plasmids 
(Rochelle etcd 1988) and degradative plasmids. Methods based on those of Hansen 
and Olsen (1978) have been also used to isolate large plasmids from B. cepacia (Xia et 
al 1996).
5.1.3 Methods for detection and purification of plasmid DNA used in this study 
The methods employed in this study were chosen on the basis of those previously used 
to isolate plasmids in B. cepacia and those previously used in this laboratory (Duggan 
1993). Methods based on those ofKado and Liu (1981), Èimboim (1983) and the 
modified method used by Lennon and DeCicco(1991), the cleared lysate method of 
Rodriguez and Tait (1983) .A number of commercially available kits were chosen for 
use to assess their usefulness in quickly obtaining large quantities of plasmid DNA in 
B. cepacia. Size of plasmids was estimated by comparison with the known plasmids in 
E. coli V517 (Macrina et al 1978) and E coli 39R (Threlfall et al 1986)
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5.2 Materials and methods
Materials
■.Chemicals
Chloroform, Molecular Biology Grade (Sigma Chemical Co., Poole, Dorset) 
Equilibrated phenol. Molecular Biology Grade (Sigma Chemical Co.) and supplied 
isoamyl alcohol
Agarose, Molecular Biology Grade (Sigma Chemical Co.) 
iLStrains
Size reference markers:
Escherichia coli V517 containing eight plasmids of known size (Macrina et al 1978).
E  coli 39R861 containing four plasmids of known size (Threlfall et al 1986). 
Psetidomonas aeruginosa PAO 2002/pQMl containing a single large plasmid were.
All strains were maintained as frozen stocks at -70° C with 20% v/v glycerol. The sizes 
of the plasmid standards are shown in Table 5.1.
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Table 5.1 Size of plasmids in reference strains
Strain Plasmid Size
(kb)
pVA517A 55.1
pVA517B 7.4
pVA517C 5.6
K  coli V517 pVA517D 5.2
pVASlTE 4.1
pVA517F 3.1
pVA517G 2.7
PVA517H 2.1
A 151.0
& coli 39R861 B 65.0
C 36.8
D 7.1
Ps. aeruginosa PA02002 pQMl 254.0
Other strains;
Overnight 10 ml cultures of B. cepacia and other species were grown in NB as 
previously described (Chapter 2 p.97),unless otherwise stated.
25 to 100 ml overnight cultures were grown at 37°C in an orbital incubator at 200 
r.p.m for 16 h.
iii. Media
Luria Bertani (LB) broth (Appendix 1), pre-warmed to 37°C where indicated.
iv. Solutions
Lysing solution (Appendix 1)
1 mg ml'1 lysozyme prepared in filter sterilised distilled water (Sigma Chemical Co., 
Poole, Dorset)
Alkaline sodium dodecyl sulphate solution (Appendix 1)
High salt solution (Appendix 1)
Acetate MOPS buffer (Appendix 1)
Gel loading buffer (Appendix 1)
TBE buffer (Appendix 1)
TE buffer (Appendix 1)
Chloroamphenicol solution, 34 mg ml'1, dissolved in ethanol (Sigma Chemical Co., 
Poole, Dorset)
Ethidium bromide solution, Img ml"1, prepared in double distilled water (Sigma 
Chemical Co., Poole, Dorset)
Saturated sodium chloride solution: Analar grade NaCl (BDH, Poole, Dorset), 
dissolved in double distilled water under saturated, then sterilised by autoclaving at 
121°C, 15 p.si. for 15 mins.
v. Equipment
Horizon 58 mini gel electrophoresis tank(Gibco BRL, Paisley Scotland)
Bio Rad sub-cell electrophoresis tank (Bio Rad.Hemel Hempstead, Herts.)
250-EX electrophoresis power supply (Gibco BRL, Paisley, Scotland)
Sorvall RC-5B, high speed centrifuge and centrifuge tubes 
MSE Microcentaur microcentrifuge 
Vi. Disposable consumables
1.5 and 0.5 ml ‘Eppendorff microcentrifuge tubes (Fisher Scientific, Lougborough, 
Leics.)
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Methods
i.Isolation of plasmid DNA
a. Plasmid isolation by modified Kado and Liu method (1981)
The method used was modified from that described by Kado and Liu (1981). Bacterial 
strains were grown from frozen stock isolates, or from plate cultures from the frozen 
stocks, overnight at 35° C in 10 ml of nutrient broth. 1.5 ml o f culture was pelleted at
13,000 g for 4 min in a MSE Microcentaur microcentrifuge. The supernatant was 
poured off and the pelleted cells were lysed by agitating the pipette tip into the pellet 
and any residual broth followed by addition of 150 pi of lysing solution, then mixed to 
form a suspension. The suspension was heated at 65°C for 90 min in a waterbath. 150 
pi o f phenol/chloroform, produced by mixing equilibrated phenol, chloroform and 
isoamyl alcohol, in a ratio of 25:24:1 (Sambrook et al 1989), was added and an 
emulsion produced by vigorous shaking of the tubes. The emulsion was broken by 
centrifugation at 13,000 g for 3 min. 75 pi of the upper aqueous layer was removed to 
a fresh tube using a pipette tip with the end removed to reduce shearing of large 
plasmids and the possibility of disturbing the precipitate at the interface. 7.5 pi of 
loading buffer was added to each sample prior to immediate loading onto an agarose 
gel. A number of modifications were also tried. The ratio of phenol:chloroform was 
varied, and a second phenol/chloroform extraction step also used.
b. Plasmid isolation by Birnboim method (1983)
1.5 ml of overnight culture was pelleted by centrifuging at 13,000 g in a MSE 
Microcentaur microcentrifuge for 5 min. The supernatant was decanted and the pellet 
resuspended in 100 pi o f lysozyme solution, and placed on ice for 5 min. 200 pi of
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alkaline SDS was added and the tubes mixed by inverting . The tubes were placed on 
ice for 5 min. 150 pi o f high salt solution was added and the tubes placed on ice for 15 
min to form a ‘curd-like’ precipitate. The precipitate was pelleted by centrifuging at
13,000 g for 2 min. 350 pi of supernatant was removed and pipetted into a clean tube. 
900 pi o f ice cold ethanol was added and the tubes maintained at -  20° C in a freezer 
for 5 min. The tubes were centrifuged for 1 minute and the supernatant decanted. The 
pellet was dissolved in 100 pi o f acetate MOPS buffer. Plasmid DNA was precipitated 
by the addition o f 200 pi of ethanol and pelleted for 2 min at 13,000 g. The ethanol 
was removed and the DNA pellet resuspended in 40 pi of TE or TBE buffer. 10 pi was 
removed and added to 5 pi of loading buffer and loaded immediately into an agarose 
gel. The remaining 30 pi was frozen at -70 °C for future use.
c. Modified Birnboim method for isolation of B. cepacia plasmid DNA (Lennon 
and DiCicco 1991)
The method follows the Birnboim method to the precipitation with 900 pi of ethanol. 
At this point the pellet was resuspended with 100 pi of TE buffer rather than acetate 
MOPS buffer. An equal volume of phenol/chloroform was added and the tubes shaken 
vigorously to form an emulsion. The emulsion was broken by centrifuging at 13,000 g 
for 3 min. The upper aqueous layer was removed to a clean tube. 100 pi of acetate 
MOPS was added and the remainder of the method was as for the Birnboim method.
d. Isolation of plasmid DNA by commercial kits and the Rodriguez and Tait 
method (1983)
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A number of commercial kits for plasmid isolation were also used. Qiagen plasmid mini 
kits and QiaFilter plasmid maxiprep kits were both tried with and without 
chloramphenicol amplification. These kits were used following manufacturers’ 
instructions. Promega ‘Wizard’ kits were also used following manufacturers' 
instructions A number o f modifications to the method were also used: 6 or 9 ml of 
culture were used for the initial bacterial pellet and/or a phenol/chloroform extraction 
was carried out on the lysate prior to mixing with the resin and loading on the column.
The Rodriguez and Tait method (1983) was also used, following the published 
protocol.
ii. Amplification of plasmid DNA with chloramphenicol (Sambrook et al 1989)
500 ml LB broths were pre-warmed to 37°C in a shaking incubator for 1 h. The 25 ml 
overnight cultures were added to the broths and the flasks were incubated at 37°C for
2.5 h shaking vigorously at 300 cycles min"1. After the 2.5 h 2.5 ml of 34 mg ml'1 
chloramphenicol was added to each of the flasks to give a final concentration o f 170 pg 
ml"1. The culture was then incubated for 15 h at 37°C maintaining the shaking at 300 
cycles min"1. The amplified culture was then used in the previously described Kado and 
Liu, modified Promega Wizard and Qiagen QiaFilter maxi methods(p. 173). 
Amplification by growth in Terrific Broth was also used.
iii.Agarose gel plasmid DNA electrophoresis
0.21 g of agarose was weighed and placed into 30 ml of TBE buffer to give a 0.7% 
agarose gel. The gel was melted either in a microwave or over a Bunsen burner, mixed
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well and allowed to cool before pouring. The cooled gel was poured into the chamber 
of a Gibco BRL Horizon 58 gel electrophoresis tank to give an approximate gel 
thickness of 5 mm. After allowing to cool and set for 1 h, TBE running buffer was 
added to the tank. 20 pi of samples with loading buffer was added to the wells of the 
agarose gel.
Electrophoresis was carried out at 4 V cm"1 for 90 to 120 min until the bromocresol 
tracking dye in the loading buffer had nearly reached the end of the gel. The gel was 
stained with ethidium bromide made to 0.5 pg ml"1 in distilled water for 15 min. Gels 
were then destained for 15 min under running tap water.
Gels were photographed over a short wave ultraviolet light (UV) source (UVP UV 
transilluminator). Polaroid 667 film was exposed through an UV filter , Kodak 
Wratten No. 9 filter and F-l 1 aperture for 4 sin  a Polaroid CU5 land camera fitted with 
88-46 or 88-48 camera hoods. Film was developed at room temperature for 60 s.
iv. Restriction endonuclease digests of plasmid DNA
Restriction digests using the restriction endonucleases Hind  III and EcoRI (Promega, 
Southampton, Hants) were set up in the supplied buffers under manufacturers’ 
recommended conditions using plasmid DNA obtained from commercial plasmid DNA 
isolation kits outlined previously (P. 174). XDNA (Promega, Southampton, Hants) 
digests were included as digestion controls. Digested samples were loaded onto 0.7% 
agarose gels and run at 3 V cm 1 for Ih. The gels were then stained and photographed 
as described above .
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v. Isolation of plasmid DNA from preparative gels
. Samples were prepared by the modified Kado and Liu (1981) method using 3 ml 
pellets and double quantities of all buffers and solutions. Six sets of samples were 
prepared of each strain giving a final 1.2 ml volume of pooled supernatants.
Preparative gels were cast in BioRad large sub-cells using 1.08 g of agarose in 180 ml 
of TBE yielding a 0.6 % agarose gel or in a BioRad sub-cell using 0.6 g of agarose in 
100 ml of TBE to give a 0.6 % agarose gel. Gels were run at 4 V cm'1 and stained with 
ethidium bromide and the plasmid band was cut out. The gel slices were re-stained 
with ethidium bromide and checked under UV transillumination for presence of the 
DNA. The slice was macerated with an equal volume of TE buffer. The samples from 
were run on a standard 0 .7 % agarose mini gel to check for the presence of plasmid 
DNA.
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5.3 Results
5.3.1 Isolation of plasmid DNA
Plasmid DNA could not be isolated or detected in B. cepacia by the Rodriguez and 
Tait method, the Qiagen plasmid miniprep kit or the Promega Wizard miniprep kit 
though both the Qiagen and Wizard kits could detect the 2.7 kb plasmid pUC19 from 
E. coli DH5a Extensive modification of the Wizard method (increasing pellet size and 
adding a phenol/chloroform extraction) detected a plasmid in B. cepacia C59 but not in 
other isolates The method of Birnboim (1981) detected plasmid DNA in a number of 
B. cepacia isolates, but proved to be inconsistent in subsequent repeats. The modified 
method described by Lennon and DeCicco (1991) failed to detect plasmids in the B. 
cepacia strains tested .
The modified Kado and Liu method (1981) detected plasmids reasonably consistently 
in a range of B. cepacia strainss (Plate 5.1). On the basis o f this the Kado and Liu 
method was chosen for the subsequent detection of plasmid DNA in all B. cepacia 
strainss and for their size estimation. A further example o f typical results obtained is 
shown in Plates 5.2. In each of the gels fragments o f chromosomal DNA can be seen, 
running approximately equivalent to 10 kb, as marked on the gels (Burton, personal 
communication 1994).
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Plate 5.1 Agarose gel electrophoresis characterisation of plasmids isolated by 
the modified Kado and Liu method (1981) and E. coli V517 standard reference 
plasmids
1 2 3 4 5 6 7 8
Chromosomal
fragments
Lane
1 B. cepacia C51
2 B. cepacia C5
3 B. cepacia C95
4 E. coli V517 marker strain
5 B. cepacia Cl 1
6 B. cepacia Cl
7 Ps. aeruginosa PAO 1 /pQM 1 /R300B
8 Blank
11^
Plate 5.2 Agarose gel electrophoresis characterisation of plasmids isolated by 
the modified Kado and Liu method (1981) and E. coli V517 standard reference 
plasmids
Chromosomal
fragments
Lane
1 E.
2 B.
3 B.
4 B.
5 B.
6 B.
7 B.
8 B.
 coli V517 marker strain
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5.3.2 Estimation of plasmid size and distribution of plasmids
Plasmid size was estimated from agarose gels by regression analysis o f logio molecular 
size (kb) against logio mobility or distance migrated (mm) using E. coli V 517 or 39R 
plasmids as standards The sizes of 8 plasmids in V517 and the 4 in 39R have been 
well characterised and used as size markers (Macrina et al 1979, Threlfall et al 1986). 
The distance migrated was measured with a calliper or rule as the distance from the 
origin (front of well) to the leading edge of the band on the Polaroid photograph. The 
data was analysed by MINITAB for Windows .
Example calculation
Using Plate 5.2 with V517 as standard (lane 1), the plasmid sizes and distances 
migrated:
Distance migrated Plasmid size
(mm)
10
19
22
24
26
28
32
33
(kb)
55.1 
7.4
5.6 
5.2
4.1
3.1
2.7
2.1
181
log
lO
 
di
st
an
ce
 
m
ig
ra
te
d
The values for both distance travelled and plasmid size were log,, transformed, and
108,0 m° lecular size was P'otted against log,, distance travelled (Figure 5.1), with 
simple linear regression analysis used to give the regression equation.
Figure 5.1 Standard plot of log,, molecular size against log,, distance 
travelled for £  coli V517 from Plate 5.2
1.6
1.4
1.2
0.8
0.4 -
0.2  -
0.5 1.5
loglO E coli V517 plasmid size
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The regression equation obtained : 
y = c-mx
y = 1.64 - 0.374 x
Where y = logio distance migrated 
x = logio plasmid size
As the distance migrated by the plasmids can be obtained from the gel the value for y 
can be substituted for the distance migrated by a plasmid of unknown size.
Therefore for the plasmid in PW6, the distance migrated = 12 mm
logio 12 = 1.64 - 0.374 x
Where x= log i0 plasmid size
1.08 = 1.64-0.374 x
1.08-1.64 = x 
-0.374
1.49 = x
antilog 1.49 = plasmid size (kb)
31.4 kb = plasmid size in PW6
The plot was well predicted with a good line of fit shown by the coefficient of 
correlation and Durbin Watson values. The coefficient of correlation (squared 
correlation coefficient value), R 2 was 98.7%. The method was subsequently used to 
estimate the size of plasmids from agarose gels using V517 and 39R size standards,
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with an individual regression equation obtained for the plasmid standards in each gel 
The regression analysis gave both good consistency and prediction for line o f fit. 
Consistently high values were obtained for R2 . From 14 gels a mean R2 value of 
98.73% was found, with values ranging from 97.1% to 99.8%.
Some difficulty arose with larger plasmids (>150 kb) as the 251 kb plasmid pQMl was 
not detected reliably by agarose gel electrophoresis and so could not be used as a size 
standard. Therefore the 151 kb plasmid of 39R was used as the largest standard and it 
was necessary to extrapolate the regression equation beyond the values o f the standard 
to estimate the sizes of the larger plasmids.
Plasmids detected in the B. cepacia plasmids and their estimated sizes are given in 
Table 5.2. The data shown here represents mean values obtained for each plasmid for a 
minimum of two repeated gels, though with some strains up to eight repeat 
experiments were conducted. Figure 5.2 shows the frequency distribution o f plasmids 
found in the B. cepacia strainss investigated in this study.
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Table 5.2 Size and distribution of plasmids in tested B. cepacia isolates
Isolate Plasmid sizes 
(kb)
Cl 134
C5 134
C ll 134
C23 139, 24, 13
C49 2.1, 1.7
C51 ND
C59 20
C79 90
C81 40
C93 ND
C95 ND
C96 109, 2.1, 1.7
C l 16 144, 29.3, 2.1,1.7
C187 51,4.4, 4.0
C190 ND :
C205 ND
J543 90
3478 152
A548 ND
A562 70, 4.5
C1858 ND
C l 860 185,3.4
) J2552 ND
D2 41
D3 ND
D4 36 .
D5 36
D6 ND
| NCPPB 2993 224
NCPPB 3480 200, 177 !
NCI MB 9085 58
j NCIMB 9087 ND
NCIMB 9088 38
NCIMB 9092 ND
PW1 ND
PW2 132, 51, 31, 16, 9, 8, 3.6, 1.1
PW3 93 1
PW4 31
PW5 ND
PW6 31
Table 5.2 (Continued)
PW7 132,51,45, 11,7, 6.2, 3.6, 2.5
PW8 ND
PW9 >250 1
PW10 16, 12,7.1
PW11 ND
PW12 ND
PW13 ND
PW14 ND
PW15 ND
PW16 ND
PW17 ND
PW18 ND
PW19 ND
PW20 ND
PW21 ND
B. gladioli NCPPB 2478 116
ND = no plasmid(s) detected
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5.3.3 Isolation of plasmid DNA for transformation and plasmid 
mapping studies.
As insufficient plasmid DNA was isolated for transformation or mapping of plasmids by 
the mini-prep and commercial methods used, it was decided to use commercial maxi 
prep methods. Use of the Qiagen QiaFilter maxiprep kit detected small amounts 
plasmid DNA in NCPPB 2993 and C79. Digestion with EcoRl or Hind III failed to 
yield any fragments. This was also found using plasmid DNA from the Kado and Liu 
method. The use of preparative gels also failed to yield plasmid DNA.
5.3.4 Amplification of plasmid DNA by growth in Terrific broth and by 
chloramphenicol amplification.
Growth in Terrific broth was unsuccessful in increasing plasmid yield. Growing 
overnight cultures in Terrific broth increased overall growth and the amount of DNA 
leading to smearing and a large chromosomal fragment band The use of 
chloramphenicol amplification failed to increase plasmid DNA by Kado and Liu (1981), 
QiaFilter maxiprep or modified Promega Wizard miniprep methods. In both the 
QiaFilter and Wizard methods, the plasmid yield appeared to decrease.
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5.4 Discussion
5.4.1 Characterisation of plasmid DNA
Generally the methods used in this study were poor at detecting and characterising 
plasmid DNA in B. cepacia . The Qiagen miniprep, Rodriguez and Tait (1983) or 
Promega Wizard methods failed to detect plasmid DNA. The Birnboim method was 
reasonably good in detecting smaller plasmid but was inconsistent in detecting larger 
plasmids. The modified method of Lennon and DiCicco (1991), developed for & 
cepacia plasmids, was unsuccessful in this study. Modification of the Promega Wizard 
miniprep by increasing pellet size and using a phenol/chloroform extraction was only 
able to detect a small 20 kb plasmid from C59. The Kado and Liu (1981) method 
appeared to be the best method overall, though this also failed to yield sufficient 
quantities of purified DNA for future work, though was a good method for plasmid 
screening.
A number of groups have had difficulty in isolating plasmids in B. cepacia. Both 
Williams et or/ (1979) and Hirai et al (1982) found difficulty in isolating antibiotic 
resistance plasmids from B. cepacia. Williams et al (1979) suggested that nucleases 
present in the extraction method might cause problems in obtaining consistent plasmid 
profiles. Lennon and DiCicco (1991) found difficulty in obtaining consistent plasmid 
profiles with either the Kado and Liu or Birnboim methods, with consistency only 
achieved by the addition of a phenol/chloroform extraction step to the Birnboim 
method though in this study the Kado and Liu method was found to be more 
consistent. Other groups have also found success with versions of the Kado and Liu
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method (Bhat et al 1995). Large degradative plasmids have also been detected in 
Pseudomonas sp. by this method (Cork and Khahlil 1995). The failure to isolate 
plasmid DNA from B. cepacia by these methods was one of the main factors 
considered when trying to develop the use of commercial kits to obtain a high yield of 
DNA, though these were with hindsight even less suitable for use with B. cepacia.
Factors that may contribute to the poor isolation of B. cepacia plasmid DNA are a low 
plasmid copy number, the large size of the plasmids and the nature of B. cepacia itself, 
particularly its’ cell wall structure. The cell wall structure may not be broken by 
‘milder’ lysing methods employed in cleared lysate methods such as the Rodriguez and 
Tait method, so no plasmids are released. Large plasmids may be sheared by 
conventional methods. The low copy number may mean that there is too little DNA to 
be detected by agarose gel electrophoresis.
Both large size and low copy number could lead to problems with commercial kits. 
These methods are developed mainly for use with small high copy number plasmids 
such as vector plasmids like pGEM. Large plasmids, often' in excess o f 100 kb, are 
found in B. cepacia, and even with a raised elution temperature cannot be isolated by 
these methods. The methods are also usually employed with plasmids in E. coli. As 
mentioned previously, it is significant that the only plasmid isolated in B. cepacia by 
commercial methods, was the relatively small 20 kb plasmid in C59 by a highly 
modified Promega Wizard method.
It would appear that the stronger lysis of the Kado and Liu method is more successful 
in breaking the B. cepacia cell wall and that the rather crude phenol/chloroform 
extraction is the most successful method to isolate B. cepacia plasmids. On the basis of 
this it was chosen to estimate the size of plasmids and their distribution in B. cepacia.
5.4.2 Sizing of B. cepacia plasmids
The use o f regression analysis of logio molecular size against logio of the distance 
migrated gave good consistent results, with well predicted lines of fit with a mean R2 
value of 98.7%. Logio o f the distance travelled rather than logio of the relative mobility 
used by Meyers et al (1976) or Rochelle et al (1985) was used in this study. A simple 
linear regression was used in this study rather than multiple regression used by Rochelle 
et al (1985) who obtained more accurate and consistent values using multiple 
regression of logio molecular weight against logio o f the relative mobility and reciprocal 
square root of the mobility. This gave a mean R2 value of 98 .6% compared with 
97.5% for a single linear regression. In this study the mean R2 value o f 98.73% 
showed a good linear relationship with little variance, the high R2 value indicating no 
real requirement for multiple regression. Rochelle et al (1085) also stated that the 
single linear regression underestimated the sizes of large plasmids. The only 
benchmark to which the estimated sizes can be compared in this study is the large 
plasmid in the species type strain NCPPB 2993/ATCC 25416, that has been reported as 
being 212 kb (Lennon and DiCicco 1991) or 220 kb (Rodley et al 1995) by restriction 
mapping. In this study plasmid size was estimated at 224 kb.
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The main problems came from estimating the size of larger plasmids. The failure to 
detect the 251 kb plasmid pQMl with any consistency meant the largest available 
standard was the 151 kb plasmid of E. coli 39R. Therefore to estimate the size of the 
larger plasmids the regression equation was extrapolated to values outside the 
standards. Though this is not regarded as good statistical practice, the high correlation 
of the line, with a mean R2 value of 98 .75% over the size range of 2.1 kb to 151 kb, 
and that the larger plasmids were only slightly beyond the standard size range were 
taken into account before making the decision to extrapolate the regression equation to 
estimate the larger sizes. The relatively good agreement between published estimates 
of the large plasmid in NCPPB 2993 and those found here suggests this was reasonably 
successful Good reproducibility between gels was also achieved, and also between 
V517 and 39R as standards. This is best illustrated by size estimation of the large 
plasmid in NCPPB 3480. The plasmid was estimated to be 177 kb with 39R as the 
standard, and 178 kb with V517 as the standard. However, these sizes can only really 
be regarded as a rough estimation of size. A number o f factors such as the relatively 
small difference in distances migrated by plasmid molecules on the mini gels used, the 
potential presence o f cccDNA and ccDNA forms of the plqsmid may lead to large 
inaccuracies of measurement. It is almost certainly the case that restriction digestion of 
the large plasmids in B. cepacia would be far more accurate and consistent in size 
estimation, though the failure to isolate sufficient pure plasmid DNA meant this method 
could not be used.
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5.4.3 Distribution and sizes of plasmids
In total 28 of 54 B. cepacia strains were found to contain plasmids (52 %) (Table 5.2). 
17 o f the 26 B. cepacia CF strains were found to contain plasmids (65 %). This is 
considerably more than the 23 % of B. cepacia CF strains (11 of 48) found to contain 
plasmids by McKevitt and Woods (1984), but somewhat lower than the 92 % of 
clinical and environmental strains containing plasmids reported by Gonzalez and 
Vidaver (1979) or the 82 % of clinical and environmental strains containing plasmids 
reported by Lennon and DeCicco (1991).
Only 11 o f 28 environmental isolates were found to contain plasmids (39 %). It was 
notable that 5 of 7 (71 %) of isolates obtained from industrialised regions of South 
Wales contained plasmids compared with only 2 o f 13 (15%) o f isolates from the 
Brecon Beacons national park. Two isolates from water downstream of a former 
colliery (PW2) or from soil near to a coking works (PW7) both showed multiple 
plasmids. Both isolates contained 8 plasmids, with both containing 132 kb and 51 kb 
plasmids. It is possible that plasmids from these sites may encode for degradative 
properties that would give an advantage in polluted sites, whereas in clean sites there is 
no requirement for such properties and hence no plasmids.
Few plasmids of greater than 200 kb were found in this study, whereas Lennon and 
DeCicco (1991) found 20 of 37 isolates contained plasmids of 208, 212 or 222 kb, 
though in this study 13 isolates were found to contain plasmids larger than 100 kb. 
PW9 (and possibly Cl 16) was found to contain a megaplasmid in excess of 250 kb. 
McKevitt and Woods (1984) found plasmids in the size range of approximately 70 to
150 kb in B. cepacia CF isolates. Similar sizes were found in this study (Table 5.2), 
though a number of smaller plasmids (between 2 to 40 kb) were also found.
It is notable that B. cepacia isolates from CF siblings were not only of the same 
ribotype (Chapter 8 p.258) but had plasmids of identical or of similar sizes. Isolates C5 
and C ll  from siblings were found to contain a 134 kb plasmid. Cl was found to 
contain a plasmid of 134 kb, whilst C23 isolated from a sibling contained a 139 kb 
plasmid. It is possible that these plasmids are the same, but differences in sizes were 
estimated as being different from different gels. Plasmids of a similar size (132 kb) 
were also found in the environmental isolates PW2 and PW7. To assess the relatedness 
o f these plasmids, restriction mapping could be used, provided sufficient DNA could be 
isolated.
5.4.4 Isolation of R  cepacia plasmid DNA for restriction mapping and 
transformation studies.
Many o f the problems associated with small scale isolation or detection of plasmid 
DNA also apply to the larger scale isolation of plasmid DI^A. The QiaFilter maxiprep 
kit was able to isolate the large 224 kb plasmid in the species type strain. However this 
was accompanied by a considerable amount of chromosomal DNA. The yield of DNA 
was also poor, as shown by the failure to obtain a digest pattern with either EcoBJ or 
Hind III.
The attempts at using the Kado and Liu method with preparative gels also resulted in 
failure to obtain any significant quantities of plasmid DNA. Attempts to increase
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plasmid DNA by growth in Terrific broth or by chloramphenicol amplification were 
made (Sambrook et al 1989), though both methods proved unsuccessful. The lack of 
success o f the chloramphenicol amplification may be largely explained by the recent 
discovery of an active chloramphenicol efflux mechanism preventing accumulation of 
the drug within B. cepacia cells (Bums et al 1996b).
From this study it would appear that none o f the methods used are particularly suitable 
for isolation of plasmid DNA for use in transformation or restriction mapping of the 
plasmids. Caesium chloride equilibrium gradient centrifugation, as used by Haak et al 
(1995) to isolate the degradative plasmid pBAHl, may be the only viable method for 
isolation o f B. cepacia plasmid DNA.
5.4.5 Improvements, alternatives and future work
As outlined in the previous sections, the detection of plasmid DNA in B. cepacia has 
proved difficult. Although a number of methods have been applied in this study, this is 
by no means an exhaustive list o f methods. Cork and Khalil (1995) described a number 
of methods for isolating megaplasmid DNA (250 kb) from .Pseudomonas sp. Cork and 
Khalil (1995) found that boiling methods such as those of Holmes and Quigley 
(1981)cleared lysate methods or polyethylene glycol precipitation all failed. The 
method of Wheatcroft and Williams(1982), using SDS and sodium hydroxide lysis then 
direct running of the sheared lysate on an electrophoresis gel, and the use of, SDS lysis 
followed by a phenol extraction were both successful, though the method o f Kado and 
Liu produced better results and was more convenient to perform. A more gentle lysis 
method with lysozyme, EDTA, glucose, sucrose and tris followed by SDS, then two
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precipitations of the DNA with sodium acetate and isopropanol was found to be the 
most successful and reproducible method. Additionally the Hansen and Olsen method 
(1978) could be tried, as this has proved successful in isolation of large plasmids in B. 
cepacia (Xia et al 1996).
The other main improvement could be made in plasmid size estimation. The use of 
simple linear regression of logio molecular size against logio distance migrated would 
appear to be a good, consistent method of size estimation. The main problem being the 
larger plasmid sizes. Improved isolation could allow sizing by restriction digest 
analysis. Alternatively more consistency in use of a large plasmid standard may be 
achieved by an alternative method. The 224 kb plasmid in the species type strain may 
be a candidate for such a standard.
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Chapter 6 Plasmid curing and its effect on phenotype
6,1 Introduction
Curing is the spontaneous loss of a plasmid-borne characteristic, either through loss of 
a complete plasmid or through dissociation of plasmid genes. Curing may be promoted 
through the use of curing agents that affect DNA replication such as ethidium bromide, 
acridine orange or ultraviolet light ( Day 1982). Curing can be used in the 
determination of phenotypic properties of plasmids. The loss o f a phenotype 
correlating with the loss o f the plasmid indicates it may encode for that property.
Curing of plasmids encoding for antibiotic resistance may be achieved by culture on 
non-selective media. This was used as the basis of the curing method in this study, 
where B. cepacia isolates were serially transferred into fresh nutrient broth for 25 
transfers. Loss of antibiotic resistance was determined by failure to grow on media 
containing antibiotics at levels lower than the MIC level. The loss or partial loss of 
plasmid DNA was confirmed by the modified Kado and Liu method (1981) described in 
Chapter 5, followed by gel electrophoresis.
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6.2 Materials and methods
Materials
(.Strains
B. cepacia strains as described in Chapter 2
ii. Media
10 ml aliquots of nutrient broth (Oxoid, Unipath Ltd., Basingstoke, Hants.)
20 ml aliquots o f molten DST agar, maintained at 45 to 50 °C (Oxoid, Unipath Ltd., 
Basingstoke, Hants.)
Nutrient agar plates (Oxoid, Unipath Ltd., Basingstoke, Hants.)
iii. Solutions 
Sterile 0.85 % saline
Stock solutions o f ceftazidime, gentamicin and piperacillin at 5 mg ml"1, prepared as in 
Chapter 4 (Sigma Chemical Co.,Poole, Dorset)
iv. Disposable consumables 
Sterile wooded toothpicks 
Petri dishes.
In addition the materials for plasmid isolation by the Kado and Liu (1981) method as 
outlined in Chapter 5 (p. 173) were used.
Methods 
ii.Plasmid curing
Curing was carried out by the serial transfer of a loopfull o f B. cepacia static broth 
culture grown at 35 °C as previously described (Chapter 2 p.97), from the frozen stock 
of wild type, into fresh NB daily for 25 days. After the 25th transfer, dilutions of the 
culture from 10 "3 to 10"5 in sterile saline were produced and plated onto NA plates and
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incubated to give discrete colonies of B. cepacia, ideally between 100 to 200 colonies. 
100 or 50 colonies were picked from the plates to give a good representative sample, 
and then replica plated onto DST agar plates containing sub-MIC levels of gentamicin, 
ceftazidime and piperacillin to determine any loss of antibiotic resistance. These plates 
were produced by adding stock solutions of the antibiotics to 20 ml of molten DST 
agar, pouring and allowing to set and dry. The final antibiotic concentration was 
approximately half of the MIC level for that strain. The levels used were determined 
from the MIC levels described in Chapter 4 for each of the strains used. These ranged 
from 1 to 5 pg ml"1 for ceftazidime, 5 to 20 pg m l1 for piperacillin and 10 to 50 pg ml'1 
for gentamicin. A template was used to place 25 inoculum sites onto a single plate and 
to interpret their position after incubation. Following inoculation onto the 3 antibiotic 
plates, the picked colony was inoculated onto a nutrient agar plate, using the template 
as above, The nutrient agar acted to determine viability for each colony tested.
The inoculated plates were incubated at 35°C for 48 h. After incubation growth on 
each plate was recorded. Where a colony failed to grow on the antibiotic plate but 
grew on the nutrient agar, it was said to have lost or been ‘cured’ of a resistance 
phenotype to that antibiotic. The number of colonies of each isolate failing to grow 
was recorded and percentage of colonies cured of the phenotype calculated. A 
selection o f ‘cured’ colonies was sub-cultured from the control plate for investigation 
of plasmid loss.
ii.Investigation of plasmid loss in ‘cured’ strains
The loss of plasmid DNA was investigated by the modified Kado and Liu method, 
followed by agarose gel electrophoresis as described in Chapter 5 (p. 175). ‘Cured’
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strains were run alongside the original wild type stock isolates, previously confirmed as 
containing plasmids.
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6.3 Results
6.3.1 Loss of antibiotic resistance by curing
The numbers of colonies and percentage of each isolate found to have lost antibiotic 
resistance after curing by serial transfer is shown in Table 6.1:
Table 6.1 Numbers and percentage of B. cepacia strains cured of 
antibiotic resistance by serial transfer
Strain
Growth on 
nutrient agar 
to confirm 
viability
Number of colonies failing to grow on sub-MIC 
antibiotics (% cured of antibiotic resistance)
Ceftazidime Gentamicin Piperacillin
C5 96/100 NR 0 (0 ) 0 (0 )
C23 91/93 NR 0 (0 ) 3(3)
Cl 860 49/50 0 (0 ) 32 (66) 4 (8 )
A562 98/100 0 (0 ) 4 (4 ) 0 (0 )
NCIMB 9085 100/100 0 (0 ) 0 (0 ) 0 (0 )
J543 100/100 0 (0 ) 0 (0 ) 0 (0 )
C l 90 50/50 9(18) 0 (0 ) 8(16)
NCPPB 3480 49/50 13 (26) 0 (0 ) 8(16)
C l 16 100/100 6(6) 0 (0 ) 4 (4 )
NCPPB 2993 49/50 3 (6) 1(2) 1(2)
C187 49/50 4 (8 ) 0 (0 ) 4 (8 )
J478 47/50 10(21) 0(0) 7(15)
NR = No result obtained
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6.3.2 Investigation of plasmid loss
Using the modified Kado and Liu method, plasmid loss was seen in 5 o f the 9 strains in 
which there was evidence of loss of antibiotic resistance by curing. The plasmids lost 
and the loss of resistance associated with the colony are summarised in Table 6.2
Table 6.2 Summary of plasmid loss and resistance loss in cured
B. cepacia strains
Isolate Plasmid loss and loss of resistance
C5 None
C23 None
C l 860 Loss of 185 kb plasmid in 3 /3 (3 out of 3) colonies 
tested with loss o f gentamicin resistance
A562 None
C l 90 None
NCPPB 3480
200 kb plasmid lost in 1/3 colonies tested with loss of 
ceftazidime resistance and 1/ 2 with loss of piperacillin 
resistance.
177 kb and 200 kb plasmids lost in 1/2 colonies tested with 
loss o f both piperacillin and ceftazidime resistance. 
Change of position (decreased size) of both plasmids in 1/3 
colonies with loss o f ceftazidime resistance
C l 16
29 kb plasmid lost in 1/1 colonies tested with loss of 
piperacillin resistance, and 1/1 colonies with loss of 
ceftazidime resistance.
No loss found in colonies losing both ceftazidime and 
piperacillin resistance
NCPPB 2993 224 kb plasmid lost in 1/1 colonies with loss of 
ceftazidime resistance and 1/1 colonies with loss of 
gentamicin resistance
C187 None
J 478
152 kb plasmid lost in 2 /2 colonies with loss of piperacillin 
resistance and 1/1 colony with loss of piperacillin and 
ceftazidime resistance
Polaroid photographs showing the loss of plasmids are shown in plates 6.1 to 6.4
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Plate 6.1 Plasmid presence in cured and wild-type B. cepacia strains
1 2 3 4 5 6 7 8
Cl 16 plasmid NCPPB 3480
plasmids
Lane
1 Cured B. cepacia C l 16 -loss o f piperacillin resistance
2 Cured B. cepacia C l 16 -loss o f ceftazidime resistance
3 B. cepacia C l 16- original stock isolate 29 kb plasfnid
4 Cured B. cepacia NCPPB 3480-loss of piperacillin resistance
5 Cured B. cepacia NCPPB 3480-loss of piperacillin and ceftazidime
resistance
6 Cured B. cepacia NCPPB 3480-loss o f ceftazidime resistance
7 B. cepacia NCPPB 3480 original stock isolate- 200 and 177 kb plasmids
8 E. coli V517 plasmid strain marker
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In Plate 6.1 the 29 kb plasmid of Cl 16 can be faintly seen in lane 3. In the cured 
strains in lanes 1 and 2 there is no evidence of the plasmid, indicating probable loss 
during curing. 2 plasmids of 200 and 177 kb can be seen in NCPPB 3480 in lane 7 
but faintly. There is evidence o f bands in lanes 4, 5 and 6 but the results are too faint 
to interpret. The NCPPB 3480 cure strains are repeated in Plate 6.4.
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J478 p l a s m i d _ _ _ _ _ e * S e ^ ^ ^ * *  NCPPB 2993
Plate 6.2 Plasmid presence in cured and wild-type B. cepacia strains
1 2 3 4 5 6 7 8
lasmid 
l ' -  ^ V. "I Plasmid
Lane
1 Cured B. cepacia J478- Loss of piperacillin and ceftazidime resistance
2 Cured B. cepacia 3478- Loss of piperacillin resistance
3 Cured B. cepacia 3478- Loss of piperacillin resistance
4 B. cepacia 3478 w/stock isolate- 152 kb plasmid
5 Cured B. cepacia NCPPB 2993- loss of gentamicin resistance
6 Cured B. cepacia NCPPB 2993- loss of ceftazidime resistance
7 B. cepacia NCPPB 2993 wt stock isolate - 224 kb plasmid
8 E. coli V517 plasmid marker strain.
> 0 5
B. cepacia J478 contains a single large plasmid of 152 kb that can be seen clearly in 
lane 4. The cured J478 colonies in lanes 1, 2 and 3 show no evidence of the plasmid 
indicating loss o f the plasmid. B. cepacia NCPPB 2993 contains a single plasmid of 
224 kb, as can be clearly seen in lane 7. There is no evidence of plasmids in the cured 
NCPPB 2993 in lanes 5 and 6, again suggesting loss o f the plasmid.
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Plate 6.3 Plasmid presence in cured and wild-type B. cepacia strains
1 2 3 4 5 6 7
C l860 plasmid
Lane
1&2 Blank
3 Cured B. cepacia C 1860- loss o f gentamicin resistance
4 Cured B. cepacia C 1860- loss of gentamicin resistance
5 Cured B. cepacia C l 860- loss o f gentamicin resistance
6 B. cepacia C 1860 wt stock isolate- 185 kb plasmid
7 Blank
B. cepacia C l860 , lane 6, shows a single large plasmid. The cured C l860 show no 
evidence of a band, indicating loss o f the plasmid.
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Plate 6.4 Plasmid presence in cured and wild-type B. cepacia strains
1 2 3 4 5 6 7 8
NCPPB 3480 
plasmids
Lane
1 E. coli V517 reference strain
2 Cured B. cepacia NCPPB 3480- loss of resistance to ceftazidime
3 Cured B. cepacia NCPPB 3480- loss o f resistance to piperacillin and
ceftazidime
4 Cured B. cepacia NCPPB 3480- loss o f resistance to piperacillin
5 Cured B. cepacia NCPPB 3480- loss of resistance to ceftazidime
6 Cured B. cepacia NCPPB 3480- loss of resistance to ceftazidime
7 B. cepacia NCPPB 3480 wt stock isolate- 200 and 177 kb plasmids
8 Cured B. cepacia NCPPB 3480- loss of resistance to piperacillin
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B. cepacia NCPPB 3480, lane 7 shows 2 plasmids of 200 and 177 kb. The strains of 
NCPPB 3480 in lanes 8 and 6 show the same plasmid arrangement indicating curing 
has not occured. The cured strains in lanes 4 and 5 show the loss of the larger 200 kb 
plasmid but retain the smaller plasmid. In lane 2 a change of size of the 200 kb 
plasmidseems to have occured. The cured isolate containing a plasmid that appears 
slightly smaller than 200 kb,.though this is difficult to confirm as the difference in 
mobility on a mini-gel is small.
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6.4 Discussion
Evidence of loss of an antibiotic resistance phenotype occurred in 10 of 12 strains 
cured by serial transfer. Plasmid loss was subsequently confirmed by gel 
electrophoresis in 5 of the 10 strains. Loss of resistance to piperacillin was most 
common, occurring in 7 strains, loss of ceftazidime resistance occurred in 6 strains and 
loss o f gentamicin resistance occurred in 4 strains. The levels of gentamicin resistance 
loss were low, with the exeption of Cl 860, with levels of less than 4%. The levels of 
curing of ceftazidime and piperacillin resistance were generally higher ranging from 6 to 
26% for ceftazidime and 2 to 16% for piperacillin. In a number of cases the resistance 
to both piperacillin and ceftazidime were lost by the same clone. The rates o f curing 
for piperacillin and ceftazidime were also similar in a number o f strains. For instance 
C l90 had a curing rate o f 16% for piperacillin and 18% for ceftazidime, C l87 had a 
rate o f 8% for both.
The above evidence suggests that plasmids bearing genes that encode for antibiotic 
resistance may occur in B. cepacia. Wilkinson and Pitt (1995b) stated there had been 
little exploration of the role of plasmids in antibiotic resistance in B. cepacia. As 
described in Chapter 1 only two cases of antibiotic resistance plasmids have been 
reported in B. cepacia, a 49kb streptomycin and mercury resistance plasmid (Hirai et al 
1982), and 4.4kb tetracycline and 8 kb ampicillin resistance plasmids in strain 4G9 
(Williams et al 1979). The curing levels for the p-lactam drugs piperacillin and 
ceftazidime would suggest some plasmid mediated resistance to these drugs. Such 
resistance is likely to be mediated by a P-lactamase enzyme. Plasmid encoded p-
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lactamases have been widely reported in Ps. aeruginosa (Prince 1986), but not in B. 
cepacia, though there is strong evidence o f chromosomally encoded enzymes (Baxter 
and Lambert 1995).
^-lactamases can be detected and typed by a number o f biochemical tests such as starch 
hydrolysis ( British Society for Antimicrobial Chemotherapy 1991). Inducible (3- 
lactamases that are only induced by the stimulus of /Mactam drugs, such as those in B. 
cepacia, can be detected by the use of two antibiotics, one a strong inducer, the other a 
weak inducer in disc approximation tests or by incorporating a strong inducer into agar 
in a disc diffusion test using a disc of the weak inducer. An inducible enzyme would 
give an inhibition zone with the strong inducer, but smaller or no zone would occur 
without the inducer ( British Society for Antimicrobial Chemotherapy 1991). 
Comparison of ^ -lactamase production between cured and uncured B. cepacia strains 
could be used to confirm the presence of a p-lactamase encoded by the cured plasmid, 
though the presence of chromosomally encoded plasmids may adversely affect the 
results.
Transfer of antibiotic resistance either by transformation or conjugation could be used 
to confirm the presence o f a plasmid encoding for antibiotic resistance. However the 
failure o f methods used in Chapter 5 to obtain plasmid DNA for transformation 
prevents its’ use in this context. Although conjugal transfer of plasmids may be 
achieved (see Chapter 7), this does not rule out the possible transfer o f chromosomal 
elements. The transfer o f a plasmid to a p-lactamase free strain çould be used to allow 
analysis o f possible plasmid encoded P-lactamases.
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The levels o f curing of gentamicin resistance, generally less than 4%, would suggest 
that plasmids play little or no role in resistance of B. cepacia to the drug.
The exeption to this is C l860 with a curing rate of 66%. In addition the confirmatory 
evidence of loss o f the 185 kb plasmid in C l860 and the 224 kb plasmid in NCPPB 
2993 strains cured of gentamicin resistance would suggest that plasmids might play a 
role in gentamicin resistance in these strains.
Loss o f plasmids was also confirmed in C l 16, J543 and NCPPB 3480 corresponding to 
loss of resistance to P-lactam drugs described previously. The loss of 224 kb plasmid 
in NCPPB 2993 is associated both with loss of p-lactam and gentamicin resistance.
This suggests the possibility of a multi-resistance plasmid. Cured strains could be 
tested against a wider range of antibiotics to assess the presence of multi-resistance 
plasmids. It is notable that a strain of NCPPB 3480 had a decrease in the size of the 
200 kb plasmid. This decrease in size could be due to the deletionof a gene involved in 
antibiotic resistance, possibly the loss o f a transposon or an integron ‘cassette’ 
encoding the resistance.
Higher levels of curing may be obtained by using agents such as ethidium bromide or 
ultraviolet light than by serial transfer. The use of such agents could increase curing 
efficiency giving larger numbers of cured strains for analysis. Curing could also be 
used to analyse other phenotypic properties o f plasmids, most notably degradative 
properties. Growth or failure to grow on minimal media plates containing the putative 
degraded chemical could be used to assess cured strains of B. cepacia
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Chapter 7 Conjugal transfer of plasmid DNA in B. cepacia
7.1 Introduction
7.1.1 Investigation of conjugal transfer of plasmid DNA
Investigation of conjugal transfer may be carried out by laboratory mating experiments. 
Filter mating experiments are commonly used, where donor and recipient cultures are 
deposited together onto a membrane filter. This allows close contact between cells 
allowing easier pilus formation and transfer. Broth matings may also be used but are 
less efficient as cells are free in broth and do not have the close contact afforded by the 
filter. After the filtering process the filter is placed onto a nutrient medium to allow 
conjugation to occur.
Following the mating the selection for recipient cells containing the transferred plasmid, 
transconjugants, is made. This is usually achieved by plating cells out on to a medium 
containing selective agents for the recipient strain and for a plasmid borne phenotype. 
An example of this would be a selective media containing rifampicin and mercuric 
chloride where the recipient strain is resistant to rifampicin and the plasmid in the donor 
confers resistance to mercury. The rifampicin would prevent growth o f the donor and 
mercuric chloride the growth of the recipient; transconjugants with the properties of 
both the recipient and plasmid from the donor would grow. By dividing the number of 
transconjugants arising from a mating by the number o f donor or recipient cells, it is 
possible to arrive at the transfer frequency for a particular plasmid for either or both.
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7.1.2 Conjugative transfer in the epilithon
Conjugative plasmids have been investigated in a number of natural environments 
including soils and aquatic environments such as river epilithon (Fry and Day 1990). 
Epilithon is a community o f micro-organisms on the slime layer found on stone surfaces 
in the aquatic environment. Stones are thought to be initially colonised by bacteria that 
secrete polysaccharides that form a slimy layer, which is then colonised by protozoae 
and algae. This community will grow until the micro-organisms are grazed by 
invertebrates or slough off. A nutrient rich environment for epilithic bacteria occurs as 
a result of algae fixing carbon dioxide during photosynthesis and secreting organic 
materials. In addition carbon sources may enter the epilithon from overlying water, 
particularly in rivers where the current constantly renews the nutrients available to the 
epilithon. Such an environment leads to both high viable and total bacterial counts. 
Movement o f stones by strong currents following rainfall leads to the removal of the 
epilithic layer due to stones colliding, the layer then re-grows on ‘clean’ stones. These 
properties have made such an environment an excellent candidate for the study of 
plasmids and their transfer (Fry and Day 1990).
Plasmids may be isolated from the environment endogenously by the use o f a suitable 
selective medium for the plasmid, though such a method does not demonstrate plasmid 
transfer, or by exogenous isolation. Exogenous isolation involves introducing a culture 
o f plasmid-free recipient to a community of naturally occurring bacteria. Plasmids may 
be transferred to the recipient, which may then be isolated by growth on a suitable 
selective medium. Usually recipients are selected on the basis o f a resistance 
phenotype, such as rifampicin, not commonly found in environmental bacteria. This
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method therefore isolates those plasmids capable of conjugative transfer. Epilithic 
bacteria may be recovered by aseptically scrubbing stones with a toothbrush then used 
in laboratory matings (Burton et al 1982), or recipients may be placed on membrane 
filters placed face down on stones either in microcosms or in situ in rivers without 
disturbing the epilithon (Bale et al 1988a). Plasmids isolated exogenously such as the 
251 kb mercury resistance plasmid pQMl have subsequently been used to study 
transfer within and between a number of bacterial species, both in the laboratory and in 
in situ experiments (Bale et al 1988b, Rochelle et al 1989).
In this study it was decided to investigate the transfer of broad host range plasmids into 
B. cepacia isolates from other species, between B. cepacia isolates and from B. 
cepacia into other species by laboratory matings. It was also decided to investigate the 
conjugative transfer of plasmid encoded antibiotic resistance as suggested by the data 
from curing experiments in Chapter 6, and also to investigate the transfer o f epilithic 
plasmids into a B. cepacia recipient by exogenous isolation.
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7.2 Materials and methods 
Materials
i. Chemicals
Mercuric chloride(Sigma Chemical Co., Poole, Dorset) lOOmM stock solution in 
distilled water.
Rifampicin (Sigma Chemical Co.) at 200 mg ml"1 stock solution in methanol.
Gentamicin sulphate (Sigma Chemical Co.) at 100 mg ml'1 stock solution in distilled 
water.
Piperacillin (Sigma Chemical Co.) at 10 mg ml"1 stock solution in distilled water.
ii. Strains
E. coli DH10B/pQKH6, pQKH6 = 60 kb plasmid encoding mercury resistance (Hill et 
al 1992)
Ps. aeruginosa PAO 2002/RP1; RP1 = 59 kb plasmid encoding a range of resistances 
to antibiotics including piperacillin at MIC 500 pg ml"1 (Grinstead et al 1972, Stanisich 
and Ortuz 1976, Stanisich et al 1989)
E. coli J53R recipient, MIC rifampicin = 500 pg ml"1.
B. cepacia recipient and donor strains, antibiotic or mercury resistance phenotypes as 
outlined in methods.
Flat stones, approximately 10x10 x2cm, removed aseptically from the River Taffin 
sterile polypropylene stomacher bags for isolation of epilithic bacteria as described in 
the methods.
iii. Media
DST agar plates (Oxoid CM261, Unipath Ltd., Basingstoke, Hants.) containing 
selective agents as detailed in the methods.
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Nutrient agar plates (Oxoid, Unipath).
10 ml Nutrient broth (Oxoid, Unipath)
Plate Count agar plates(Oxoid, Unipath), 
i.v. Solutions 
Sterile 0.85% saline, 
v. Equipment
Seitz filter units and vacuum pump.
Sterile nylon toothbrushes 
v.i. Disposable consumables
47 mm diameter, 0.45pm WCN type membrane filters (Whatman, Maidstone, Kent.) 
Methods
i. Investigation of broad host range plasmid transfer by conjugation
Conjugative transfer into B. cepacia strains has previously been achieved for the broad 
host range trimethoprim resistance plasmid R 751 from Ps. aeruginosa (Lennon and 
DeCicco 1991), and with the 60 kb broad host range plasmid pQKH6 from Ps. putida  
(Hill et a l 1992). On this basis it was decided to investigate the conjugal transfer of two 
broad host range conjugative plasmids by filter mating into B. cepacia, between B. 
cepacia strains and from B. cepacia to other species. The plasmids chosen were 
pQKH6, a 60 kb Inc P -1 mercury resistance plasmid isolated exogenously from the 
River Taff. (Hill et al 1992). Conjugal transfer o f pQKH6 has been demonstrated into 
a range o f bacterial species including E. coli, Alcaligenes eutrophus and, as described 
above, B. cepacia.
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The second plasmid used, RP1 is a 59 kb Inc P plasmid encoding resistance to a range 
of antibiotics including many p-lactam drugs. RP1 was initially described in Ps. 
aeruginosa and conjugal transfer has been demonstrated with a number o f species 
including E. coli (Grinsted et al 1972, Stanisich and Ortuz 1976, Stanisich et al 1989). 
Piperacillin resistance was used as the plasmid marker, the host strain containing the 
plasmid having a MIC of greater than 500 pg ml"1
A mating mix was produced by mixing 5 ml of donor culture and 5 ml of recipient 
culture, both at 5 x 107 ml"1 which was then added to a Seitz filter unit containing a 
sterile membrane filter. The mating mix was filtered onto the membrane filter which 
was then removed and placed bacteria side up onto a dry nutrient agar plate, then 
incubated for 24 h at 35° C. Supplemented DST plates were used to select for 
transconjugants were made and allowed to dry prior to use (overnight). After 
incubation the filter was placed into 10 ml of fresh nutrient broth and cells resuspended 
by vortexing for 5 min Decimal serial dilutions were prepared in sterile saline and 
spread onto the transconjugant selective medium. As controls donor and recipient 
cultures were also spread onto selective media. The plates were incubated at 35 °C for 
up to 48 h and then checked for the presence of transconjugant colonies. Physical 
transfer o f plasmids was confirmed by the Kado and Liu method described in 5 .2. . 
Each experiment was conducted in triplicate with triplicate dilutions Donor and 
recipient counts were conducted at the termination of mating by spread plates of serial 
dilutions of the donor and recipient cultures.
Transfer frequencies were calculated per donor and per recipient. Frequency was 
calculated by:
Transconjugants/ml of mating mix 
Donors/ml of mating mix Transfer frequency 
per donor
Transconiugants/ml of mating mix 
Recipients/ml of mating mix Transfer frequency 
per recipient
The recipient and donor strainsin each set o f matings, and the selective markers used, 
along with any modifications are given in the following pages:
A E. coli DH10B/pQKH6 x B. cepacia NCIMB 9092
The 60 kb mercury resistance broad host range plasmid pQKH6 was chosen as donor 
plasmid; B. cepacia NCIMB 9092 was chosen as recipient as it is plasmid free and 
failed to grow on plates containing mercuric chloride at 27 pg ml"1. However NCIMB 
9092 grew poorly on rifampicin thererfore prior to use in mating experiments NCIMB 
9092 was trained to grow at 100 pg ml"1 of rifampicin as a selective marker by growing 
on plates with increasing concentrations of rifampicin, starting at 25 pg ml"1 rising to 
200. pg m l1 Selective plates were produced by the addition o f mercuric chloride m, to 
a final concentration of 27 pg ml^and rifampicin to a final concentration of 
100 pg ml^to molten DST agar. Donor counts were conducted on plates containing 
mercuric chloride at 27 pg ml"1 and recipient counts on plates containing rifampicin at
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100 jag ml"1.
A. B. cepacia NCIMB 9092 x B. cepacia C93 
B. cepacia NCIMB 9092 x B. cepacia A548
Transconjugant NCIMB 9092/pQKH6 was used as donor to transfer to plasmid-free B. 
cepacia C93 and A548 recipients. The mercury resistance encoded by pQKH6 was 
used as the selective marker for the donor, and gentamicin resistance used as marker 
for the recipient. The MIC of gentamicin to NCIMB 9092 is 25 pg ml^compared with 
250 pg ml"1 for C93 and over 500 pg ml'1 for A548. Selective plates were produced 
containing 27 pg ml"1 mercuric chloride and 100 pg ml^gentamicin. Donor counts were 
conducted on plates containing mercuric chloride at 27 pg ml"1 and recipient counts on 
plates containing gentamicin at 10 pg ml'1
B. E. coli DH10B/pQKH6 x B. cepacia C93 
E. coli DH10B/pQKH6 x B. cepacia A548
Selection o f transconjugants was based on the mercury resistanceencoded by the 
plasmid pQKH6, and gentamicin resistance o f the recipient strains. Selective plates 
were produced containing 27 pg ml^mercuric chloride and 100 pg ml ^ gentamicin. 
Donor counts were conducted on plates containing mercuric chloride at 
27 pg ml'Vecipient counts on plates containing gentamicin at 100 pg ml"1.
C. Ps. aeruginosa PA02002/RP1 x B. cepacia NCIMB 9092
Selection for RP 1, the donor plasmid, was based upon antibiotic resistance, primarily to 
piperacillin, encoded by the plasmid. The MIC value for piperacillin against
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PA02002/RP1 is in excess of 500 pg ml"1 whilst the MIC against NCIMB 9092 is 5 pg
ml"1 Selective plates were prepared containing piperacillin at 100 pg ml"1 and rifampicin
at 100 pg ml^to prevent donor growth. Donor counts were conducted on DST plates 
containing 100 pg ml" piperacillin, recipient counts on plates with rifampicin at 100 pg 
ml"1.
D. Ps. aeruginosa PA02002/RP1 x B. cepacia C93 
Ps. aeruginosa PA02002/RP1 x B. cepacia A548 
Piperacillin resistance was used as the selective marker for the plasmid, gentamicin 
resistance was used for selection of the recipients. Both C93 and A548 have MIC 
values for gentamicin in excess of 200 pg ml^but MIC values o f 25 pg ml"1 or less for 
piperacillin, whilst PA02002/RP1 has an MIC of only 1 pg ml^for gentamicin but over 
500 pg ml^for piperacillin. Selective plates were produced in DST agar with 
piperacillin at 100 pg ml"1 and gentamicin at 100 pg ml'1. Donor counts were made on 
DST agar containing 100 pg ml^of piperacillin and recipient counts on plates with 100 
pg ml"1 of gentamicin.
E E. coli DH10B/pQKH6 x E. coli J53R 
B. cepacia NCIMB 9092 x E. coli J53R 
B. cepacia C93 x E. coli J53R 
In these matings J53R was chosen as a recipient as it will grow on rifampicin at 
levels up to 500 pg ml"1. Although NCIMB 9092 and C93 will both grow on 
rifampicin at 100 pg ml"1, both are inhibited at 200 pg ml"1. On this basis selective
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plates with mercuric chloride at 27 pg ml'1 and rifampicin at pg ml"1 were produced. 
Donor counts were made on plates with 27 pg ml^mercuric chloride, recipient 
counts on plates containing 200 pg ml"1 rifampicin.
ii. Conjugal transfer of antibiotic resistance in R  cepacia
On the basis of the curing data suggesting that plasmid encoded antibiotic resistance 
may occur in some of the B. cepacia strains used in this study, it was decided to 
investigate whether piperacillin resistance putatively encoded by these plasmids could 
be transfered by bacterial conjugation. For initial studies it was decided to use strains 
known to contain plasmids and with high levels of antibiotic resistance, particularly 
strains found to have lost antibiotic resistance/plasmids in the curing studies, as donor 
strains. Plasmid-free strains with high levels of gentamicin resistance (as a selective 
marker) but low levels of piperacillin resistance were chosen as recipient strains.
A. Pilot study
The method basically followed that used for transfer o f broad host range plasmids, but 
for the pilot study matings were carried out singly, without donor or recipient counts, 
but with the appropriate donor and recipient controls to assess whether any transfer of 
resistance would occcur.. Three strains that had demonstrated plasmid-loss 
accompanied by loss of piperacillin resistance in the curing studies (in Chapter 6), C23, 
C l860 and Cl 16 along with C79, J478 and PW7 were chosen as donors. All these 
strains had a MIC of 25 pg m l'W  greater to piperacillin, with the exeption of PW7 
which has a MIC of 10 pg m l1. All strains had a MIC of 50 pg ml"1 or less for
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gentamicin. Although NCIMB 9092 was initially used as a recipient, several donors 
grew on selective plates with rifampicin at 100 pg ml"1. On the basis o f this A548 was 
chosen as a recipient as it has a low MIC with piperacillin (5 pg ml"1), but a high level 
of gentamicin resistance as a selective marker. C93 was not considered as a recipient 
due to a relatively high MIC of 25 pg ml'1 for piperacillin.
Selective plates were produced by adding piperacillin to DST agar to give a final 
concentration of 20 pg ml'1 (10 pg ml^for PW7) and gentamicin at 100 pg ml'1. 
Evidence o f transfer of piperacillin resistance was taken as growth of transconjugants 
on the selective plates with no growth of donor or recipient controls.
B.Calculation of transfer frequency
Strains chosen from the pilot study for calculation of transfer frequency were mated in 
triplicate with triplicate counts following the methods used for broad host range 
plasmids. Donor counts were done on plates containing 20 pg ml^piperacillin (10 pg 
ml"1 for PW7). Recipient counts were conducted on plates containing 100 pg ml' 
‘gentamicin. Physical transfer o f plasmids was investigated by the previously described 
Kado and Liu method.
iii. Exogenous isolation of plasmids encoding mercury resistance from the 
environment (river epilithon).
It was decided to investigate B. cepacia as a recipient for exogenous isolation and 
transfer of mercury resistance plasmids from the River Taff, an organically polluted 
river in South Wales. Detection o f plasmid encoded resistance to mercury was chosen
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on the basis of a number of other mercury resistance plasmids such as the 
aforementioned pQKH6 and pQMl being isolated from this river(Fry and Day 1990, 
Hill et al 1992),. A plasmid-free B. cepacia rifampicin resistant mutant was selected as 
a recipient. A mixture of water and sediment and epilithon from scrubbed stones was 
used as the donor source
The method used a bacterial mating between B. cepacia recipient and epilithic bacteria 
donors from the River Taff (Fry and Day 1990, Hill et al 1992). Epilithic bacteria 
were obtained by scrubbing 3 large, flat stones from the River Taff with a sterile nylon 
toothbrush in 100 ml of sterile distilled water in a stomacher bag (Burton et al 1982). 
The stone was then removed and the sample placed in a stomacher for 5 min. 3 
sediment samples were collected in an upstream direction in sterile universal containers. 
10 ml o f sterile distilled water was added to the container and the whole vortexed for 5 
min. Equal volumes of rock scrubbings and sediment wash sample were then mixed to 
give a donor sample. In previous work 10* epilithon donors, estimated by acridine 
orange counts, have been mixed with 108 recipient cells, filtered and placed on PC A 
agar for 24 h at 20 °C to mate (Bale et al 1987). Previously viable count estimates of 
106 bacteria/ml in epilithon produced in this way have been made (Burton et al 1982). 
This represents 5 % of the acridine orange count, so around 5 ml of bacterial 
suspension would be required to give 108 cells per mating. Therefore 5 ml of the 
epilithon was mixed with 10 ml of the recipient (NCIMB 9092), filtered onto a 0.45 pm 
filter and placed on PC A for 24 h at 30 °C. As controls 5 ml o f epilithon and 10 ml of 
NCIMB 9092 was filtered and placed on PCA. The epilithon was counted on PCA by 
spread plating of serial decimal dilutions.
Transconjugant selective plates were produced in DST agar with 27 pg ml "^mercuric 
chloride to select for mercury resistance plasmid from donors and 100 pg ml "^rifampicin 
and 10 pg ml ^gentamicin to select for the B. cepacia recipient. DST plates containing 
gentamicin and rifampicin were produced to check growth of controls. After the 24 h 
incubation time the filters were resuspended in nutrient broth by vortexing for 5 min. 
The resuspended cells were then diluted serially to 10"4. The mating mix was plated in 
triplicate, epilithon control and NCIMB 9092 recipient control were plated in duplicate 
onto : PCA agar plates, DST plates containing gentamicin, piperacillin and mercuric 
chloride, and DST plates containing gentamicin and piperacillin. All plates were 
incubated at 30 °C for 24 h.
After incubation, growth o f bacteria, their numbers and morphology of colonies were 
noted. Transconjugant colonies were sub-cultured onto DST agar with gentamicin, 
rifampicin and mercuric chloride and identity with the recipient checked by the API 20 
NE system by the method given in Chapter 2.
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7.3 Results
7.3.1 Transfer of broad host range plasmids
Transfer of pQKH6 and RP1 were demonstrated into B. cepacia NCIMB 9092. 
Transfer into B. cepacia C93 and between B. cepacia strains was demonstrated for 
pQKH6, as well as transfer from B. cepacia into E. coli J53R. Transfer of RP1 could 
not be achieved between B. cepacia strains or from B. cepacia to E. coli. No transfer 
of pQKH6 or RP1 could be detected with B. cepacia A548 as a recipient. Transfer 
frequencies are shown in Tables 4.1 and 4.2. In all cases no growth or less than 10 
colonies at 10° dilution were found on recipient or donor control plates, indicating that 
few or no resistant mutants had not evolved.
Physical transfer of the plasmids was confirmed in each mating by the modified Kado 
and Liu method. Examples are shown in Plates 7.1 to 7.2. Plate 7.1 confirms the 
presence of pQKH6 in NCIMB 9092 transconjugants, the plasmid being transferred 
from E. coli DH10B pQKH6 donor. Plate 7.2 shows NCIMB 9092 RP1 
transconjugants, RP1 being transferred from Ps. aeruginosa PA02002 RP1 donor, and 
Plate 7.3 confirms the transfer of pQKH6 into E. coli J53R from B. cepacia C93 
pQKH6 donor.
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Table 7.1 Transfer frequencies for broad host range plasmids per donor
Donor
Reci pient
B. cepacia 
NCIMB 
9092
B. cepacia 
C93
B. cepacia 
A548
E. coli 
J53R
E. coli 
DH10B/ 
pQKH6
7.8 x 10"2 8.2 x 10"3 ND -
B. cepacia 
NCIMB 9092/ 
pQKH6
- 6.5x 10"3 ND 2.0 x tO 2
B. cepacia 
C93/ 
PQKH6
- - ND 7.6 x IQ"6
Ps. aeruginosa 
PA020002/ 
RP1
2.2 ND ND -
B. cepacia 
NCIMB 9092/ 
RP1
- ND ND -
ND = Transfer not detected 
= Not performed
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Table 7.2 Transfer frequencies for broad host range plasmids 
per recipient
Donor
Reci pient
B. cepacia 
NCIMB 
9092
B. cepacia 
C93
B. cepacia 
A548
E. coli 
J53R
E. coli 
DH10B/ 
pQKH6
1.0 x 10' 2.1 x 1 0 -1 ND -
B. cepacia 
NCIMB 9092/ 
PQKH6
- 7.3 x 10'3 ND 2.6 x 10"2
B. cepacia 
C93/ 
pQKH6
- - ND 2.0 x 10"5
Ps. aeruginosa 
PA02002/ 
RP1
3.5 x 1 0 -1 ND ND -
B. cepacia 
NCIMB 9092/ 
RP1
- ND ND -
ND = No transfer detected 
- = Not performed
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Plate 7.1 Confirmation of conjugal transfer of plasmid pQKH6 from
E. coli DH10B pQKH6 to B. cepacia NCIMB 9092 by modified 
Kado and Liu method (1981) and agarose gel electrophoresis
pQKH6
60 kb
Lane
1 E. coli DH10B pQKH6 donor (plasmid obscured through overloading)
2 B. cepacia NCIMB 9092 recipient
3 B. cepacia NCIMB 9092 pQKH6 transconjugant
4 B. cepacia NCIMB 9092 pQKH6 transconjugant
5 B. cepacia NCIMB 9092 pQKH6 transconjugant
6 B. cepacia NCIMB 9092 pQKH6 transconjugant
7 B. cepacia NCIMB 9092 pQKH6 transconjugant
8 B. cepacia NCIMB 9092 pQKH6 transconjugant
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Plate 7.2 Confirmation of conjugal transfer of plasmid RP1 from 
Ps. aeruginosa PA02002 to B. cepacia NCIMB 9092 by 
modified Kado and Liu method (1981) and agarose gel 
electrophoresis
1 2 3 4 5 6 7 8
RP1
59 kb
Lane
1 B. cepac/tir NCIMB 9092 RP1 transconjugant
2 B. cepacia NCIMB 9092 RP1 transconjugant
3 B. cepacia NCIMB 9092 RP1 transconjugant
4 B. cepacia'HCIMB 9092 RP1 transconjugant
5 B. c e p a c i a 9092 RP1 transconjugant
6 B. cepacia NCIMB 9092 recipient
7 Ps. aeruginosa PA02002 RP1 donor
8 B. cepacia NCIMB 9092 RP1 transconjugant
Plate 7.3 Confirmation of conjugal transfer of plasmid pQKH6 from 
B. cepacia C93 to E. coli J53R by modified Kado and Liu 
method (1981) agarose gel electrophoresis
1 2 3 4 5 6 7 8
Lane
J53R
plasmid
E. coli 39R plasmid size marker reference strain
E. coli J53R recipient
B. cepacia C93 pQKH6 donor
E. coli J53R pQKH6 transconjugant
E. coli J53R pQKH6 transconjugant
E. coli J53R pQKH6 transconjugant
E. coli J53R pQKH6 transconjugant
E. coli J53R pQKH6 transconjugant
pQKH6 60 kb
J53R plasmid
7.3.2 Transfer of antibiotic resistance between B. cepacia strains 
The results obtained from the pilot study of conjugal transfer of piperacillin resistance 
to B. cepacia A548 with a range of B. cepacia donors indicated thatPW7, C79 and 
C23 appeared to be the most suitable donors for conjugal transfer o f resistance into 
A548 at an apparently high frequency. On this basis PW7 and C79 were chosen to 
calculate transfer frequency. The results obtained are shown in Table 7.4.. No 
colonies were found on either recipient or donor control plates, indicating that resistant 
m utantj had not evolved. In both the pilot study and the triplicate mating used to 
calculate transfer frequency no physical transfer of plasmid DNA was found either by 
the Kado and Liu method or Promega Wizard plasmid miniprep for PW7, C79 or C23
Table 7.4 Transfer frequency for conjugal transfer of piperacillin 
resistance from B. cepacia C79/PW7 x B. cepacia A548 
matings
Donor Transfer frequency 
per donor
Transfer frequency 
per recipient
C79 4.4 x 10*3 1.7 x 10"9
PW7 5.7 x 10'2 2.7 x 10"4
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7.3.3 Exogenous isolation of mercury resistance plasmids from river 
epilithon with a B. cepacia recipient
Epilithon count:
The mean count of epilithon bacteria on PCA was 4.2 % io 5 ml"1 
Epilithon controls:
PCA - dense growth to 10"2 dilution 
DST rifampicin/gentamicin - dense growth
DST rifampicin/gentamicin/mercury - growth of around 150 Pseudomonas-Mke 
colonies at 10 0 dilution.
NCIMB 9092 controls:
PCA - Confluent growth to 10 3
DST rifampicin/gentamicin - Confluent growth at 10"4
DST rifampicin/gentamicin/mercury - Growth on 10° , counts of 7, 3 and 12. B. 
cepacia -like appearance 
Transconjugant counts
Confluent growth was recorded at all dilutions on both the PCA and DST 
rifampicin/gentamicin plates.
DST rifampicin/gentamicin/mercury transconjugant selective plates - Growth recorded 
only at 10° dilution. 7, 3 and 12 Burkholderia-Xikt colonies were recorded giving a 
mean count of 7.
API 20NE results:
7 apparent transconjugants were tested. All failed to identify the transconjugant as B. 
cepacia, with the profiles differing from that of the recipient NCIMB 9092.
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7.4 Discussion
7.4.1 Conjugal transfer of broad host range plasmids
Transfer o f the broad host range plasmids pQKH6 and R P1 into B. cepacia was 
achieved. Transfer of pQKH6 both between B. cepacia strains and from B. cepacia 
into other species was achieved. The transfer frequency per recipient o f pQKH6 into
B. cepacia NCTC 10661 from a Ps. putida donor has been reported as 1.0 x 1 0 1 (Hill 
et al 1992). High levels o f transfer frequency were obtained in this study with a rate of 
1.0 x 10 1 per recipient into NCIMB 9092 and 2.1 x 10 1 into C93. A high frequency 
of transfer was also achieved between NCIMB 9092 pQKH6 transconjugants as donor 
and B. cepacia C93 recipient. The frequencies per donor were 6.5 x 10'3 and 7.3 x io*3 
at per recipient. Transfer o f pQKH6 from NCIMB 9092 to E. coli J53R also occurred 
at a fairly high rate 2.6 x 10"2 per recipient, and 2.0 x 10 2 per donor. Transfer could 
also be detected from C93 pQKH6 to E. coli J53R, though the transfer rates were 
somewhat lower, in the region of 10"5 to 10"6 both per donor and recipient.
Transfer o f the antibiotic resistance plasmid RP1 was also demonstrated at a high 
frequency into NCIMB 9092, though unlike pQKH6 no transfer into C93 could be 
detected, either directly from the Ps. aeruginosa donor or from NCIMB 9092 
transconjugants. It was also notable that A548 was a poor recipient with no transfer of 
either plasmid detected, though conjugal transfer of antibiotic resistance from other B. 
cepacia strains was apparently achieved. It is notable that this strain demonstrates a 
very high resistance to aminoglycosides and it is possible that the cell membrane
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structure in this particular strain may inhibit transfer from other species or distantly 
related strains, possibly by inhibiting pilus attachment.
The mating experiments succeeded in their main aim in demonstrating conjugal transfer 
of plasmid-encoded phenotypic traits into B. cepacia, between B. cepacia strains and 
from B. cepacia to other species. Transfer o f plasmids into B. cepacia has previously 
been reported (Lennon and DeCicco 1991, Hill et al 1992), as has transfer between B. 
cepacia strains (Lennon and DeCicco 1991). The transfer rates between B. cepacia 
strains and from a Ps. aeruginosa donor into B. cepacia strains for the broad host 
range trimethoprim resistance Inc-P plasmid R751 reported by Lennon and DeCicco 
(1991) per donor, were lower than those described for Inc-P plasmids in this study. 
Lennon and DeCicco (1991) found a transfer rate of IO-4 to 10'7 from Ps. aeruginosa 
compared with rates o f 10 1 and higher for RP1 in this study, and values of 10'5 to ÎO7 
between Æ cepacia strains compared to around 10‘3 for plasmids in this study. There 
are few reports of plasmid transfer from B. cepacia to other species. In this study we 
have demonstrated transfer of the mercury resistance plasmid pQKH6 to an E. coli 
recipient at rates per donor and per recipient in the region o f 102 to 10*6. Conjugal 
transfer of other mercury resistance plasmids to other species from B. cepacia donor 
strains has been previously demonstrated (Rochelle et al 1988, Sabate et al 1994). 
pQM3 had a transfer frequency of 1.9 x ÎO 2 from B. cepacia to a Ps. putida  recipient, 
but was somewhat lower (10*4 to 10'8) for oihtr Pseudomonas recipients (Rochelle et 
al 1988). pAMJ3 transferred into Ps. putida recipients at a similar rate (IO 2 to ÎO7), 
but was lower for a range of other recipients (Sabate et al 1994). Other groups have
had little success in the conjugal transfer of plasmids, particularly antibiotic resistance 
plasmids, to other species (Hirai et al 1982).
It is o f significance that plasmid transfer by conjugation can occur in both 
environmental isolates and in clinical isolates such as C93. Although in this study the 
antibiotic resistance plasmid RP1 could not be transferred to C93, the potential of 
plasmid transfer, particularly antibiotic resistance, in clinical isolates o f B. cepacia is of 
concern. This point was raised by Lennon and DeCicco (1991), who transferred an 
antibiotic resistance plasmid into and between B. cepacia strains. The fact that 
conjugal transfer can occur in environmental strains adds to the potential o f B. cepacia 
as a degradative bacteria, as genes encoding for degradative pathways, or steps in such 
pathways may be transferred on conjugative plasmids.
Study o f conjugative transfer in B. cepacia is somewhat difficult. The high levels of 
antibiotic resistance makes the use o f antibiotics as selective markers difficult, the 
diverse nutritive properties make the use of auxotrophic markers difficult as B. cepacia 
can utilise a wide range of substrates and the difficulties in isolating plasmid DNA (as 
outlined in Chapter 5) make confirmation of transfer rather tricky. Such problems 
would appear to be a major factor in the study of plasmids in B. cepacia. A number of 
groups have transformed B. cepacia plasmid DNA, usually obtaining the DNA by 
equilibrium gradient ultracentrifugation, into other species such as E. coli for ease of 
use in studies such as mating, incompatibility and studies into plasmid phenotypic 
properties (Hirai et al 1982, Sabate et al 1994, Haak et al 1994, Bhat et al 1995)
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7.4.2 Transfer of piperacillin resistance between B. cepacia strains 
. Although apparent transfer of resistance was found, this was not accompanied by any 
evidence of the physical confirmation of plasmid transfer. The transfer frequency from 
PW7 was reasonably high, 5.7 x 10"2 per donor, and 2.7x 10"4 per recipient. The 
frequency was somewhat lower for C79, around 10*3 per donor and as low as 10"* per 
recipients frequency so low that in effect no transfer has occured. The huge 
differences between values between frequencies per donor and per recipient could be 
largely due to the failure to obtain accurate estimations of donor counts in plates 
containing piperacillin, and in counts of transconjugant colonies where an inoculum 
effect had apparently occured with growth only found where high numbers o f bacteria 
were inoculated.
There are a number of possible reasons for the apparent transfer o f resistance with no 
physical detection of transfer. A simple explanation would be that the plasmids 
transferred but could not be detected by the methods used. This is certainly possible 
considering the difficulties described in Chapter 5. A second explanation is that the 
apparent transconjugants were actually mutants of the recipient or donor cells though 
growth at high levels at 10"1 indicate that an extremely high mutation rate would be 
required. Inducible resistance, particularly inducible ^-lactamases have been described 
in B. cepacia (Baxter and Lambert 1994), so it is possible that inducible resistance has 
occurred. However as there was no growth of donor or recipient controls on 
transconjugant selective plates, it seems unlikely that either mutation or induction of
resistance has occurred, as growth on at least one set o f these plates should have also
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occurred It is also possible that high levels of contaminant growth have occurred, 
though this seems unlikely as several repeats gave similar results. Another possible 
explanation is that conjugal transfer of a mobile element such as a transposon may have 
occurred. Transposons have been strongly implicated in the development o f multiple 
antibiotic resistance in Gram-positive bacteria such as streptococci and staphylococci 
(Scott 1992). The IS element rich genome of B. cepacia could easily incorporate a 
transposon encoding for antibiotic resistance, or indeed the genomic plasticity 
described by Lessie et al (1996), could lead to the incorporation of a plasmid into the 
genome. In either case no detection of plasmid DNA would be achieved by the 
methods used.
7.4.3 Exogenous isolation of mercury resistance plasmids from the 
environment
The exogenous isolation experiments failed with a B. cepacia recipient. The putative 
transconjugants sub-cultured and identified by API 20NE were not B. cepacia 
recipients, but more likely epilithic bacteria resistant to rifampicin, mercury and 
gentamicin. The high levels of growth on the epilithic bacteria controls suggest the 
level or combination of selective markers on the recipient (NCIMB 9092) was 
insufficient to prevent growth of epilithic bacteria. Obviously the experiment is 
somewhat limited in scope and scale, with only one B. cepacia recipient used.
Although NCIMB 9092 was demonstrated to be a good recipient in previous matings, 
it displays only low levels of antibiotic resistance, so a plasmid-free strain with a higher 
level o f antibiotic resistance may be a more suitable recipient. To achieve exogenous 
isolation of mercury resistance plasmids from epilithic or other bacteria of
environmental origin may require the testing of a wide range of potential recipients, 
under a broad range of selective conditions, basically selecting the most suitable 
conditions and recipients through trial and error.
7.4.4 General considerations and future work
Only a small proportion o f the B. cepacia strains in this study have been investigated 
as donor or recipient cells for conjugal transfer of plasmids. Further work could 
investigate other B. cepacia strains as donors or recipients, possibly using different 
selective markers. An example of this is B. cepacia NCTC 10661 (NCIMB 9085), an 
strain used in this study, has been demonstrated as a recipient for pQKH6 (Hill et al 
1992). A wider range of transfer between B. cepacia strains, and between B. cepacia 
and other species could also be investigated. In this study only transfer into E. coli was 
shown, though other groups have shown transfer into other species, notably Ps. putida 
and A. eutrophus (Rochelle et al 1988, Sabate et al 1994), and it would seem 
appropriate to investigate the transfer of plasmids from B. cepacia to Pseudomonas 
and other (3-2 bacteria such as Alcali genes, as well as other Burkholderia species such 
as B. gladioli. Overcoming problems with selection of suitable markers may prove 
difficult. A possible method of overcoming this could be the use of a psychrophilic 
bacterium as a recipient. Selection of the recipient could then be based on the reported 
inability o f B. cepacia to grow at low temperatures (Gilardi 1983), and selection of the 
plasmid based on its phenotype.
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In this study although there was apparent conjugal transfer of piperacillin resistance, no 
plasmid transfer could be detected. Future work could investigate this, particularly the 
presence of transposons or incorporation of plasmids into the B. cepacia genome. The 
plasmid transferred could be used as the basis of a probe, or PCR primer to detect 
plasmid DNA incorporated into the genome.
Other than the transfer o f broad host range plasmids in B. cepacia, only transfer of 
antibiotic resistance was investigated. Although the transfer of mercury resistance 
plasmids has been investigated, there is relatively scant information regarding the 
conjugal transfer of degradative plasmids in B. cepacia, though there is rather more 
information on the transformation of such plasmid DNA (Haak et al 1994, Bhat et al 
1995). Future work could involve investigation of conjugal transfer o f such plasmids.
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Chapter 8 Typing of B. cepacia strains
8.1 Introduction
A number of methods have been developed and used for typing B. cepacia. In this 
study two molecular methods were examined. Macro-restriction analysis, (restriction 
digestion of the B. cepacia genome then followed by pulsed field gel electrophoresis) 
and PCR ribotyping. These were chosen both for their typing properties and the fact 
that they may give a comparison of the genetic structure o f the strains.
8.1.1 PCR Ribotyping
The method of PCR ribotyping to study B. cepacia was first used by Kostman et al 
(1992) and has subsequently been further developed in the USA ( Dasen et al 1995) 
and in Europe ( Ryley et al 1995, 1996). The technique uses PCR to amplify the 16S- 
23s intergenic spacer (ITS) region o f bacterial rRNA opérons (rrn opérons) using 
primers based on conserved sequences flanking the ITS region . Differences in the 
number o f opérons and heterogeneity in the length o f the ITS region allows differences 
between strains to be characterised.
The polymerase chain reaction (PCR )is an in vitro technique to amplify specific DNA 
sequences from a specific DNA template primer(Reviewed by Taylor 1991)
The method used in this study is based on that of Ryley et al (1995), itself a 
modification of the method of Kostman et al (1992). Two sets of primers were used, 
the first based on a sequence conserved in many Gram negative bacteria. The primers 
react with a range of Gram negative species including B. cepacia, E. coli, Ps.
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aeruginosa and Clostridium difficile (Ryley et al 1995). The second set o f primers 
was specific to B. cepacia, designed from a specific sequence in a B. cepacia CF strain( 
Ryley personal communication 1996).
The method can be considered to have three main steps. The first is the extraction of 
DNA from B. cepacia. This was achieved by boiling cells with a suspension of Chelex 
100, a chelating ion exchange resin. This was originally developed as a method to 
extract DNA for PCR from forensic samples (Walsh et al 1991) and has subsequently 
been developed for DNA extraction from bacteria. The second stage is the 
amplification of B. cepacia DNA by PCR. The final stage is the analysis of the 
products by agarose gel electrophoresis. Products may be digested with Taq I 
restriction enzyme prior to running, or through the use o f ‘Infinity’ agarose extender 
(Appligene Oncor) that may allow analysis without restriction digestion by increasing 
the gel’s resolution (Ryley personal communication 1996). Using the method with 
Taq I digestion Ryley et a l (1995) found seven different ribotypes amongst isolates 
from South Wales CF patients (four paediatric ribotypes and three adult). The method 
was subsequently used to type 8 different ribotypes amongst CF patients in Denmark 
(Ryley et al 1996). In this study it was decided to initially analyse PCR products on 
agarose gels with the addition of the agarose enhancer, ‘Infinity’ agarose extender, and 
to use Taq I digests if there was insufficient differentiation between the strains.
, 8.1.2 Typing of B. cepacia by macro-restriction analysis
The use of restriction enzyme digests of bacterial whole chromosomal DNA followed 
by pulsed field gel electrophoresis (PFGE) to type bacterial strains uses the same
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principles as restriction fragment length polymorphism (RFLP) analysis, though due to 
the large size of the DNA rare-cutting restriction endonucleases are used to give a 
reasonable number of fragments. The method has been named macro-restriction 
analysis ( Grouthes and Tummler 1991, Lessie et al 1996) or genome fingerprinting 
(Rodley et al 1995).. The digest pattern is then analysed either qualitatively or 
quantitatively to type strains. Grouthes et al (1988) developed genome fingerprinting 
for Ps. aeruginosa isolated from CF patients. Genomic DNA was digested with Spel, 
Dra I, Xba  I, Ssp I and Nhe I then separated by FIGE (Field Inversion Gel 
Electrophoresis) (Smith and Cantor 1987). Degrees o f relatedness of strains could be 
analysed by the differences in the bands obtained. The method was further developed 
for 32 Pseudomonas and related species (Grouthes and Tummler 1991). PFGE was 
used following digestion with Asn I, Dra I, Spel, Ssp I or Xba I. Qualitative analysis 
can be made by direct comparison of restriction fragment patterns and is usually 
sufficient to tpye closelt related strains. Quantitative analysis may be made by using the 
Dice coefficient to assess similarity, and is usually made when there are large 
differences between strains. Both quantitative and qualitative analysis has subsequently 
been applied to B. cepacia strains infecting CF patients (Pitt et al 1996). The basic 
method of Grouthes et al (1988) was used, and the banding patterns were analysed 
qualitatively and then quantitatively using the Dice coefficient. A total o f 366 isolates 
from 178 CF patients were analysed both using PFGE and ribotyping. Ribotyping gave 
more that 50 patterns, with 68 isolates being of a single ribotype, termed ribotype 1. 
The PFGE macro-restriction analysis showed these ribotype 1 strains to have a very 
similar banding pattern and genetic structure. There were high levels of heterogeneity 
amongst the restriction patterns of other strains.
.8.2 Materials and methods 
Materials
i. Chemicals
Chelex 100 resin (Bio-Rad laboratories, Hemel Hempstead, Herts.)
Ethanol (James Burroughs, Witham, Essex)
Molecular Biology grade agarose (Sigma Chemical Co., Poole, Dorset.) 
Pulsed Field grade agarose (Sigma Chemical Co.)
Low Gelling Temperature grade agarose (Sigma Chemical Co.)
‘Infinity’ Agarose Extender (Appligene Oncor, Durham)
Proteinase K (ICN Biochemicals, Thame, Oxon)
ii. Media
Nutrient agar (Oxoid, Unipath, Basingstoke, Hants.)
iii. Strains
B. cepacia strains grown overnight on NA as described in Chapter 2 (p.97)
iv. Solutions
N-lauroyl sarcosinate buffer (Appendix I)
MacFarland standards (BioMerieux, Marcy 1’Etoile, France)
TE buffer (Appendix I)
TBE buffer (Appendix I)
SE buffer (Appendix I)
0.5 M EDTA solution (Fisons, Loughborough, Leics.)
v. Primers, enzymes and markers
Taq DNA polymerase 5,000 units ml'1 (Appligene Oncor, Durham)
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Tris HC1 Taq buffer as supplied with enzyme (Appligene Oncor, Durham) 
Deoxynucleotide triphosphates (dATP, dCTP, dGTP, dTTP) at 100 mM in water 
(Promega UK, Southampton, Hants)
Magnesium Chloride 25 mM (Promega UK, Southampton , Hants.)
Primers (oligonucleotides synthesised by MWG-Biotech UK Ltd., Milton Keynes, 
Bucks.) supplied in water:
Conserved Primer No. 1 (C l) at concentration o f 39.3 pmol pi"1 
5’ - TTG TAC AC A CCG CCG GTC A - 3’
Conserved Primer No.2 (C2) at concentration of 54.1 pmol pi'1 
5’ - GCT ACC TTA GAT GTT TCA GTT C - 3 ’
Specific Primer No. 1 (SI) at concentration of 36.9 pmol pi"1 
5’- AGA AGT GGC TAG TCT AAA CA - 3’
Specific Primer No 2 (S2) at concentration of 30.6 pmol pi"1 
5’ - CAA ATA AAG AGT GCA AGG CTC - 3’
Genome qualified restriction endonucleases, supplied with buffers and acetylated 
BSA (Promega UK, Southampton ,Hants,):
Xba I at 12 units ml"1, recognition site- TACTAGA 
Spel at 18 units ml"1, recognition site- AACTAGT 
Not I at 10 units ml"1, recognition site- GCAGGCCGC 
Pulsed field size markers (Sigma Chemical Co., Poole, Dorset). Marker sizes given 
overleaf.
Saccharomyces cerevisae CHEF size marker (BioRad, Hemel Hempstead, Herts ). 
Marker sizes given overleaf.
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Pulsed field gel size marker sizes
a. Sigma 0.1 - 200 kb pulse marker:
Fragment Size (kb) Fragment Size (bp)
1 194.0 7 6.6
2 145.5 8 4.4
3 97.0 9 2.3
4 48.5 10 2.0
5 23.1 11 0.6
6 9.4 12 0.1
b. Sigma 225-2200 kb pulse marker {Saccharomyces cerevisiae [Strain No. YPH80] 
chromosomes)
Chromosome size (kb) Chromosome Size (kb)
XII 2200 X 745
IV 1640 XI 680
VII 1120 V 610
XV 1100 VIII 555
XVI 945 X 450
XIII 915 III 375
II 815 VI 295
XIV 785 I 225
c. Bio-Rad CHEF Saccharomyces cerevisiae [ Strain No. YNN 295] size marker
Band Size (kb) Band Size (kb)
1 2,200 9 680
2 1,600 10 610
3 1,125 11 565
4 1,020 12 450
5 945 13 365
6 825 14 285
7 785 15 225
8 750
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vi. Disposable consumables
CHEF plug moulds (BioRad, Hemel Hempstead, Herts.)
Disposable L-shaped spreaders (Met-Lab, Hawarden, Clwyd.)
0.5 and 1.5 ml ‘eppendorf microcentrifuge tubes.
vii. Equipment
CHEF DRII pulsed field gel electrophoresis system (BioRad, Hemel Hempstead,
Herts.)
Autogene II thermal cycler (Grant Instruments, Barrington, Cambs.)
Horizon 58 gel electrophoresis tanks (Gibco BRL , Paisley, Scotland)
Model 250-EX power supply (Gibco BRL , Paisley, Scotland)
Methods 
1. Isolation of DNA for PCR
The method used was based on that of Ryley et al (1995) with some modifications. 
Around 10 -20 colonies were picked off a fresh overnight culture on NA, and 
suspended in 1 ml of TE buffer in a 1.5 ml ‘Eppendorf tube and then harvested by 
centrifugation,. The buffer was carefully removed and the pellet was resuspended in 
the remaining buffer by vortexing mixing. 100 pi of distilled water was added and the 
tube mixed. 100 pi o f Chelex suspension, produced by mixing 1 g o f Chelex 100 with 
9 ml o f distilled water , was added and vortex mixed. This was freshly produced for 
each set of DNA extractions. Care was taken to mix the Chelex suspension at regular 
intervals to ensure the resin remained in suspension. Next the samples were heated in a 
boiling waterbath for 5 min, then allowed to cool for a few min, and spun at 13,000 g 
for 2 min to pellet out resin and cell debris. This was reduced from the 10 min,
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recommended by Ryley et al, as it was found to be sufficient to completely remove 
resin and debris whilst giving a better yield of DNA for PCR. The supernatant was 
removed into a clean tube and used as the DNA source for PCR ribotyping. The 
remaining DNA was frozen at -70°C.
ii. PCR amplification of B. cepacia 16S-23s intergenic spacer DNA
The method used was based on that of Ryley et al (1995). 11 bacterial strains were 
tested in each PCR run with B. cepacia C 1 and NCPPB 2993 run as controls in each 
set. A twelfth tube with water instead of B. cepacia DNA was also set up as a control. 
A reaction master mix sufficient for 12 tubes was produced for each pair of primers. 
The reaction mixture consisted of 999.8 pi of water, 6 pi o f each of the 2 primers in a 
set, 2.4 pi o f each dNTP, 120 pi o f x 10 Taq buffer, 6 pi of magnesium chloride and 
4.8 pi o f the Taq polymerase. 95 pi o f the master mix was pipetted into 0.5 ml tubes 
and 5 pi of each template DNA was added. 5 pi of water was added to the final 
control tube instead of DNA.
The samples were placed into a Grant Autogene II thermal-cycler The conditions were 
altered slightly from those o f Ryley et al (1995). The preliminary heating step was 
reduced from 98 °C to 94 °C for 5 min in order to prevent any inactivation o f the 
enzyme using a ‘ hot start’. After the initial heating/denaturation stage, the cycler was 
programmed for 30 cycles of three steps; an annealing step at 55 °C for 30 s, followed 
by an elongation step at 72 °C for 90 s and then a dissociation step at 92 °C for 60 s. 
After 30 cycles there were three final steps; a final annealing step at 55 °C for 30 s, 
followed by a prolonged elongation step for 5 min at 72 °C to ensure fully-double
stranded molecules from all products. Finally there was a cooling step at 17 °C until 
the samples were removed. 10 pi of sample was then taken for analysis by agarose gel 
electrophoresis.
iii. Agarose gel electrophoresis of PCR products
A high resolution gel equivalent to a 3% agarose gel was produced by adding 150 mg 
of agarose and 450 mg o f ‘Infinity’ agarose extender to conical flask with 3 ml of 
ethanol. This was then mixed to form an even slurry. 30 ml o f TBE was gradually 
added, mixing to maintain the even slurry. The agarose was melted by heating over a 
Bunsen flame. The gel was allowed to cool briefly before pouring in a Horizon 58 gel 
electrophoresis tank. The gel was allowed to set for 2 h , giving an approximate gel 
thickness o f 5 mm. TBE was added as running buffer. 10 pi of PCR product was 
mixed with 2 pi of loading buffer before loading onto the gel.
The gel was run at 4 V cm"1 for 1 h until the tracking dye had run two-thirds to three- 
quarters o f the length of the gel. The gel was then stained with ethidium bromide and 
photographed as described in Chapter 5 (p. 177).
Analysis was performed by comparison of the number and sizes of products, initially to 
the type strain, NCPPB2993, . Isolates were placed in the same ribotype if the number 
o f, and size of products was identical. Where differences, even in the size o f a single 
product, were found then the isolate was placed into a different ribotype.
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iv. Preparation of agarose embedded bacterial DNA
Cells were harvested from fresh overnight cultures on NA plates by pipetting 5 ml of 
SE buffer onto the surface of the plate and agitating with a disposable spreader. The 
liquid was drawn off and mixed with additional SE buffer to give a turbidity equivalent 
to MacFarland standard 3, approximately to 9.0 x 10* cells ml'1. Initially MacFarland 
standard 5 was used as this was closer to the value of 1 x 1010 c.f.u. ml"1 used by 
Grouthes et al (1988). This number of cells gave rise to too high a concentration of 
DNA resulting in only partial digestion and heavy smearing in the subsequent 
macrorestriction analysis, therefore the concentration o f cells was decreased to the 
turbidity equivalent to MacFarland standard 3. 500 pi of this suspension was mixed 
with 500 pi of 2 % molten low gelling temperature agarose, maintained molten at 
40 °C. The resulting 1 % agarose/cell suspension was pipetted into the plug mould, 
approximately 100 pi for each plug, taking care to avoid air bubbles.
The agarose was allowed to set at room temperature for 1 to 2 h. The agarose plugs 
were then removed using the tool provided and placed into 1.5 ml ‘Eppendorf tubes. 
Proteinase K was added to the lysing buffer at a final concentration of 500 pi ml"1, and 
1 ml of lysing solution added to the agarose plugs. The plugs were incubated overnight 
at 56 °C. After the overnight incubation the lysing solution was removed and fresh 
buffer added. The plugs were then incubated overnight at 56 °C for a second time.
After the incubation the plugs were removed and washed four times in TE buffer.
Plugs were stored at 4 °C in TE buffer for up to 3 weeks.
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v. Macrorestriction digestion of agarose embedded bacterial DNA
The initial method of digestion was based on that o f Pitt et al (1996). Agarose plugs 
were equilibrated on ice for 1 h in 200 pi o f the appropriate restriction enzyme buffer. 
The buffer was removed and replaced with fresh buffer containing 0.1 mg ml"1 
acetylated BSA and the restriction endonuclease at the concentration recommended by 
the manufacturer. In this case 20 units per plug for Xba  I and Not I, and 5 units per 
plug for Spel. The plugs were incubated for 4 h at 37 °C, after which the reaction was 
stopped by the addition of 12 pi of 0.5 M EDTA to each plug. Plugs were then 
washed 3 times in TE buffer before running by PFGE.
Little digestion of the DNA was found by this method. To increase the amount of 
digestion 50 units per plug with the above conditions was used as recommended by 
Bio-Rad Laboratories (1992). This increased digestion giving macro-restriction 
patterns. Increasing the digestion time to 12 to 16 h as recommended by Sambrook et 
al (1989) increased the definition of the digestion patterns. On the basis o f these 
results all digests were then carried out using 50 units /plug of restriction enzyme at 
37°C for 14 h. The other conditions were kept to those o f Pitt et al (1996).
vi. PFGE (CHEF) of digested agarose embedded bacterial DNA 
Optimisation of PFGE conditions
The intitial PFGE conditions used were based on those of Pitt et al (1996), using a 
1.2% running gel in 0.5 * TBE buffer, electrophoresed at 5 V cm"1 for 35 h with initial 
and final pulse times o f 5s and 35s maintained at 8°C. These conditions proved 
unsuitable as many of the genomic DNA were clustered at the bottom of the gel, or had
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passed out of the gel. In an attempt to remedy this shorter running times o f 18 and 25h 
were tried but failed to give sufficient separation of the DNA fragments.
Upon advice from the BioRad technical department, a lower gel strength o f 1 %, with 
pulse times ranging from 5 to 100s were used. Initially these gels were run for 15h at 
8°C. This greatly improved resolution, which was further enhanced by increasing the 
running time to 21 h. These conditions were then adopted for PFGE macrorestriction 
analysis.
PFGE conditions for macrorestriction analysis
The conditions outlined above were adopted for PFGE. A 1% pulsed field grade 
agarose gel was prepared by mixing 1 g of agarose with 100 ml of 0.5 XTBE buffer, 
and heating over a Bunsen flame to melt the agarose. After allowing to cool 
sufficiently, the gel was poured into the PFGE gel casting mould and allowed to set for 
1 h. The CHEF DR II PFGE system was assembled and the gel tank and recirculating 
pipes filled with 0.5 x TBE buffer. The buffer was maintained at 8°C by recirculation 
through an iced water bath. Agarose embedded DNA plugs and PFGE size markers 
were trimmed and inserted into the wells of the gel using a flamed spatula. The plugs 
were then sealed in the gel with 1 % low gelling temperature agarose. The gel was 
electrophoresed at 5 V cm'1 for 21 h with initial and final pulse times o f 5 and 100s. 
After electrophoresis the gel was stained in 0.5 pg ml'1 ethidium bromide solution for 
30 mins, destained in water for 30 mins, then photgraphed under UV transillumination 
as described in Chapter 5 (p. 176).
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8.3 Results
8.3.1 PCR ribotyping
PCR products were obtained with the conserved primers C 1 and C2 though no 
products were found with the specific primers S 1 and S2 Results obtained with the 
conserved primers were compared qualitatively with each other and with the PCR size 
marker. Representative results are shown in Plate 8.1. A common pattern was found 
in all Cardiff CF strains with the exception of C93. These products yielded a strong 
band, suggesting a high accumulation of product, at approximately 800 bp, with two 
much fainter bands of around 2,000 and 2,500 bp on agarose gel electrophoresis. The 
same pattern was also found in the Edinburgh CF isolate C l858, the Strasbourg CF 
isolate J543 and the Dublin CF isolate D2.
Other clinical strains showed different patterns of PCR products with between 2 to 8 
products ranging in approximate size from 700 -2,500 bp. On initial observation 
several patterns seem very similar, but on closer examination differences in the number 
of bands or their sizes were found. Every environmental strain gave a different pattern 
of products. In all 9 different PCR ribotypes were found in the clinical strains and 22 
different ribotypes in the environmental strains. 31 different ribotypes were therefore 
found in a total. The assignment of ribotypes to B. cepacia isolates is shown in Table
8.1
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Plate 8.1 PCR ribotyping : Composite photograph of representative results
1 5  10 15 20
Lanes 1& 20 are PCR size markers
Lanes 2 to 13, except 5, show environmental isolates of B. cepacia
Lane 5 & Lanes 14 to 19 show CF isolates o f B. cepacia o f the same ribotype,
designated Ribotype ell.
2 5 4
Table 8.1 Assignment of ribotypes to isolates on the basis of PCR ribotyping
Ribotype Isolates in ribotype
cl NCPPB2993: Species Type strain
ell C1,C5, C23, C41, C49, C51, C59, C79, C95, 
C96, Cl 16, C l90, C1858, J543, D2
d l l C93
cIV A548
cV J548
cVI D3
cVII D4
cVII D5
cVIII D6
cVIX Cl 860
cX NCPPB3480
cXI NCIMB9088
cXII NCIMB9092
cXIII NCIMB9087
cXIV NCIMB9085
cXV J2552
cXVI PW1
cXVII PW2
cXVIII PW3
cXIX PW4
cXX PW6
cXXI PW9
cXXII PW10
cXXIII PW11 ;
cXXIV PW12
cXXV PW13
cXXVI PW14
cXXVII PW17
cXXVIII PW18
cXXIX PW19
cXXX PW20
cXXI A562
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8.3.2 Macrorestriction analysis
Following digestion with Xba I around 40 fragments of less than 1 kb to over 200 kb 
were found by PFGE. Initial results were poor, though there was great improvement in 
later gels. Representative results of Xba I macro-restriction are shown in Plate 8.2. 
The results were in general not sufficiently clear to accurately determine sizes or 
numbers of bands so quantitative analysis was not possible as the bands were smeared, 
though qualitative analysis between isolates was possible in many cases.
The results obtained were in close agreement to the PCR ribotypes obatined. Identical 
or near identical patterns were seen in all Cardiff isolates with the exeption o f C93.
This macro-restriction pattern was also found in the Edinburgh CF isolate C l858, the 
Dublin CF isolate D2 and the Strasbourg CF isolate J543 when directly compared to 
the pattern of Cardiff CF isolates on the same gel. Identity between Cardiff isolates was 
confirmed by macro-restriction analysis with Not I (Plate 8.3).
Different patterns were found with Xba I digests of all other clinical and environmental 
B. cepacia isolates with the exeption of the Dublin isolates. D4 and D5, which were 
identical by Xba I digestion . The two phytopathogenic strains NCPPB 2993 and 
NCPPB 3480 were also similar in macro-restriction pattern. Confirmation o f the 
identity between D4 and D5 and differences between NCPPB 2993 and NCPPB 3480 
was determined by Not I digestion (Plate 8.4). In all 10 digest patterns were found 
amongst 25 clinical strains tested, compared with 11 PCR ribotypes for the same 
strains. As with PCR ribotyping no identity was found between the environmental 
isolates tested.
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Plate 8.2 Macrorestriction analysis of B. cepacia by Xba I digestion followed 
by PFGE. Composite photograph of representative results.
1 5 10 15 19
Lanes 1 to 9, except lane 2 are CF isolates are CF isolates of Ribotype ell.
Lane 2 is CF isolate C93 o f Ribotype d l l
Lanes 11 & 13 are CF isolates D4 & D5
Lanes 10, 12 & 14 to 17 are environmental isolates
Lane 18 & 19 are size markers ;
3 5 7
Plate 8.3 Macrorestriction analysis: confirmation of identity by Xba I and
Not I digestion followed by PFGE
1 2 3 4 5 6
lane
1 Xba I digested B. cepacia C49
2 Xba I digested B. cepacia C 1
3 Not I digested B. cepacia C49
4 Not I digested B. cepacia Cl
5 0.1 - 200 kb PFGE marker
6 225 - 2200 kb PFGE marker
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Plate 8.4 Macrorestriction analysis: confirmation of identity/non-identity of
by Xba I and Not I digestion followed by PFGE
1 2 3 4 5 6 7 8 9  10
lane
1 0.1 - 200 kb PFGE marker
2 Xba I digested B. cepacia NCPPB 2993
3 Not I digested B. cepacia NCPPB 2993
4 Xba I digested B. cepacia NCPPB 3480
5 Not I digested B. cepacia NCPPB 3480
6 Xba I digested B. cepacia D4
7 Not I digested B. cepacia D4
8 Xba I digested B. cepacia D5
9 Not I digested B. cepacia D5
10 225 - 2200 kb PFGE marker
2.5 e!
8.4 Discussion
8.4.1 Typing of B. cepacia by PCR ribotyping and macrorestriction analysis
PCR ribotyping with the conserved primers and macro-restriction analysis gave very 
similar patterns of results. Both methods indicated that 15 o f 16 Cardiff CF isolates 
along with one B. cepacia isolate from each of the Strasbourg, Dublin and Edinburgh 
CF centres are of a common strain type and genetic structure. This was somewhat 
surprising as the Cardiff CF isolates used in this study had previously been typed to 7 
different ribotypes or digest patterns (Ryley et al 1995, H. Ryley Personal 
Communication 1996). These results were achieved by Taq I digestion o f PCR 
products, and by using different macro-restriction digest conditions (Pitt et al 1996), 
that used somewhat lower amounts of restriction enzymes with shorter incubation 
times. It is possible in this study that the conditions used gave a fuller digest pattern. 
The additional Taq I digestion step in PCR ribotyping may detect very slight 
differences in the rrn operon giving typing at a higher level o f discrimination not 
detected by electrophoresis of undigested product.
Typing of B. cepacia strains infecting CF patients in Denmark (Ryley et al 1996) has 
been achieved by running undigested PCR products on an agarose/infinity extender gel 
matrix as used in this study. The technique also detects different ribotypes amongst 
both other CF isolates and all the environmental isolates tested. The fact that two very 
different methods give near identical typing of nearly 50 B. cepacia isolates, along with 
results in Chapter 9 showing strains with identical PCR ribotyping and macro- 
restriction analysis to have identical replicon structures, suggests that the 18 isolates
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identical by the typing methods are either identical or very closely related.
PCR ribotyping gave different electrophoresis patterns of products for all the remaining 
isolates, though all were in the same size range and many had similar patterns. An 
example of this is the similar patterns seen in the CF isolates A548 and D3 to the 
environmental isolate J2552 and the phytopathogenic collection strains NCPPB 3480 
and NCPPB 2993 which appear to have several PCR products of the same size.
Macro-restriction analysis gave very similar patterns of results to the PCR ribotyping. 
Most notable was that the same 18 isolates with identical PCR results had identical or 
near identical macro-restriction profiles and again all the environmental isolates 
differed. The only significant difference was that 2 Dublin CF isolates , D4 and D5, 
different by PCR ribotyping showed identity with both Xba I and Not I digestion. 
Possibly these strains are very similar in the overall genome but differ at the rRNA 
genes leading to ribotyping differences.
8.4.2 Significance of typing results ‘
It is perhaps of little surprise that 31 different ribotypes from 48 isolates tested by PCR 
ribotyping and 30 different macro-restriction patterns from 47 tested isolates were 
found. Pitt et al (1996) found more than 50 different strains from 366 B. cepacia CF 
isolates, with 68 strains o f a single type found in various centres. In this study 18 of 25 
CF isolates showed a common type, whilst the remainder , with the exeption o f 2 
Dublin isolates all differed by PCR ribotyping and macrorestriction analysis. The 
finding o f a common type in 4 CF centres suggests that this strain may be of a common
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origin. As there is strong evidence of person to person transmission of B. cepacia 
amongst CF patients It is conceivable that these isolates had a common single source 
and were spread through social contacts such as CF summer camps, meetings or within 
a single centre at CF clinics. The ET 12 epidemic isolate was found to have been 
transmitted from a source in Canada to the UK by patients attending summer camps in 
Canada (Govan et al 1993). It is certainly possible this strain was spread in a similar 
manner.
It is also significant that all the environmental strains both from type collections and 
isolated in this study were of different strains. This suggests a great diversity of B. 
cepacia in the environment. As described in Chapter 2, only one sample gave more 
than one strain using different media, though these had different API profiles. 
Unfortunately the failure of PW21 to grow consistently from frozen stocks prevented 
confirmation of differences between it and PW17. However the techniques did show 
the diversity of B. cepacia strains in the environment, even amongst samples obtained 
from within close proximity of each other in South Wales. No identity was found with 
any clinical strains. High levels of variation amongst environmental populations have 
also been reported in other studies. Wise et al (1996) found 65 unique 
electropherotypes (ET s) from 217 B. cepacia isolates from a 5 km stretch o f stream 
over a period o f 32 days in the south-eastern USA. One ET type was found 
consistently over the survey (64 of 217 isolates). It would be of interest to repeat 
isolation at a limited number of sites to assess if the same type would be found 
consistently as in the survey of Wise et al (1996). This survey, like this study, shows 
that there is a high degree of strain variability amongst environmental populations of B.
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cepacia e v e n  w ith in  a sm all area.
8.4.3 Failure of specific PCR primers
No PCR products were obtained through the use of B. cepacia specific primers. This 
was not a problem in achieving ribotyping as the conserved primers have proved more 
than adequate in this study and others (Ryley et al 1995, Ryley et al 1996). The most 
obvious advantage with specific primers is that they positively identify the isolate as B. 
cepacia, as well as typing. Other workers (H. Ryley personal communication 1997) 
have reported difficulties in the use of these primers with some B. cepacia strains. The 
fact they were designed on the basis of a specific sequence from a CF strain o f B. 
cepacia suggests that the sequence may not be conserved throughout the species 
complex, and so will only react with a limited number of strains, and therefore would 
be of little use in typing.
Other B. cepacia specific PCR primers, including primers to the 16S-23s internal 
transcribed spacer, have also been found to react poorly with a large proportion of 
tested isolates (Tyler et al 1995). This could be due to variation of the 16S-23s rRNA 
genes at a species level. The conserved primer sequences that react with a number of 
Gram negative species may be more suitable for ribotyping.
8.4.4 Problems and improvements to methods
There would appear to be several areas in which the techniques used could be 
improved and refined, some of which improved as new equipment and techniques to 
the laboratory became more familiar and better developed . This was certainly the case 
with macro-restriction analysis. Early gels gave blurred ,poorly separated fragments,
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particularly when using the conditions o f Pitt et al (1996) . Alterations to both digest 
and PFGE running conditions lead to an improvement, and although the majority of the 
gels were not sufficiently clear to undertake quantitative analysis described by Grouthes 
et al (1992), later gels such as those in Plate 8 .4 were in the order of sufficient clarity 
to allow quantitative analysis.
The use of Xba  I or Spe\ give sufficiently different patterns between isolates with 
around 40 fragments resulting (Spe\ has been reported to give 38 fragments with the 
type strain (Lessie et al 1996)). Xba I was used primarily as it is less expensive than 
Spel. Not I digests were used to confirm identity. Although more rare cutting enzymes 
such as Pac I or Swa I could be used, and the smaller numbers of resulting fragments 
would make analysis easier, the relatively low cost of Xba  I makes it more suitable for 
the analysis of large numbers of samples.
The PCR ribotyping followed by agarose/infinity gel electrophoresis gave sufficiently 
clear results to type strains. The use of a further digest step, such as the Taq I digest 
used by Ryley et al (1995), may allow more detailed typing, though the undigested 
products were sufficient in this study, particularly in conjunction with macro-restriction 
analysis, and in studies in Denmark (Ryley et al 1996). Although there were initial 
problems with the PCR, these were largely resolved by decreasing the length of time of 
the pelleting stage after boiling the cells with Chelex in the DNA purification method. 
Consistent results were achieved with the Appligene Taq polymerase, though use of an 
alternative polymerase failed to give any PCR products. It was noticeable that DNA 
prepared by Chelex extraction began to deteriorate after 2 or 3 thawing and freezings,
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This was evident using Cl and NCPPB 2993 DNA as controls. Sharpness of bands 
and the presence of larger bands were reduced after use on 3 or 4 occasions. 
Preparation of fresh DNA samples for control strains witheach set of PCR ribotyping 
overcame this problem.
Both methods typed isolates to the same groups or ribotypes, though the PCR 
ribotyping was far quicker and easier to perform . However the process o f macro- 
restriction analysis is far less time consuming if agarose embedded DNA is prepared for 
multiple chromosome analysis^ as in Chapter 9) at the same time. Both methods 
showed great variability in the environmental population of B. cepacia, and differences 
between environmental and CF isolates suggesting that they form a separate 
population, or possibly species. Identical patterns found amongst CF isolates from 
different centres strongly support a common source of these isolates and o f person-to- 
person transmission ofB.  cepacia in CF (Govan et al 1996)
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■Chapter 9 Investigation of multiple replicons in B. cepacia
9.1 Introduction
9.1.1 Multiple bacterial replicons
PFGE has been used to investigate chromosomes in protozoa and yeasts. Multiple 
replicons have been described in a number o f bacterial species including Rhizobium and 
Agrobacîerium (Sorbal et al 1991, Allardet-Servet et al 1993) and Burkholderia 
cepacia ( Rodley et al 1995, Lessie et al 1996).
Two main approaches have been used to investigate multiple bacterial chromosomes. 
The first o f these involves genome mapping by macrorestriction analysis with rare- 
cutting enzymes. These produce very large fragments o f DNA (up to Mb size) that can 
be mapped into their multiple replicons (Rodley et al 1995). Alternatively undigested 
DNA directly examined by PFGE (Rodley et al 1995, Lessie et al 1996). Circular 
DNA molecules in Leishmania have been reported to migrate in PFGE in an unusual 
way (Beverly 1988), and it appears that large circular replicons in bacteria have little 
or no mobility in PFGE (Lessie et al 1996). However multiple replicons may be 
detected due to small numbers of randomly linearised replicons being formed during the 
preparation of the agarose embedded DNA plugs. This method was employed by 
Lessie et al to study multiple chromosomes in twelve B. cepacia strains using freeze 
thawing o f samples or the use of irradiation to increase linearisation. Rodley et al 
(1995) employed random hit linearisation by irradiation before running undigested 
DNA on PFGE. Circular replicons remain within the agarose plug
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9.1.2 Detection of rRNA genes on multiple replicons
Both Cheng and Lessie (1994) and Rodley et al (1995) used Southern blotting 
hybridisation to detect rRNA genes (rrn opérons) on multiple replicons in B. cepacia. 
Cheng and Lessie found rrn opérons on each of the three large replicons in B. cepacia 
ATCC 17616. Rodley e/or/(1995) found one rm  operon on the 3.17 Mb and 1.07 Mb 
replicons and four rrn replicons on the larger 3.65 Mb replicon in the type strain. The 
222 kb replicon had no rRNA genes suggesting it is a plasmid, and the larger replicons 
are chromosomal in nature carrying rRNA genes essential to function.
To detect rRNA genes in multiple replicons observed by PFGE, the replicon band was 
removed and the agarose digested with a hydrolysing enzyme (AgarAce). The product 
was then used as a DNA source in PCR ribotyping (described in the previous chapter). 
A similar method was also used to obtain plasmid DNA from the PFGE gel.
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9.2 Materials and methods 
Materials
i. Chemicals
Pulsed field grade agarose (Sigma Chemical Co., Poole, Dorset)
Molecular biology grade agarose (Sigma Chemical Co., Poole, Dorset) 
Chromosomal grade agarose (Bio-Rad Laboratories, Hemel Hempstead, Herts.)
Low gelling temperature agarose (Sigma Chemical Co., Poole, Dorset)
AgarAce agarose digestion enzyme, 0.225 units pl'^Promega, Southampton, Hants.)
ii. Strains
Agarose embedded DNA of B. cepacia and other strains to be tested (as described in 
Chapter 8, p.250)
CHEF size markers; Saccharomyces cerevisiae (Bio-Rad Laboratories, Hemel 
Hempstead, Herts.) (Sizes given in Chapter 8)
CHEF size markers; Hansenula wingei (Bio-Rad Laboratories, Hemel Hempstead, 
Herts.) (Sizes given overleaf)
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Bio Rad Hansenula wingei CHEF size markers, sizes o f chromosomes:
Chromosome band Size (Mb)
1 3.13
2 2.70
3 2.35
4 1.81
5 1.66
6 1.37
7 1.05
iii. Solutions
0.5 X TBE
Ethidium bromide for staining (As described in Chapter 5, p. 175)
1.v. Equipment
Bio Rad CHEF DRII PFGE system (Bio Rad, Hemel Hempstead, Herts.) 
v. Dispoable consumables
CHEF plug moulds (Bio Rad, Hemel Hempstead, Herts.)
Universal containers
1.5 ml microcentrifuge tubes.
Methods
i. PFGE separation of chromosomal DNA
On the basis of the sizes o f replicons reported in B. cepacia, 0 .9 to 3 .6 Mb, and 
following discussion with the Bio-Rad technical helpline and the CHEF applications 
guide (Bio-Rad 1992) electrophoresis conditions based on the H. wingei marker were 
chosen. A 0.8 % gel was prepared by adding 0.8 g of chromosomal grade agarose to 
100 ml o f 0.5 x TBE in a flask . The gel was melted by heating over a Bunsen flame 
and allowed to cool for 10 to 15 min before pouring into the gel casting frame. The gel 
was then allowed to set for 1 to 2 h before trimmed agarose embedded DNA plugs 
were placed into the wells using a flamed spatula. The plugs were then sealed using 
molten 0.8 % low gelling temperature agarose and allowed to set and cool, before the 
gel was placed into the electrophoresis cell o f a Bio-Rad CHEF-DRII PFGE system. 
The cell was filled with 0.5X TBE as running buffer maintained at a temperature of 
between 5 to 8°C. The gel was electrophoresed at 3 V cm"1 for 50h with an initial 
pulse time of 250 s and a final pulse time o f 900 s. After electrophoresis gels were 
stained with ethidium bromide and photographed as previously described (Chapter 5.,p. 
177).
ii. Detection of rRNA genes on B. cepacia replicons
PFGE was used to separate multiple replicons. Using a sterile scalpel and under UV 
transillumination, the replicon bands were cut out and weighed. Slices were also taken 
from the ‘inter band’ space, from the edge of the gel as a control and from the agarose 
DNA plug. The gel slices were cut in half and placed in separate tubes. One half of the
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slice was macerated with a sterile pipette tip and by freeze/thawing. This was frozen at
-70 °C for storage.
The other half of the slice was digested using the AgarAce enzyme isolated from a 
marine Flavobacterium. The amount of enzyme used was determined by the weight of 
the gel slice. 0.5 to 1 unit o f enzyme was recommended per 100 mg o f 1 % agarose ) 
0.8 units of enzyme was therefore used per half gel slice equating to approximately 200 
mg o f 0.8 % agarose gel. The gel slice was melted by heating at 70 °C, and then pulse 
spun in a MSE Microcentaur microcentrifuge. The tubes were transferred to a heating 
block at 45 °C. 3.5 pi of AgarAce enzyme was added and incubated for 15 min. After 
incubation the samples were frozen at -70 0 C for future use.
The samples from both methods were then used as the DNA source for PCR 
ribotyping. The materials and methods used were those described previously in 
Chapter 8 (p. 249) with the modification of adding 10 pi of DNA to 95 pi o f reaction 
master mix, rather than 5 pi.
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9.3 Results
9.3.1 Detection of multiple replicons
Initial attempts to investigate replicon structure in B. cepacia were tried using the 
conditions o f Pitt et al (1996). A 1.2 % pulsed field grade or molecular biology grade 
agarose gel electrophoresed at 5 V cm'1 for 37 h with initial and final pulse times of 5 s 
and 35 s with S. cerevisiae and/or H. wingei markers. Although there was some 
indication of multiple replicons the methodology was unsuitable leading to poor results, 
particularly of the larger markers which were insufficiently separated. Several 
modifications were tried, but after discussion with the Bio Rad technical helpline 
conditions based on the H. wingei marker protocols were tried and were found to give 
good identification of multiple replicons in the majority of B. cepacia isolates tested. 
The method also indicated multiple replicons in the B. gladioli and Alcaligenes 
eutrophus strains tested. Multiple replicons were not detected in E. coli, 
Stenotrophomonas maltophilia or Ps. aeruginosa. A selection of representative results 
are shown in Plates 9.1 to 9.6 .
It is notable that all the Cardiff CF isolates, with exeption of C93, appeared to show a 
common 2 replicon structure. This structure is also found in strain C l90, an isolate 
sent to clinical laboratories to assess quality control o f identification, in the Strasbourg 
CF isolate J543, the Dublin CF isolate D2 and the Edinburgh isolate C l858. A 
number o f the environmental isolates also show very similar replicon structure. The 
Dublin CF isolates D4 and D5 also appear to have an identical structure.
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A number of strains also show a smaller DNA band. It was thought this may be plasmid 
DNA or degraded chromosomal DNA. The appearance of a band slightly larger than 
these in Ps. aeruginosa PA O l/ pQMl/RJOOB appears to correspond with the 251 kb 
plasmid pQM l, suggesting this band may be large plasmids (100 - 200 kb) in the B. 
cepacia strains, rather than chromosomal fragments.
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Plate 9.1 Identification of multiple replicons (chromosomes) B. cepacia and
other species by PFGE .
1 2 3 4  5 6 7 8  9 10
r— 3 -13 M b 
— 1.81 Mb 
— 1.05Mb
lane
1 B. cepacia C l 16
2 B. cepacia NCPPB3480
3 B. cepacia NCIMB9092
4 B. cepacia C79
5 H. wingei marker
6 B. cepacia PW 11
7 Alcaligenes eutrophus NCIMB11842
8 B. cepacia PW6
9 B. cepacia C 1
10 B. cepacia PW 17
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Plate 9.2 Identification of multiple replicons (chromosomes) B. cepacia and
other species by PFGE .
lane
1 Stenotrophomonas maltophilia
2 B. cepacia NCIMB 9087
3 B. gladioli NCPPB 2478
4 B. cepacia NCIMB 9092
5 B. cepacia J2552
6 B. cepacia J543
7 B. cepacia A562
8 B. cepacia D6
9 B. cepacia C 1
10 H. wingei marker
—  3 1 3 M b  
1-81 Mb 
— 1 0 5 M b
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Plate 9.3 Identification of multiple replicons (chromosomes) B. cepacia by
PFGE
3.13Mb
1 8 1 M b
1 0 5 M b
lane
1 B. cepacia C l87
2 B. cepacia C93
3 B. cepacia C23
4 B. cepacia C5
5 B. cepacia C205
6 B. cepacia C l90
7 B. cepacia C i l
8 B. cepacia C96
9 B. cepacia C\
10 H. wingei marker
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Plate 9.4 Identification of multiple replicons (chromosomes) B. cepacia and
other species by PFGE .
1 2 3 4 5 6 7 8 9  10
3.13Mb
1.81Mb
1.05Mb
lane
1 B. cepacia PW2
2 B. cepacia PW 11
3 B. cepacia PW7
4 B. cepacia PW6
5 B. cepacia PW 10
6 B. cepacia PW 17
7 B. cepacia NCPPB 2993
8 B. gladioli NCCPB 2478
9 B. cepacia C 1
10 H. wingei marker
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Plate 9.5 Identification of multiple replicons (chromosomes) B. cepacia and
other species by PFGE .
1 2 3  4 5 6 ' 7' 8 9 10
—  3 1 3  Mb
181 Mb 
U  1 0 5 M b
lane
1 B. cepacia PW 10
2 B. cepacia PW 17
3 5. cepacia PW14
4 B. cepacia PW3
5 B. cepacia PW19
6 B. cepacia PW6
7 B. cepacia NCPPB 2993
8 B. gladioli NCCPB 2478
9 B. cepacia C 1
10 H. wingei marker
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Plate 9.6 Identification of multiple replicons (chromosomes) B. cepacia and
other species by PFGE .
1 2 3 4 5 6 7
3 1 3 Mb —
1 3 7  Mb —
lane
1 H. wingei marker
2 E. coli NCTC 10418
3 Stenotrophomonas maltophilia
4 Ps. aeruginosa PAO 1 /pQM 1 /R300B
5 Alcaligenes eutrophus NCIMB 11842
6 B. cepacia C 1
7 B. cepacia D4
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In addition several strains were electrophoreses for an additional 18 h at3 V cm'1, with 
a pulse time of 900s in an attempt to improve the resolution of replicons in the size 
range of 2.5 to 3.5 Mb. Plate 9.7 shows a gel electrophoresed for an additional 18 h. 
The visualisation o f the larger replicons such as those in NCPPB 2993 was improved, 
but to the detriment of visualisation of those in the 1 to 2 Mb region.
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Plate 9.7 Identification of multiple replicons (chromosomes) B. cepacia by 
PFGE with an extended electrophoresis time
1 2  3 4 5  6 7 8 9  10
3.13Mbm  #
1.81Mb
1.05Mb
lane
1 Blank
2 B. cepacia C51
3 B. cepacia C49
4 B. cepacia C l 16
5 B. cepacia C59
6 H. wingei marker
7 B. cepacia PW4
8 B. cepacia NCPPB 2993
9 B. cepacia PW8
10 Blank
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9.3.2 Size estimation of large replicons in B. cepacia 
There is no generally accepted methodology for sizing of undigested replicons 
separated by PFGE. A regression analysis method similar to that used in Chapter 5 for 
the estimation of plasmid sizes was used to estimate the replicon sizes, using the 
Hansenula wingei CHEF marker as size standard. A number of logm transformations 
were tried to obtain a good plot including logio molecular size against distance 
travelled in mm, and logm molecular size against logm distance travelled. The best 
results were achieved by plotting molecular size (in Mb) against distance travelled (in 
mm). The determination of correlation, R2 value for Plate 9.1 was 99.2 % compared to 
a R2 value o f 92.7 % for logm molecular size against logm distance migrated.
The sizes of the B. cepacia replicons were estimated by replacing the y value in the 
regression equation, the distance migrated of the H. wingei standard, with the distance 
migrated by the B. cepacia replicons. The size o f the replicon, x, can then be 
calculated from the equation.
Example calculation
For Plate 9.1, the distances travelled by the H. wingei markers (lane 5):
H. wingei marker sizes (Mb) Distance migrated (mm)
The plot o f molecular size of marker against distance travelled is shown in Figure 9.1
3.13
2.70
2.35
1.81
1.66
1.37
1.05
5
7.5 
9
13.5
14.5 
17 
19
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Figure 9.1 Plot of molecular size against distance migrated for H. wingei 
marker from Plate 9.1
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Hansenula wingei CHEF marker sizes (Mb)
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From the plot the regression equation was obtained 
y = me- x 
y = 26.10 - 6.90 x
Where y = distance migrated (mm) 
x = molecular size (Mb)
Substituting the values for Cl from Plate 9.1 (lane 9)
For the larger replicon distance migrated = 5 mm 
Therefore: 5 = 26.10 - 6.90 x 
5 -2 6 .1 0  = x  
-6 .90
3.06 = x 
Size o f replicon = 3.1 Mb
For the smaller replicon distance migrated = 13 mm 
Therefore: 13 = 26.10 - 6.90 x 
13 - 26.10 = x 
- 6.90
1.89 = x 
Size o f replicon = 1.9 Mb
As described earlier the line is well predicted with a good degree of fit, the R2 value 
being 99.2 %. The above process was repeated for both the other isolates in Plate 9.1, 
and for replicons in other isolates. The mean R2 value for the 12 gels used to estimate 
replicon size was 99.0 %, ranging from 98.2 % to 99.5 % showing good consistency
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and correlation for the method, with a consistent and well predicted plot with a good 
degree of fit.
As with the plasmid size estimation, a number of bands were outside the range of the 
standards. Again the regression equation was extrapolated to estimate the sizes beyond 
the standards. This was done on the basis of the good linear relationship between 
distance travelled, shown by the mean R2 value of 99.0%, and that the values were only 
just outside the sizes of the standards.
The method used could effectively estimate the size o f the replicons found in this study, 
with replicons ranging from around 0.5-2.4 Mb. The sizes o f replicons in B. cepacia 
and other species determined by regression analysis are shown in Table 9.1. Although 
in some o f the representative gel photographs shown replicons are not seen for some 
strains, the results given in the table are a mean value that includes several repeats 
where more clear results for that strain were seen. The frequency distribution of large 
replicons amongst the B. cepacia strains investigated in this study is shown in Figure 
9.2.
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Table 9.1 Sizes of multiple replicons in B. cepacia and other species
Isolate Replicon sizes (Mb) Total genomic size 
(Mb)
Cl 3.1, 1.9 & plasmid (approx.200 kb) 5.0
C5 3.1, 1.9 & plasmid (approx.200 kb) 5.0
C ll 3.1, 1.9 5.0
C23 3.1, 1.9 & plasmid (approx.200 kb) 5.0
C49 3.1, 1.9 5.0
C51 3.1,1.9 5.0
C59 3.1, 1.9 & plasmid (approx.200 kb) 5.0
C79 3.1, 1.9 5.0
C93 3.1, 2.3 5.4
C95 3.1, 1.9 5.0
C96 3.1, 1.9 5.0
Cl 16 3.1, 1.9 5.0
C187 3.1, 1.9 & plasmid (approx.200 kb) 5.0
Cl 90 3.1, 1.9 & plasmid (approx.200 kb) 5.0
C205 3.1, 1.9 & plasmid (approx.200 kb) 5.0
J543 3.1, 1.9 & plasmid (approx.200 kb) 5.0
J478 3.2, 3.1, 1.1 7.4
A548 3.1, 2.8, 0.8, 0.7 7.2
A562 3.2, 3.0, 0.8, 0.6 7.6
C1858 3.1, 1.9 5.0
Cl 860 3.1, 2.5 5.6
J2552 NR -
D2 3.1, 1.9 5.0
D3 3.1, 2.8, 0.7, 0.5 7.1
D4 3.1, 2.9, 0.7 6.7
D5 3.1, 2.9. 0.7 6.7
D6 3.2, 3.0, 0.6, 0.5 7.3
NCPPB 2993 3.4, 3.1, 1.1, & plasmid (approx.200 kb) 7.6
NCPPB 3480 3.1, 2.6, 0.6 & plasmid 
(approx.200 kb)
6.3
NCIMB 9087 3.2, 3.0 6.2
NCIMB 9092 3,2, 2.8, 0.8 6.8
PW1 3.0, 2.8 5.8
PW2 3.1 3.1
PW3 3.2 3.2
PW6 3.2, 3.0 & plasmid (approx.200 kb) 6.2
PW7 3 .1 ,2 9 6.0
PW9 3.2, 2.9 6.1
PW10 3 2 ,3 .0 6.2
PW11 3.1, 2.9 6.0
PW12 3.2, 2.9 6.1
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Table 9.1 (Continued)
Isolate Replicon sizes 
(Mb)
Total genomic size 
(Mb)
PW14 3.1, 16 4.7
PW15 3.0, 2.8 5.8
PW17 3.2, 3.1 6.3
PW18 3.2, 2.9 6.1
PW19 3.1, 2.9 6.0
PW20 2.9 2.9
B. gladioli NCPPB 2478 3.2, 3.0 & plasmid (approx.200 kb) 6.2
Alcaligenes eutrophus 
NCIMB 11842
3.3, 3.0 6.3
Stenotrophomonas 
maltophilia 4543
3.3 3.3
Ps. aeruginosa 
PA01/pQMl/R300B
3.1 & plasmid (approx.200 kb) 3.1
E. coli NCTC 10418 NR -
NR = No result obtained
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Figure 9.2 Frequency distribution of large replicon numbers in B. cepacia
isolates investigated in this study
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9.3.3 Detection of rRNA genes on multiple replicons by
PCR ribotyping
Isolates C 1 and D4 were chosen as they gave well defined, well separated 
chromosomal bands and are of different ribotypes. No PCR products were found with 
the macerated D4 gel slices. A product was found with the Agar Ace digested DNA 
embedded plug slice but no products were found with any other D4 gel slice. The PCR 
products were unlike the Chelex-extracted D4 DNA, With C l there was a small 
amount with the gel slice with both the macerated and digested samples. There was 
more PCR product with the digested samples, though as with D4, the PCR products 
differed from the Chelex-extracted DNA.
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9.4 Discussion
9.4.1 Multiple replicons in B. cepacia
Between 1 to 4 large replicons were found in the B. cepacia isolates tested, with a total 
genome size in the range of 2.9 to 7.6 Mb. However, when only those isolates 
possessing multiple replicons were considered then a genome sizes o f 4.7 to 7.6 Mb 
was observed. Lessie et al (1996) found a range o f total chromosomal DNA size of 
between 4.6 to 8.1 Mb in 12 B. cepacia strains using a similar undigested PFGE 
technique but only counted replicons of 0.9 Mb and larger in their estimations, 
considering smaller replicons to be megaplasmids, but in this study all replicons o f or in 
excess of 0.5 Mb were counted in the total genome size, though in both this study and 
that o f Lessie et al (1996) these cut-off figures are arbitrary and only affect seven 
isolates in this study.
43 of the 46 isolates tested (93 %) to possess more than one chromosome. There are 
three possible reasons for the 3 environmental isolates with single replicons. Firstly 
the single replicon isolates may have been mis-identified as B. cepacia, secondly they 
may be B. cepacia strains with single chromosome and a smaller genome or thirdly they 
may have replicons identical or nearly identical in size that have not been separated by 
PFGE. The validity of the final suggestion could be confirmed by two methods. 
Macrorestriction analysis with more rare cutting enzymes such as Swa I or Pac I would 
allow replicon mapping and hence size calculation of the replicon (Rodley et al 1995, 
Lessie et al 1996), or an extended PFGE run time may increase the separation of 
replicons of a similar size.
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The replicon sizes obtained in this study for the species type strain NCPPB 2993 
(ATCC 25416) are close to those obtained by both Rodley et al (1995) and Lessie et al 
(1996) in their studies. In this study chromosomes of 3 .4, 3 .1 and 1.1 Mb were found. 
Rodley et al found replicons of 3.65, 3.17 and L07 Mb by macrorestriction analysis 
along with a 220 kb plasmid, and sizes of 3.5, 3 and 1 Mb with undigested samples and 
the 1 Mb replicon could not be readily seen without irradiation of the sample. In this 
study the corresponding band was faint. Lessie et al found 3.5, 3.1 and 1.1 Mb 
replicons by macrorestriction analysis, with mainly larger sizes of 3.6, 3.4 and 1 Mb 
found in undigested samples.
The replicon structures in the other isolates tested in this survey have not been 
previously investigated. The 12 strains described by Lessie et al were either 
environmental or laboratory strains including the 2, 4, 5-T degrading strain AC1100 
which contained replicons of 3.7 and 2.6 Mb and the toluene degrading G4 which was 
found to contain at least 4 chromosomes and at least 4 large plasmids. No multiple 
chromosomes from strains isolated from CF patients were described and there appears 
to be no work published as yet regarding such structures in these strains In this study 
26 CF isolates were run undigested on PFGE, All were found to contain at least 2 
chromosomes. As with the PCR ribotyping and macrorestriction analysis, a distinct 
pattern was seen in all the Cardiff isolates with the exception of C93. The same 2 
chromosome structure (3.1 and 1.9 Mb) was found in the Cardiff CF isolates, the QC 
isolate C l90, the Dublin CF isolate D2, the Strasbourg CF isolate J543 and the 
Edinburgh CF isolate C l858. This fits the macrorestriction analysis and PCR
ribotyping data, which suggests these isolates, are the same or closely related. C93 
also contained a 3.1 Mb chromosome but had a larger second 2.3 Mb chromosome. 
The 5.0 Mb total genome size was the smallest found in CF B. cepacia isolates. The 
other Dublin, Edinburgh and Strasbourg isolate had sizes of up to 7.6 Mb, with 2, 3 or 
4 replicons. All isolates had different sizes or numbers of chromosomes with the 
exception of the Dublin CF isolates D4 and D5. D4 and D5 were identical by 
macrorestriction analysis and also showed the same 3.1,2.9 and 0.7 Mb replicon 
structure.
Three other type collection strains were also run on undigested PFGE. These were 
found to contain two or three replicons, but did not have as large a total genome size. 
Amongst the environmental strains found in this study no more than 2 replicons were 
found. Generally the genome size in these strains was around 6 Mb with 2 replicons of 
around 3 Mb, though all strains were shown to differ by PCR ribotyping and 
macrorestriction analysis. Other than the 3 strains with the single replicon, the other 
strain that differed was PW14 that had replicons of 3.1 and 1.6 Mb giving a total size 
of 4.7 Mb. 1
A smaller replicon was also seen with several strains. The position of the 251 kb 
plasmid pQMl in PFGE gels would suggest this is a large plasmid. The band is seen in 
a number of strains known to contain large plasmids including Cl and NCPPB 2993. 
However a band is also seen in strains not previously found in this study to contain a 
plasmid such as C l90 and C205. This could be plasmid DNA not detected by the
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methods used in Chapter 5 or some fragments of chromosomal DNA, though as it is 
found consistently in the same strains it appears more likely to be plasmid in nature.
9.4.2 Multiple replicons in other species
A number of bacteria have multiple chromosomes. These include a-proteobacteria 
such as Rhizobium and also p-proteobacteria including a number of Burkholderia 
species. Rodley et al (1995) described multiple replicons in the LMG1199 and 
LMG1201 strains of the P-proteobacterium Alcaligenes eutrophus. In this study 2 
replicons of 3.3 and 3.0 Mb were found va A. eutrophus NCIMB 11842 (synonymous 
with LMG1199), confirming the observations of Rodley et al (1995).
No multiple replicons were detected in B. gladioli by Rodley et al (1995), despite 
being the most closely related species to B. cepacia. In this study 2 replicons of 3.2 
and 3.0 Mb were found in B. gladioli p.v alhcola NCPPB 2478. This suggests that 
multiple replicons are commonplace in Burkholderia species, including B. gladioli, 
and may also be found in closely related p-2 proteobacteria such as Alcaligenes and 
Ralstonia, though more distantly related p-proteobacteria such as Janthinobacterium 
and Herbaspirillium show the more typical structure of a single circular chromosome.
All the y-proteobacteria investigated in this study, E. coli, Ps. aeruginosa and 
Stenotrophomonas maltophilia were found to contain either a single chromosome or, 
as in the case of E. coli, a ‘blur’ by PFGE.
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The presence of multiple chromosomes in both the genus Burkholderia and amongst 
other P-proteobacteria has so far only been studied to a limited extent, with only B. 
cepacia investigated in significant numbers. Future work would require a wider range 
o î Burkholderia strains and other P-proteobacteria to be investigated by PFGE to give 
a better indication of both the frequency of multiple chromosomes and the numbers 
and sizes of such chromosomes. The same is true of B. cepacia strains from CF 
patients. The majority of clinical isolates in this study were also from a single CF 
centre, and therefore may represent only a small number of strains that infect CF 
patients. In the UK alone over 50 different strains infecting CF patients have been 
found by macrorestriction analysis and by ribotyping (Pitt et al 1996), and it is likely 
that many more strains are found world-wide. A more complete survey of both 
American and European strains would be needed to be representative of the B. cepacia 
strains pathogenic to man.
9.4.3 Identification of rRNA genes on replicons by PCR ribotyping
The attempt to determine the presence of rRNA genes on replicons by PCR ribotyping 
was unsuccessful. This could be due to a number of factors. The amount of DNA 
recovered by maceration or digestion from gel slices may be too small for PCR 
detection, though the ammounts observed in the gel would suggest there is sufficient 
DNA in the bands. TheDNA recovered may be too degraded for PCR. The agarose 
itself, particularly analar grades of agarose, may contain impurities that interfere with 
the PCR reaction when released by hydrolysis with Agar Ace or by maceration of the 
gel slices (Promega 1996). The use of TBE buffer may also decrease the yield of PCR 
products by up to two-thirds with AgarAce. The Agar Ace, however seems to be more
effective than maceration, as there was some reaction with these samples though this 
may be a non-specific reaction with degraded DNA from the gel slice.
The detection of rRNA genes (pit opérons) on a replicon would confirm it to be of a 
chromosomal nature. Plasmid DNA does not usually contain rm  opérons (Summers 
1996), so presence of such genes on a replicon would be a better confirmation of a 
chromosome than size alone to determine a plasmid or chromosome as used by Lessie 
et al (1996), particularly in the 0.5 to 1 Mb size range. Southern blotting of PFGE gels 
followed by hybridisation with a 16S - 23 s RNA gene probe has been used to 
successfully used to map rm  opérons on B. cepacia replicons (Cheng and Lessie 1994, 
Rodley et a l 1995, Lessie et al 1996). However such techniques are more difficult and 
time consuming to perform than PCR and also require the use of radioisotopes and/or 
other labelling techniques. PCR ribotyping to map rm  opérons to replicons would be 
therefore more convenient and quick to perform. A number of modifications to the 
technique may improve the results sufficiently to allow its use. Freeze thawing or 
irradiation of samples may increase linearisation of the DNA and hence the amount of 
DNA running in the gel. Changing the agarose to a preparative grade may reduce any 
inhibition, particularly if very accurate size estimation is not necessary. An ethanol 
precipitation step after hydrolysis of the agarose may increase the PCR yield; 
alternatively TAE buffer could be used (Promega 1996). Increasing the amount of 
DNA in the PCR reaction may also improve the yield of PCR products.
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9.4.4 Identification and sizing of multiple replicons : improvements 
and alternatives
A number of improvements or alternatives could be made to both the identification and 
sizing of B. cepacia replicons. As described in previous sections increased 
linearisation either by irradiation or freeze thawing may increase the visibility of 
chromosomal DNA in PFGE gels. The use of macrorestriction mapping as employed 
by both Rodley et al (1995) and Lessie et al (1996) would be beneficial in two ways. 
Firstly more accurate sizing could be achieved, particularly if there are identical or near 
identical sized replicons. Secondly it would provide a restriction map of the 
chromosomes. Although similar techniques were employed in Chapter 8, the enzymes 
used, primarily Xba I, although 'rare cutters' resulted in excess of 30 fragments and are 
difficult to map or size correctly. Enzymes that cut more infrequently such as Swa I 
and Pac I would be more suitable as only a few fragments are produced. For instance 
ATCC 25416 (NCPPB 2993) has 38 Spe I restriction sites, compared with 11 for both 
Swa I and Pac I (Lessie et al 1996). Their high cost, around £ 100 for 200 units, 
prevented their use in this study. Only a few B. cepacia strains have so far been
V
mapped by this method (Rodley et al 1995, Lessie et al 1996). Future work, with an 
appropriate level of funding, could use such methods to map a wider range of B. 
cepacia strains. Used in conjunction with identification of rm  opérons, this would 
provide physical maps of B. cepacia genomes.
The method used to determine size of replicons was relatively successful with the R2 
value, the correlation coefficient, having a mean value of 99.0 %, indicating a good 
degree of fit for the molecular size against distance migrated. As with the plasmid size
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estimation the biggest problem was estimation of size of the replicons larger than the 
biggest size standard, although with the PFGE this was mot as significant as the largest 
replicon was only 0.4 Mb larger than the 3.13 Mb H. wingei size marker. As with the 
plasmid size estimation, extrapolation of the regression equation was used to estimate 
the largest and smallest replicons. Extrapolation of the regression equation was only 
used after considering the excellent degree of fit and low variation obtained, and that 
the values were only marginally larger than those of the standards. This gave sizes of 
replicons in the type strain (NCPPB 2993/ACTC 24516) consistent with those 
published (Rodley et al 1995, Lessie et al 1996). The H. wingei marker and 
electrophoresis conditions used gave good and reliable results over a range of 1 to 3 .1 
Mb. However there was some difficulty in the 3.1 to 3.6 Mb size range both due to 
the lack of a direct size comparison described above, and the poor separation of larger 
replicons in this size range. An increased electrophoretic run time may increase 
separation of the larger replicons, though this may adversely affect smaller sizes. To 
overcome the marker problem, a second larger marker such as Schizosaccharomyces 
pombe could be used. This would cover a broader size range as Schizosacch. pombe 
possess chromosomes of 3.5 to 5.7 Mb (Bio-Rad 1992). A set of electrophoretic 
conditions between those used for Schizosacch. pombe and H. wingei size markers 
could be used with both markers on a single gel, or alternatively 2 gels could be run, 
the first with H. wingei marker and conditions suitable for that marker, the second with 
Schizosacch. pombe marker and conditions suited to that. Though this would be more 
costly and time consuming it should give accurate size determination for all replicon 
sizes. The S. cerevisiae marker could also be used to more accurately determine the 
smaller replicons.
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Despite the problems in accurate size determination the data in this study indicates the 
vast majority of A  cepacia strains have a genome consisting of 2 or more replicons, 
with 93 % of strains tested in this study having this organisation. The distribution of 
replicons in B. cepacia (Figure 9.1) also indicates that a 2 replicon structure is the most 
prevalent organisation of chromosomes in B. cepacia.
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Chanter 10 General discussion and conclusions
10.1 B. cepacia in the environment
It would be fair to state that B. cepacia is primarily an environmental bacterium, with 
its natural habitat being soils, waters and vegetation. Recovery rates of around 20% in 
this and other studies (Butler et a l 1995) from soil, water and rhizosphere samples are 
considerably higher than recovery rates from surveys in more ‘urban’ areas (Fisher et al 
1993, Mortensen et al 1995).
There would appear to be great genetic and phenotypic variability in environmental 
populations of B. cepacia. Variability in phytopathogenicity has been previously 
described (Gonzalez and Vidaver 1979, Yohalem and Lorbeer 1994, Butler et al 1995). 
Although in this study it was demonstrated that environmental strains can cause in vitro 
maceration of onion tissue, the levels of maceration vary greatly from no apparent 
maceration, to levels of maceration similar to that of the type strain/pathotype NCPPB 
2993.
V
Genetic variability in an environmental population of B. cepacia has been previously 
reported (Wise et al 1996). In this study high levels of genetic variability were found. 
Each of the 21 isolates obtained from the environment in the course of this study, and 
the environmental isolates from the various type collections were found to differ both 
by PCR ribotyping and by macrorestriction analysis. It was notable that no identical 
isolates were obtained at the same survey site or within the same sample using different 
isolation media indicating variability of B. cepacia even within a sample. Despite
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differences by the molecular typing techniques, replicon analysis by undigested PFGE 
revealed similar replicon structures in the majority of environmental strains with 2 
replicons in the region of 3 Mb each. It would appear that this replicon structure is 
common amongst South Wales environmental strains. The typing differences could be 
due to rearrangements of the genome or incorporation of genetic material promoted by 
the IS element rich, highly plastic genome of B. cepacia. Future work could 
investigate the presence of IS elements, either by looking in sequences of 5. cepacia 
DNA for the terminal repeats that flank IS elements, the presence of 17 kb (Ferrante 
and Lessie 1991) and 26 kb (Byrne and Lessie 1994) repeats having been shown in B. 
cepacia IS elements. Alternatively known IS elements could be use as the basis of 
genetic probes in hybridisation (or PCR) studies to determine their presence. The first 
method has the advantage of also detecting IS elements from new IS families, or IS 
elements with sequences differing significantly from known IS element sequences.
Plasmids would appear to be reasonably common in environmental strains of 5. 
cepacia, with 11 of 28 strains (39% ) found to harbour plasmids, though this is 
somewhat lower than the 65 % of the clinical isolates found to harbour plasmids. 
However greater numbers of strains would need be screened for detailed analysis of the 
rate at which plasmids are found in environmental and clinical strains. A notable point 
regarding both the distribution of plasmids and B. cepacia in the environment was 
raised by the results of this study. Considering recovery rates using Mast PC medium 
alone, the levels of 5. cepacia found in the polluted industrial regions of S. Wales are 
considerably higher than those of the unpolluted Brecon Beacons National Park, a 24 
% recovery rate compared with 8 %. The plasmid content is considerably higher at
300
polluted sites, some 71 % of isolates at polluted sites were found to harbour plasmids 
compared with 13 % amongst isolates from clean sites. This is in agreement with 
Burton et al (1982), who found higher levels of pseudomonads in polluted stretches of 
the River Ely in South Wales (18 % of total isolates) compared with clean stretches (7 
% of isolates), though no significant differences in plasmid content were found between 
the sites.. It may be that the higher levels o fB. cepacia found in polluted sites are a 
result of the highly versatile bacterium occupying an ecological niche due to its ability 
to degrade a number of chlorinated and organic pollutants that are recalcitrant to 
breakdown by other bacteria and may inhibit their growth. Plasmids found in isolates at 
such sites could encode for some of these degradative properties, or for resistance to 
heavy metals such as mercury that may contaminate soils and rivers in the vicinity of 
old mineworldngs, coking works or other industrial sites. A number of mercury 
resistance plasmids having been described in B. cepacia including one from a strain 
from the River Taff in S. Wales (Rochelle et al 1988). The strains PW2 and PW7 
found to contain multiple plasmids were found at pollutes sites; PW2 downstream of 
the site of abandoned mineworldngs and slag heaps, PW7 downstream of the former 
Coed Ely coking works, a site reported as having high levels of organic and toxic 
contamination, suggesting the possibility of some of these plasmids encoding for 
degradation or resistance to toxins. Although, as described in Chapter 5, the levels of 
plasmid DNA isolated were insufficient to allow restriction mapping ( or sequencing), 
the plasmid bands on the gel electrophoresis were of sufficient quality and clarity to be 
used Southern blotting and hybridisation either with well characterised degradative 
plasmids such as NAH or TOL (Day 1982), or with B. cepacia degradative plasmids 
such as TOM ( Shields et al 1995) or pBAHl (Haak et a / 1994). The implication of
the role of IS elements in the degradative ability of B. cepacia could also be 
investigated by future work (Haugland e ta l 1991, Lessie et al 1996), particularly in 
strains such as PW2 and PW7.
10.2 Relationship between clinical and environmental strains of 
B. cepacia
As mentioned in the introduction there is considerable controversy regarding the 
possibility of the environment acting as a reservoir of B. cepacia with potential to cause 
infection in man. Though some groups have claimed that environmental strains are 
incapable of causing human infections (Bevivino et al 1994), the evidence that B. 
cepacia is the causative agent o f ‘swamp foot* (Taplin e ta l 1971), and more recent 
evidence of infections in CF patients from environmental sources (Cazzola et al 1996, 
Amalfitano et a l 1996) add considerable weight to the need for caution in the use oîB . 
cepacia as an agent of biocontrol or bioremediation (Butler et al 1995, Govan et al 
1996).
Phenotypic and genetic variability between clinical and environmental strains of A 
cepacia has been described by a number of groups (Gonzalez and Vidaver 1979, 
Yohalem and Lorbeer 1993, Butler e ta l 1995, Vandamme 1995). In this study 
phytopathogenicity to onion was largely confined to environmental strains, with 
clinical (CF) strains generally being poor pathogens of onion . Such results were also 
found by Gonzalez and Vidaver (1979). However a small number of CF strains, most 
notably 2 strains from the Edinburgh CF centre, demonstrated a high level of pathology 
against onion. A number of strains from this centre have previously been shown to
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cause a high degree of onion maceration in vitro (Butler et al 1995). Differences in 
the levels of antibiotic resistance between clinical and environmental strains of B. 
cepacia were also found in this study, with in general lower levels of antibiotic 
resistance amongst environmental strains. This is in broad agreement with Butler et al 
(1995) who found that MIC levels to a number of antibiotics were higher in clinical 
strains. It should be noted that considerable differences in the MIC levels to individual 
antibiotics, or groups of antibiotics were observed for B. cepacia CF strains from 
different centres. Strains from the Edinburgh CF centre had high levels of resistance to 
aminoglycoside antibiotics, but relatively low MIC levels for P-lactam drugs. The 
reverse is true in the Cardiff CF centre where in general there were higher MIC levels 
to p-lactams, but considerably lower MIC values than the Edinburgh isolates to 
aminoglycosides. This may well be a reflection of prescribing practice at these centres 
(Govan and Nelson 1992). It is also true to say that virtually all B. cepacia strains 
show intrinsic resistance to many antibiotics, including aminoglycosides. It is certainly 
possible that the differences observed in antibiotic resistance both amongst clinical 
populations of B. cepacia, and between clinical and environmental strains are as a 
result of exposure to antibiotics in antimicrobial therapy rather than being due to any 
fundamental differences between clinical and environmental strains. It would be of 
interest to investigate whether long-term exposure to antibiotics would lead to the 
development of acquired resistance in environmental strains, giving equivalent levels of 
resistance to strains from CF patients.
Genetically the majority (93 % of tested isolates) of both clinical and environmental B. 
cepacia isolates investigated in this study have a genomic structure consisting of 2 to
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5 multiple replicons or chromosomes. The use of molecular typing techniques, PCR 
ribotyping and macrorestriction analysis, reveal considerable variation both within and 
between clinical and environmental populations of B. cepacia. Two main points 
emerged from these results. Firstly there was no common identity found between any 
of the clinical and any environmental strains supporting the claims of Bevivino et al
(1994), though similarity between clinical and environmental strains was found with 
both the PCR products and macrorestriction digest patterns. This was particularly the 
case with the Edinburgh CF strains Secondly, a common molecular type or clone 
occurs in the majority of Cardiff CF isolates tested in this study, which is also found in 
isolates from patients attending the Dublin, Strasbourg and Edinburgh CF centres. 
These results would suggest the isolates have a common source, and have been spread 
by direct or indirect person to person transmission. There is strong evidence that such 
transmission occurs amongst CF patients (Millar-Jones et al 1992, Govan et al 1993, 
Smith ef a / 1993).
Both clinical and environmental isolates were found to harbour plasmids, though as 
mentioned previously they would appear to be more common in clinical isolates. 
Although in this study there is evidence of antibiotic resistance plasmids, the majority 
of plasmids in B. cepacia are described as cryptic, the phenotypic property or 
properties encoded being unknown. Those that have been described are mostly large 
degradative plasmids from environmental B. cepacia strains. Lennon and DeCicco
(1991) described a number of large plasmids (up to 222 kb) in strains of clinical or 
pharmaceutical origin, and suggested they played a significant role in the antibiotic 
resistance of such strains, though no phenotypes were assigned. However they failed to
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detail that several of the environmental strains harboured plasmids of similar sizes (208 
and 212 kb). In this study large plasmids were found in both clinical and 
environmental strains, many of the largest plasmids (130 kb to in excess of 250 kb) 
being found in environmental strains though the failure to isolate sufficient plasmid 
DNA prevented any investigation into whether any plasmids were common to more 
than one isolate. Future work may develop better isolation techniques so plasmids 
could be mapped by restriction analysis, or alternatively, a limited number could be 
isolated (possibly by density gradient ultracentrifugation), and used as probes to 
investigate relatedness of plasmids in different isolates.
Overall there appear to be a number of genetic and phenotypic differences between and 
within populations of clinical and environmental strains, adding weight to the 
suggestions of different genomovars within the species of B. cepacia, or even that B. 
cepacia is in fact a number of separate species such as B. multivorans (Vandamme 
1995, Govan et al 1996, Revets et al 1996, Vandamme et al 1997). The evidence of 
this study would point to differences between clinical and environmental strains, and 
that * environmental B. cepacia1 is distinct from the strains that infect CF patients.
This would suggest that B. cepacia in the environment poses little or no risk to CF 
patients. The evidence in this study suggests that the source of B. cepacia infecting CF 
patients in South Wales is not the local environment but rather via person to person 
transmission. This is strengthened by the fact that identical or very closely related 
strains have been found to infect CF patients from a number of centres. However this 
does not explain where the infective strains of B. cepacia originally came from. More 
detailed PCR ribotyping studies suggest that the Cardiff CF isolates may consist of up
to 7 different ribotypes (Ryley et al 1995), the evidence of the 2 typing techniques and 
replicon analÿsis used in this study indicates they are extremely closely related, if not 
identical. Despite the evidence in this study it would be rather naive, and arguably 
foolish, to firmly conclude that the environment is of no risk to CF patients in terms of 
acquiring a B. cepacia infection, particularly considering recent evidence of 5 . cepacia 
acquisition from the environment (Govan et al 1996, Cazzola et al 1996). Extensive 
phylogenetic surveys of B. cepacia throughout Europe and North America would be 
required to make such a conclusion and it is of interest and possibly concern, that some 
CF isolates more resemble environmental isolates than those from the Cardiff CF 
centre. Some of the Edinburgh CF isolates are arguably more closely related to the 
type strain NCPPB 2993/ACTC 25416 bn the basis of PCR ribotyping, 
macrorestriction digest pattern, antibiotic resistance patterns and phytopathogenicity.
In addition, Johnson et a l (1994) demonstrated a high degree of genetic relatedness 
between the ET 12 epidemic strain and the type strain by multilocus enzyme 
electrophoresis. The fact that spontaneous cases of B. cepacia infection arise amongst 
CF patients despite strict segregation of infected individuals would suggest there is an 
environmental source of B. cepacia (Govan et al 1996, Cazzola et al 1996). Such a 
source may represent a small sub-population of B. cepacia in the environment and that 
environmental surveys such as those conducted in this study have failed to detect such 
a group as yet. Though the evidence in this study does not indicate the environment is 
a source of B. cepacia it would appear to be wise advice to proceed with caution in the 
use of B. cepacia as an agent of biocontrol or bioremediation, at least until it is 
conclusively shown that such B. cepacia strains are of no risk to CF patients. An 
increased phylogenetic understanding of the species, whether as separate genomovars
or indeed species may help in coming to a firm conclusion. The development of animal 
models, such as cystic fibrosis mice (Wilson and Collins 1992), may allow the 
pathogenicity of B. cepacia strains to be studied and Koch's postulates to be tested and 
confirm whether environmental strains of B. cepacia are pathogenic, something that 
obviously cannot be undertaken with cystic fibrosis patients. The cftrm  1 HGU mutant 
CF mouse appears to be a possible candidate for such studies as it fails to clear B. 
cepacia or S. aureus from the lungs and displays lung disease and mucus retention in 
response to repeated microbiological exposure (Davidson et al 1995).
10.3 Genetic organisation of B. cepacia
In this study three main areas of genetic interest were investigated; the presence and 
biology of plasmids in B. cepacia, the organisation and size of the B. cepacia genome 
and the use of molecular typing to determine the relationship of different strains.
From this study and others it is clear that plasmids are commonly harboured by B. 
cepacia strains of both clinical and environmental origins ( Gonzalez and Vidaver 1979, 
McKevitt and Woods 1984, Lennon and DeCicco 1991). Despite difficulties in the 
isolation of plasmid DNA it would appear that more than half of all B. cepacia isolates 
contain plasmids. 52% of isolates in this study were found to contain plasmids, whilst 
both Gonzalez and Vidaver and Lennon and DeCicco found plasmids in over 80% of 
isolates. It is notable that the majority of B. cepacia plasmids are large, mostly in 
excess of 100 kb, but that very few have been assigned a phenotypic trait. This is 
particularly true of antibiotic resistance plasmids where there are few reports of such 
plasmids being found in B. cepacia. In this study there is strong evidence of plasmid
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encoded resistance to p-lactam antibiotics. This was demonstrated by curing studies in 
Chapter 6 where loss of resistance to the ureidopenicillin piperacillin was accompanied 
by plasmid loss. Mating experiments also indicated the conjugal transfer of resistance 
to piperacillin, though transfer of a plasmid could not be confirmed. Transformation of 
sensitive host bacteria with plasmid DNA accompanied by an increased resistance to 
piperacillin, or another antibiotic, would confirm an antibiotic resistance phenotype.
The failure to obtain sufficient plasmid DNA prevented the use of transformation in this 
study.
Lennon and DeCicco (1991) suggested the presence of antibiotic resistance plasmids in 
B. cepacia, but did not assign a phenotype to any plasmids. It would appear that the 
apparent absence of antibiotic plasmids in B. cepacia is due to a lack of investigation 
into such plasmids rather than the plasmids not occurring in the bacterium (Wilkinson 
and Pitt 1995b). The evidence of plasmids commonly encoding for ^-lactamases in Ps. 
aeruginosa (Prince 1986), and the fact that these plasmids are largely of the Inc-P 
incompatibility group adds weight to the argument that .such plasmids may occur in B. 
cepacia. Many plasmids described in B. cepacia are Inc-P plasmids (Haak et al 1995, 
Bhat et al 1995), and in this study the transfer of Inc-P plasmids in B. cepacia has been 
demonstrated, indeed transfer of the antibiotic resistance plasmid RP1 from a Ps. 
aeruginosa donor to a B. cepacia recipient was shown.
Conjugative transfer of plasmids into and between B. cepacia strains, and from B. 
cepacia to other species was clearly demonstrated in this study. Though the transfer of 
broad host range plasmids in B. cepacia described above has previously been
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demonstrated (Rochelle et al 1988, Lennon and DeCicco 1991, Sabate et al 1984), the 
transfer frequencies found in this study were higher ; as high as 10"* per donor for the 
transfer of pQKH6 from B. cepacia NCIMB 9092 to an £  coli recipient. In this study 
transfer into and from B. cepacia of both clinical origin, C93, and environmental origin, 
NCIMB 9092, was demonstrated showing the possibility of horizontal genetic transfer 
by conjugation both in the environment and in clinical situations. Considering the 
highly plastic nature of the B. cepacia genome, such transferred DNA could be 
incorporated into the genome; this possibly being the reason why there was no 
detection of plasmid DNA accompanying the transfer of piperacillin resistance.
One of the most striking features of B. cepacia is the size, organisation and variability 
of its genome. In this study genome sizes of up to 7.6 Mb were found by PFGE, and in 
other studies genomic sizes of over 8 Mb have been reported (Lessie et al 1996). This 
is considerably larger than other Gram negative bacteria, for example the genome of 
Helicobacter pylori ( Tomb e ta l 1997) is around 1.7 Mb and that of E. coli K-12 is 
around 4.6 Mb (Blattner et al 1997). The complexity of the genome is also unusual, 
organised into between 2 to 4 circular chromosomes. As outlined in both the 
introduction and Chapter 9, this occurs in a number of species, including the a- 
proteobacteria Agrobacterium and Rhizobium. Rodley et al (1995) found multiple 
chromosomes by PFGE in B. cepacia, Alcaligems eutrophus and other Burkholderia 
species, though not in B. gladioli.
In this study 45 of 48 B. cepacia isolates tested were found to contain 2 or more 
chromosomes by PFGE. This, along with the description of multiple chromosomes in
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12 environmental B. cepacia strains shown by Lessie et al (1996), would indicate that 
this is feature of both clinical and environmental B. cepacia. The evidence of Rodley 
e ta l (1995), along with the discovery in this study of chromosomes of 3.2 and 3.0 Mb 
in A  gladioli NCPPB 2478 and the confirmation of 3.3 and 3.0 Mb chromosomes in
A. eutrophus NCIMB 11842 would suggest that multiple chromosomes are a feature 
of the genus Burkholderia, and may be common throughout P-2 proteobacteria. The 
failure to detect multiple chromosomes in £  coli, Ps. aeruginosa or Stenotrophomonas 
maltophilia would indicate that this is probably not a feature ofy-proteobacteria.
Considerable variation in the size of the genome and numbers of chromosomes was 
found both by Lessie et a l (1996) and in this study. The size of the genome would 
appear to vary between around 4 to 8 Mb, with 2 to 4 replicons of less than 
1 Mb to more than 5 Mb in size. This large genome size may be a consequence of the 
high plasticity of the IS element rich genome of B. cepacia. The acquisition of 
* foreign* DNA such as plasmids or transposons mediated by the IS elements may lead 
to an increasing genome size. This plasticity may also play a major role in the wide 
ranging nutritive and degradative properties oîB . cepacia. There is strong evidence 
that genes involved in the degradation of 2, 4, 5-T were acquired in such a manner 
(Lessie et al 1996). However this does not explain the differences in chromosome 
numbers. Although there is evidence that smaller replicons may recombine to form 
larger structures (Lessie et al 1996), no common macrorestriction fragments were 
found in the 3 replicons of the type strain ACTC 25416 (NCPPB 2993) during physical 
mapping with very rare cutting restriction enzymes. This lack of a common genetic 
sequence would indicate that the chromosomes are not deleterious derivatives of a
larger chromosome ,or fragments of a larger chromosome broken in sample processing 
(Rodley et cd 1995, Lessie et al 1996). This would suggest that the B. cepacia genome 
consists of a number of distinct chromosomes, with genes on each chromosome 
encoding essential functions. The assignment of essential genes to different replicons, 
particularly the assignment of rRNA genes to each of the 3 major replicons in the type 
strain supports this statement (Cheng and Lessie 1994, Rodley et al 1995, Lessie et al 
1996). It has been suggested that the chromosomes may behave rather like a number 
of large plasmids, rather than like the more usual ‘single* chromosome. Each 
chromosome may have a different replication control mechanism, and it may be 
possible to transfer whole chromosomes between cells by conjugal transfer in the 
manner of a plasmid (Lessie et al 1996). Such a situation requires a firm definition of a 
plasmid, particularly in view of smaller chromosomes of less than 1 Mb. It may be 
argued that a plasmid should be defined as a replicon carrying genes non-essential to 
growth in ‘normal* or ‘good*conditions but gives the advantage of allowing growth in 
certain circumstances such as the presence of antibiotics or heavy metals, rather than on 
the basis of size employed by Lessie et al (1996). As mentioned in Chapter 9, the 
mapping of rRNA genes to a replicon, either by hybridisation o r , as attempted in this 
study, by the use of PCR with primers for the rRNA genes, would allow confirmation 
as a replicon of a chromosome rather than a megaplasmid.
The reason for the multiple chromosome structure is unknown, though the rather neat 
theory that the large genome of B. cepacia makes it advantageous to have such a 
structure has been put forward (Lessie et al 1996). The time required for the 
replication of several small circular replicons, particularly if each has an independent
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control mechanism, would be less than for a single large replicon; important for a 
(relatively) rapidly proliferating bacterium such as B. cepacia. Smaller replicons may 
allow greater fidelity of replication, and if under independent control, greater flexibility 
in the control of replication and segregation of chromosomes in cell division. More 
detailed information regarding the organisation of genes upon the replicons, their 
replication and replication control, and how chromosomes segregate in cell 
proliferation would be required to understand the biology and the requirement for such 
genetic organisation in bacteria.
10.4 Conclusions
A number of conclusions may be reached on the basis of the results in this study.
Firstly that B. cepacia has a large genome of up to 8 Mb that is highly variable and 
arranged into between 2 to 4 chromosomes of varying size. This arrangement was 
observed for both clinical and environmental strains. Multiple chromosomes were 
found in both B. gladioli and A. eutrophus in this study, and along with the results of 
Rodley et al (1995), this would indicate that such genetic arrangements are common in 
the genus Burkholderia and possibly throughout p-2 proteobacteria.
Plasmids are commonly found in B. cepacia, particularly large plasmids, but appear to 
be more common in clinical strains. It also appears that plasmids are more commonly 
found in environmental strains from polluted sites than in ‘clean* sites. There is strong, 
but not conclusive, evidence of antibiotic resistance plasmids in B. cepacia. Transfer of 
plasmids by conjugation can be demonstrated to occur from other species into B. 
cepacia, between B. cepacia strains and from B. cepacia to other species.
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B. cepacia is higltly variable in both genetic and phenotypic properties. There is a high 
degree of variability within and between clinical and environmental populations.
Typing by PCR ribotyping and macrorestriction analysis showed a high level of 
variability in strains found in the environment throughout South Wales. This indicated 
21 different strains of & cepacia had been isolated, with no single strain being isolated 
at another sample site, or in the same sample using different isolation media. A total 
recovery rate of 18% from the environment was considerably higher than those of 
previous, more urbanised studies (Fisher et al 1993, Mortensen e ta l 1995), confirming
B. cepacia is primarily an inhabitant of soils, waters and vegetation. Higher recovery 
rates were also found at polluted sites, suggesting B. cepacia fills such an ecological 
niche, probably as a result of its degradative properties.
Typing of isolates also indicated there is no evidence of transmission of B. cepacia 
from the local environment to CF patients in South Wales. However, there appears to 
be a common ‘clone’ within the Cardiff CF population.. This ‘clone’ is also found at CF 
centres in Scotland, Ireland and France. This suggests that there is person to person 
transmission within the Cardiff CF population (This has previously been described by 
Millar-Jones et al [1992]), and also between patients at different CF centres. Such 
transmission could occur through social contact, such as CF patient meetings, or 
particularly with younger patients from different centres, at events such as CF summer 
camps.
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The high levels of variation in B. cepacia, particularly differences in phenotypic and 
genetic organisation between environmental and clinical strains of B. cepacia add 
weight to suggestions for the need for greater phylogenetic division in B. cepacia and 
raises questions regarding the evolution of the forms of B. cepacia pathogenic to man. 
Differences both in clinical and environmental strains of A  cepacia have been used to 
place the species into 4 or 5 distinct groups or genomovars (Vandamme 1995, Govan 
et a l 1996, Revets et a l 1996, Vandamme et a l 1997). The majority of environmental 
strains, including the type strain, fall into genomovar I, whilst the CF epidemic strain 
M s into genomovar HI. It can be said there are fundamental differences in the 
properties of genomovar I and genomovar m , and it must be considered whether these 
are in fact the same species. The strains pathogenic to man have developed distinct 
mechanisms to cause infection and the pathological damage associated with the 
infections. This allows the in vitro adherence and invasion of cells, not found in 
environmental strains (Bevivino et al 1994, Bums et a l 1996a). However such strains 
are unable to macerate onion tissue, something that can be achieved by many 
environmental strains.
It is also notable that infections in some CF patients attributed to B. cepacia have 
subsequently been found to be caused by at least 3 other Burkholderia species, B. 
vietnamensis and two others that cannot be differentiated by conventional means such 
as API 20NE (Vandamme 1995, Govan et al 1996). It is also, significant that a 
multiresistant Burkholderia having properties of both B. cepacia and B. gladioli has 
been found infecting a CF patient (Simpson et al 1994). It was also speculated that the 
infective forms of B. cepacia may have evolved through horizontal transfer of genes
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such as virulence genes from closely related species, or through the evolution of 
bacterial hybrids. There could be a strong argument that the ET 12 epidemic strain has 
features of B. pseudom allei, being an intracellular pathogen (Bums et al 1996a), and 
in causing a severe necrotising pneumonia (Tomashefski et al 1988), that is reminiscent 
of the necrotising condition found in meliodosis. Such evidence would indicate that lB, 
cepacia' infection may be caused by several closely related species that have different 
levels o f inactivity and pathology and differ from ‘true* B. cepacia, the phytopathogen 
of onion described by Burkholder.
The difficulty in separating these ‘species’ by conventional means has lead to the 
proposed genomovars, though as typing by a molecular basis becomes more 
widespread and better developed, it can be concluded that further taxonomic division 
of the B. cepacia complex within the genus Burkholderia is likely to occur. It is likely 
that B. cepacia should be used to describe strains that currently fall into genomovar I 
(phytopathogenic environmental strains like the type strain), and other genomovars
renamed, hence the proposal of B. mz//Z/Vora«5(Vandamme et a l 1997). The species,
%
several species or sub-species that infect CF patients could be renamed, possibly 
reflecting their properties, though as described by the authors themselves, the 
suggested name of 'Burkholderia cfei ' may not be entirely appropriate (Govan et al 
1996).
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Appendix I Reagents and Media
Reagents 1 Analar* or ’molecular biology grade' unless stated otherwise.
TB-T selective medium (Hagedom et al 1987)
Per litre in distilled/deionised water:
20 g bacteriological agar (Oxoid,Unipath, Basingstoke, Hants)
2 g glucose (BDH, Poole, Dorset)
1 g L-asparagine (BDH, Poole, Dorset)
IgNa HCO3  (BDH, Poole, Dorset)
500 mg KH2  PO4  (BDH, Poole, Dorset)
100 mg Mg SO4  (BDH, Poole, Dorset)
50 mg Trypan blue (BDH, Poole, Dorset)
20 mg Tetracycline (Sigma Chemical Co., Poole, Dorset)
5 mg Crystal Violet (BDH, Poole, Dorset)
Adjust to pH 5.5 with 10 % phosphoric acid (BDH, Poole, Dorset), then sterilise by 
autoclaving at 15 p.s.i, 121°C for 15 mins.
TE Buffer (Sambrook et al 1989)
Per litre in distilled/deionised water: v
1.21 g Tris (hydroxymethyl)methylamine (Sigma Chemical Co., Poole, Dorset)
0.372 g EDTA(Ethylenediaminetetra-acetic acid (disodium)) (BDH, Poole, Dorset)
Adjust to pH 7.5 with NaOH, then sterilise by autoclaving at 15 p.s.i, 121 °C for 15
mins.
TBE Buffer
Per litre in distilled deionised water:
10.8 g Tris (Sigma Chemical Co., Poole, Dorset)
0.55g Boric acid (Sigma Chemical Co., Poole, Dorset)
0.74 g EDTA (BDH, Poole, Dorset)
Adjust with NaOH/NaCl to pH 8.0 
Lysing solution (Kado and Liu 1981)
0.15 g Tris (Sigma Chemical Co., Poole, Dorset)
Sodium dodecyl sulphate (SDS) (Sigma Chemical Co., Poole, Dorset)
425 pi 2MNaOH (BDH, Poole, Dorset)
25 ml deionised/distilled water
Tris was dissolved in the deionised water by stirring, before the SDS was added and 
dissolved by stirring. The NaOH solution was added last to give a pH of 1 2 .6 . All 
mixing was done gently on a magnetic stirrer to prevent the SDS coming out of 
solution. The mixture was kept for up to 48 h at room temperature.
Set Buffer (Rodriguez and Tait 1983)
20 % w/v sucrose in distilled water (BDH, Poole, Dorset)
50 mM Tris-HCl pH 7.6 (Sigma Chemical Co., Poole, Dorset)
50 mM EDTA (BDH, Poole, Dorset)
Mix to dissolve, filter sterilise.
Lytic Mixture (Rodriguez and Tait 1983)
2 % SDS(BDH, Poole, Dorset)
0.4 M NaOH (BDH, Poole, Dorset)
Mix equal quantities before use. Store solutions at room temperature. No need to 
autoclave.
Ribonuclease solution (Rodriguez and Tait 1983)
10 pi of lOmM Tris at pH 7.6 (Sigma Chemical Co., Poole, Dorset)
7.5 pi of 15 mM NaCl (BDH, Poole, Dorset)
Ribonuclease A (Sigma Chemical Co., Poole, Dorset)
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500|il distilled/deionised water
Mix and heat to 100 °C for 10 mins. Allow to return to room temperature slowly. 
Store frozen at -20°C.
Sodium acetate buffer (Rodriguez and Tait 1983)
3 M Sodium acetate (Sigma Chemical Co., Poole, Dorset)
4.92 g of sodium acetate was added to 1 0  ml of deionised water. The pH was adjusted 
to 4.8 with approximately 10 ml of glacial acetic acid (BDH, Poole, Dorset).
Alkaline dodecyl sulphate (Birnboim 1983)
1% w/v SDS in deionised water (Sigma Chemical Co., Poole, Dorset)
0.2 M NaOH (BDH, Poole, Dorset)
Mix together at appropriate concentrations. Keep at room temperature for up to a 
week.
Lysozyme solution (Birnboim 1983)
50 mM Glucose (BDH., Poole, Dorset)
lOmM EDTA (Sigma Chemical Co., Poole, Dorset)
25 mM Tris-HCl (Sigma Chemical Co., Poole, Dorset)
Adjust pH to 8.0 with HCl/NaOH. Stores indefinitely at room temperature. Add 
lysozyme (Sigma Chemical Co., Poole, Dorset) at 1 mg ml' 1 prior to use.
Acetate-MOPS solution (Birnboim 1983)
0 .1 M sodium acetate (Sigma Chemical Co., Poole, Dorset)
0.05 M MOPS (morpholinopropanesulphonic acid) (Sigma Chemical Co., Poole, 
Dorset).
Adjust to pH 8.0 with NaOH. Store indefinitely over a drop of chloroform.
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High-salt solution (Birnboim 1983)
29.4 g potassium acetate (Sigma Chemical Co., Poole, Dorset)
95 ml distilled/deionised water 
5 ml of 90 % formic acid (BDH., Poole, Dorset)
Store at room temperature
Loading buffer
Bromocresol purple (0.25%) in 50% glycerol with 0.05 M tris acetate pH 7.9. Stores 
indefinitely at 4 °C.
Luria Bertani (LB) medium (Sambrook et a l 1979)
Per litre:
950 ml deionised water
10g Bacteriological peptone (Oxoid, Unipath, Basingstoke, Hants)
5 g Bacteriological yeast extract (Oxoid, Unipath, Basingstoke, Hants)
10 g sodium chloride (BDH, Poole, Dorset)
Dissolve the solid and adjust to pH 7.0 with 5 M NaOH (around 0.2ml). Adjust the 
volume of the solution to 11 with deionised water. Sterilise by autoclaving at 15 p.s.i, 
121  6C for 15 mins.
LB-Miller medium (Qiagen Ltd. 1995)
1 1  deionised water
10g Tryptone (Oxoid, Unipath, Basingstoke, Hants)
5 g Bacteriological yeast extract (Oxoid, Unipath, Basingstoke, Hants)
10 g sodium chloride (BDH, Poole, Dorset)
Prepare as for LB medium.
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SE buffer (Grouthes and Tummler 1991)
4.3 g sodium chloride (BDH, Poole, Dorset)
9.3 g EDTA
Dissolve in 950 ml of deionised water. Adjust pH to 7.5 with NaOH. Make up to 11 
with deionised water. Sterilise by autoclaving at 15 p.s.i, 121°C for 15 mins.
N-lauroyl sarcosinate EDTA lysing solution (Grouthes and Tummler 1991)
1 g N-lauroyl sarcosine (Sigma Chemical Co., Poole, Dorset)
18.75 g EDTA (BDH, Poole, Dorset)
Dissolve solids in 75 ml deionised water. Adjust to pH 9.5 with NaOH pellets. Adjust 
volume to 100 ml with deionised water. Filter sterilise, and store at 4 °C for up to 12 
weeks. Prior to use add 40 pi ml"1 of 12.5 mg ml'1 proteinase K stock solution, 
prepared in sterile deionised water and stored at -70 °C .
Trace elements solution (Burton e t a t 1982)
Per litre in deionised water:
2 .0 gNaHC0 3 .10H20  
0.3 g MnS04. 4H20  
0 .2  g (CHsCO^ Zn.2H20  
0.02 g (NH^Mo^D^ . 4H20  
0.5 g CuS04. 5H20  
0.5 g CoC12. 6H20  
0.2gAl(S04)3 
0.5 g Fe(NH4)2S04
350
Appendix II  Composition of reagents in commercial plasmid isolation kits
Qiagen plasmid and Oiafilter kit»
Buffer PI
100 RNase A ‘
50 mM Tris-HCl 
10 mM EDTA 
pH 8.0 : Store at 4 °C
Buffer P2
200 mM NaOH 
1 % SDS
Store at room temperature 
Buffer P3
2.55 mM Potassium acetate 
pH 4.9 : Store at room temperature
Buffer QBT
750 mM NaCl
50 mM MOPS
15% ethanol
0.15 % Triton-X-100
pH 7.0 : Store at room temperature
Buffer QC
1 M NaCl
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50 mM MOPS 
15 % ethanol
pH 7.0 : Store at room temperature
Buffer QF
1.25 M NaCl 
50 mM MOPS 
15 % ethanol
pH 8.2 : Store at room temperature 
Promeus Wizard plasmid miniprep kit
Cell resuspension solution
50 mM Tris-HCl 
10 mM EDTA 
100 pg mlRNAse A 
pH 7.5
Cell lysis solution
0.2M NaOH 
1 % SDS
Neutralization solution
1.32 M Potassium acetate 
pH 4.8
TE Buffer
10 mM Tris-HCl
ImMEDTA 
pH 7.5
Column wash solution 
200 mM NaCl 
20 niM Tris-HCl 
5 mMEDTA 
pH 7.5
Dilute with 95 % ethanol to give 55 % ethanol concentration.
